Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

28 Jul 2017 07:00

RNS Number : 3715M
Barclays PLC
28 July 2017
 

 

Barclays PLC

Results Announcement

 

30 June 2017

 

 

Table of Contents

 

Results Announcement

Page

Notes

1

Performance Highlights

2-4

Group Chief Executive Officer's Review

5

Group Finance Director's Review

6-9

Results by Business

 

• Barclays UK

10-12

• Barclays International

13-15

• Head Office

16

• Barclays Non-Core

17-19

Discontinued Operation Results

20-21

Quarterly Results Summary

22-24

Quarterly Core Results by Business

25-29

Performance Management

Margins and balances

30

Risk Management

• Overview

31

• Credit Risk

32-37

• Market Risk

38

• Treasury and Capital Risk

39-49

Statement of Directors' Responsibilities

50

Independent Review Report to Barclays PLC

51

Condensed Consolidated Financial Statements

52-57

Financial Statement Notes

58-93

Appendix: Non-IFRS Performance Measures

94-98

Shareholder Information

99

 

BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839

Notes

The term Barclays or Group refers to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the six months ended 30 June 2017 to the corresponding six months of 2016 and balance sheet analysis as at 30 June 2017 with comparatives relating to 31 December 2016 and 30 June 2016. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary that can be accessed at home.barclays/results.

The information in this announcement, which was approved by the Board of Directors on 27 July 2017, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2016, which included certain information required for the Joint Annual Report on Form 20-F of Barclays PLC and Barclays Bank PLC to the US Securities and Exchange Commission (SEC) and which contained an unqualified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

These results will be furnished as a Form 6-K to the SEC as soon as practicable following their publication. Once furnished with the SEC, copies of the Form 6-K will also be available from the Barclays Investor Relations website home.barclays/results and from the SEC's website at www.sec.gov.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

 

Non-IFRS performance measures

Barclays management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the business' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 94-98 for further information, reconciliations and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

 

Forward-looking statements

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income growth, assets, impairment charges, provisions, notable items, business strategy, structural reform, capital, leverage and other regulatory ratios, payment of dividends (including dividend pay-out ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings, original and revised commitments and targets in connection with the Group Strategy Update, rundown of assets and businesses within Barclays Non-Core, sell down of the Group's interest in Barclays Africa Group Limited or the impact of any regulatory deconsolidation, estimates of capital expenditures and plans and objectives for future operations, projected employee numbers and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. These may be affected by changes in legislation, the development of standards and interpretations under International Financial Reporting Standards, evolving practices with regard to the interpretation and application of accounting and regulatory standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of conduct provisions, future levels of notable items, the policies and actions of governmental and regulatory authorities, geopolitical risks and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules (including with regard to the future structure of the Group) applicable to past, current and future periods; UK, US, Africa, Eurozone and global macroeconomic and business conditions; the effects of continued volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of any entities within the Group or any securities issued by such entities; the potential for one or more countries exiting the Eurozone; the implications of the exercise by the United Kingdom of Article 50 of the Treaty of Lisbon and the disruption that may result in the UK and globally from the withdrawal of the United Kingdom from the European Union; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group's control. As a result, the Group's actual future results, dividend payments, and capital and leverage ratios may differ materially from the plans, goals, expectations and guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in our filings with the SEC (including, without limitation, our annual report on form 20-F for the fiscal year ended 31 December 2016), which are available on the SEC's website at www.sec.gov.

Subject to our obligations under the applicable laws and regulations of the United Kingdom and the United States in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward looking statements, whether as a result of new information, future events or otherwise.

Performance Highlights

 

Transatlantic Consumer, Corporate and Investment Bank with Global Reach

Key strategic milestones achieved with the closure of Non-Core on 1 July 2017, selldown in Africa and

a CET1 ratio of 13.1% within our end-state target range

 

 

• Returns:

• Group Return on Tangible Equity (RoTE) of (4.6%) (H116: 4.8%). Excluding a loss on the sale of 33.7% of Barclays Africa Group Limited's (BAGL) issued share capital of £1.4bn, an impairment of Barclays' holding in BAGL of £1.1bn and charges for Payment Protection Insurance (PPI) of £700m, Group RoTE was 8.1%

• Core RoTE of 7.3% (H116: 12.5%). Excluding charges for PPI, Core delivered a double digit RoTE of 10.4% on an average allocated tangible equity base that was £5bn higher year-on-year

• Non-Core rundown and closure:

• Closure of Non-Core on 1 July 2017 with risk weighted assets of £23bn (December 2016: £32bn), below guidance of approximately £25bn. Residual assets and liabilities are to be reintegrated into the Core

• Materially lower loss before tax of £647m (H116: £1,904m)

• Cost efficiency:

• Group cost: income ratio of 71% (H116: 70%) reflected a significant reduction in Non-Core costs to £284m (H116: £950m) and charges for PPI of £700m (H116: £400m)

• Remain on track to deliver Group cost: income ratio below 60% over time

• Barclays Africa Group Limited (BAGL):

• Sale of 33.7% of BAGL's issued share capital, resulting in the accounting deconsolidation of BAGL

• 47bps increase in the Group's Common Equity Tier 1 (CET1) ratio as a result of the sale and reflecting the proportional consolidation of BAGL for regulatory reporting purposes. Estimate a further c.26bps Group CET1 ratio accretion through to regulatory deconsolidation, which is expected, subject to regulatory approval, within the next 18 months

• H117 included an impairment of Barclays' holding in BAGL of £1.1bn and a loss on the sale of 33.7% of BAGL's issued share capital of £1.4bn, primarily due to recycling of currency translation reserve losses to the income statement

• Common Equity Tier 1 (CET1) ratio:

• CET1 ratio increased to 13.1% (December 2016: 12.4%) reflecting strong organic capital generation and the benefit of the sale of BAGL, partially offset by charges for PPI, pension contributions and the redemption of USD preference shares

• Holding Company (HoldCo) transition:

• Continued to transition to HoldCo funding with £7.6bn equivalent of issuance

• H117 included the redemption of $1.375bn 7.1% Series 3 USD preference shares

 

Improved Group profit before tax driven by reduced Non-Core drag

 

Group profit before tax increased 13% to £2,341m reflecting materially lower losses in Non-Core of £647m (H116: £1,904m), while Core profit before tax reduced 25% to £2,988m impacted by charges for PPI of £700m (H116: £400m) and the non-recurrence of the £615m gain on disposal of Barclays' share of Visa Europe Limited in H116

Barclays UK RoTE of 4.6% (H116: 13.6%) and cost: income ratio of 72% (H116: 61%) reflected charges for PPI of £700m (H116: £400m). Net interest margin (NIM) improved 10bps to 3.69%, with net interest income increasing 2% to £3,045m

Barclays International RoTE of 12.4% (H116: 14.3%) reflected RoTE of 28.0% (H116: 50.9%) in Consumer, Cards and Payments and an improved RoTE of 9.7% (H116: 8.4%) in the Corporate and Investment Bank (CIB)

Loss after tax in respect of discontinued operation of £2,195m included an impairment of Barclays' holding in BAGL of £1,090m and a loss on the sale of 33.7% of BAGL's issued share capital of £1,435m, primarily due to recycling of currency translation reserve losses to the income statement

Group basic loss per share of (6.6p) (H116: earnings of 6.9p) with earnings per share in respect of continuing operations of 7.1p (H116: 6.0p). Excluding the loss on the sale of 33.7% of BAGL's issued share capital, the impairment of Barclays' holding in BAGL and charges for PPI of £700m, earnings per share were 11.8p

Tangible net asset value per share decreased to 284p (December 2016: 290p) as profit from continuing operations was offset by decreases across reserves

 

Barclays Group results

for the half year ended

30.06.17

30.06.16

YoY

£m

£m

% Change

Total income

10,881

11,013

(1)

Credit impairment charges and other provisions

(1,054)

(931)

(13)

Net operating income

9,827

10,082

(3)

Operating expenses excluding litigation and conduct

(6,989)

(7,172)

3

Litigation and conduct

(743)

(525)

(42)

Operating expenses

(7,732)

(7,697)

-

Other net income/(expenses)

246

(322)

Profit before tax

2,341

2,063

13

Tax charge

(778)

(715)

(9)

Profit after tax in respect of continuing operations

1,563

1,348

16

(Loss)/profit after tax in respect of discontinued operation1

(2,195)

311

Non-controlling interests in respect of continuing operations

(138)

(186)

26

Non-controlling interests in respect of discontinued operation1

(140)

(155)

10

Other equity holders2

(301)

(208)

(45)

Attributable (loss)/profit

(1,211)

1,110

Performance measures

Return on average tangible shareholders' equity2

(4.6%)

4.8%

Average tangible shareholders' equity (£bn)

49

48

Cost: income ratio

71%

70%

Loan loss rate (bps)

49

39

Basic (loss)/earnings per share2

(6.6p)

6.9p

Basic earnings per share in respect of continuing operations2

7.1p

6.0p

Dividend per share

1.0p

1.0p

As at

As at

Balance sheet and capital management

30.06.17

31.12.16

Tangible net asset value per share

284p

290p

Common equity tier 1 ratio

13.1%

12.4%

Common equity tier 1 capital

£42.8bn

£45.2bn

Risk weighted assets

£327bn

£366bn

UK leverage ratio (quarterly month end average)3

4.8%

4.5%

Fully loaded tier 1 capital (quarterly month end average)3

£52.1bn

£51.6bn

UK leverage exposure (quarterly month end average)3

£1,092bn

£1,137bn

Funding and liquidity

Group liquidity pool

£201bn

£165bn

CRD IV liquidity coverage ratio

149%

131%

Loan: deposit ratio4

81%

83%

 

 

1

Refer to pages 20-21 for further information relating to the Africa Banking discontinued operation. Loss after tax in respect of discontinued operation includes impairment of Barclays' holding in BAGL of £1,090m and the loss on the sale of 33.7% of BAGL's issued share capital of £1,435m in H117.

2

The profit after tax attributable to other equity holders of £301m (H116: £208m) is offset by a tax credit recorded in reserves of £82m (H116: £58m). The net amount of £219m (H116: £150m), along with non-controlling interests (NCI) is deducted from profit after tax in order to calculate earnings per share and return on average tangible shareholders' equity.

3

The UK leverage ratio uses capital and exposure measures based on the average of the last day of each month in the quarter; additionally, the average exposure measure excludes qualifying central bank claims.

4

Loan: deposit ratio for Barclays UK, Barclays International and Non-Core, excluding investment banking businesses.

 

Barclays Core and Non-Core results

Barclays Core

Barclays Non-Core

for the half year ended

30.06.17

30.06.16

YoY

30.06.17

30.06.16

YoY

£m

£m

% Change

£m

£m

% Change

Total income

11,411

11,599

(2)

(530)

(586)

10

Credit impairment charges and other provisions

(1,024)

(876)

(17)

(30)

(55)

45

Net operating income/(expenses)

10,387

10,723

(3)

(560)

(641)

13

Operating expenses excluding litigation and conduct

(6,733)

(6,315)

(7)

(256)

(857)

70

Litigation and conduct

(715)

(432)

(66)

(28)

(93)

70

Operating expenses

(7,448)

(6,747)

(10)

(284)

(950)

70

Other net income/(expenses)

49

(9)

197

(313)

Profit/(loss) before tax

2,988

3,967

(25)

(647)

(1,904)

66

Tax (charge)/credit

(1,060)

(1,181)

10

282

466

(39)

Profit/(loss) after tax

1,928

2,786

(31)

(365)

(1,438)

75

Non-controlling interests

(121)

(164)

26

(17)

(22)

23

Other equity holders

(264)

(178)

(48)

(37)

(30)

(23)

Attributable profit/(loss)1

1,543

2,444

(37)

(419)

(1,490)

72

Performance measures

Return on average allocated tangible equity

7.3%

12.5%

Average allocated tangible equity (£bn)1

45

40

5

8

Period end allocated tangible equity (£bn)1

44

41

4

8

Cost: income ratio

65%

58%

n/m

n/m

Loan loss rate (bps)

54

43

12

15

Basic earnings/(loss) per share contribution

9.5p

14.8p

(2.4p)

(8.8p)

As at

As at

As at

As at

Capital management

30.06.17

31.12.16

30.06.17

31.12.16

Risk weighted assets1

£304.6bn

£333.5bn

£22.8bn

£32.1bn

UK leverage exposure (quarterly month end average)1

£997bn

£1,026bn

£95bn

£111bn

 

 

1

Attributable profit in respect of the Africa Banking discontinued operation is reported at the Group level only. Allocated tangible equity, RWAs and leverage exposure are reported in Head Office within Core.

 

 

Half year ended

Half year ended

30.06.17

30.06.16

YoY

Income by business

£m

£m

% Change

Barclays UK

3,661

3,746

(2)

Barclays International

7,748

7,552

3

Head Office

2

301

(99)

Barclays Core

11,411

11,599

(2)

Barclays Non-Core

(530)

(586)

10

Barclays Group

10,881

11,013

(1)

 

 

 

 

 

Profit/(loss) before tax by business

Barclays UK

634

1,080

(41)

Barclays International

2,617

2,753

(5)

Head Office

(263)

134

Barclays Core

2,988

3,967

(25)

Barclays Non-Core

(647)

(1,904)

66

Barclays Group

2,341

2,063

13

 

Group Chief Executive Officer's Review

 "The second quarter saw us complete two critically important planks of our strategy; both of them ahead of schedule.

 

First, we reduced our majority shareholding in Barclays Africa Group Limited to a level which allows us to apply for regulatory deconsolidation, and we expect to achieve that in 2018. We have permission to apply proportional consolidation to our reduced shareholding, which means that our CET1 ratio stands at 13.1% today, within our end-state target range. We will realise a further c.26bps uplift resulting from the sale.

 

Second, we completed the accelerated rundown of our Non-Core unit to below our target of £25bn in Risk Weighted Assets, allowing us to close it 6 months early and incorporate the residual assets back into the Core.

 

Accomplishing both of these milestones marks an end to the restructuring of the Barclays Group, and brings forward the date when our shareholders can benefit from the full earnings power of this business.

 

That power is evident once again in the performance reported today. At the half year, Group profit before tax increased 13% to £2,341m. Our strong businesses, Barclays UK and Barclays International, posted attractive Returns on Tangible Equity of 20.4% - excluding the provision for PPI - and 12.4% respectively.

 

Our business is now radically simplified, the restructuring is complete, our capital ratio is within our end-state target range, and while we are also working to put conduct issues behind us, we can now focus on what matters most to our shareholders: improving Group returns.

 

We have accordingly established a new target today which is to achieve a greater than 10% Group Return on Tangible Equity over time.

 

Finally we will, at the full year results early next year, provide investors with an updated capital management policy for the Group."

 

James E Staley, Group Chief Executive Officer

 

 

Group Finance Director's Review

Results for the first half of the year demonstrated significant progress against the Group's strategy, evidenced by solid underlying Core performance, materially lower losses in Non-Core, the sell down to a target stake in BAGL and further progress on capital. The Core business reported a double digit RoTE of 10.4%, excluding the impact of charges for PPI, on a materially increased average tangible equity base. The closure of Non-Core on 1 July 2017 represented a significant milestone in the restructuring of the bank, with RWAs of £23bn, less than the previous guidance of c.£25bn, and the sale of a 33.7% stake in BAGL resulted in the accounting deconsolidation of the entity. Group H117 results were impacted by a loss on the sale of, and an impairment of Barclays' holding in, BAGL. The Group's CET1 ratio benefitted by 47bps from the sale and reflecting the proportional consolidation of BAGL, which, along with underlying organic capital generation, contributed to the capital ratio increasing to 13.1%, within the end-state target range.

 

Group performance

 

Profit before tax increased 13% to £2,341m, driven by materially reduced losses from the Non-Core which reported a loss before tax of £647m (H116: £1,904m). Core profits decreased 25% to £2,988m, impacted by charges for PPI of £700m (H116: £400m) and the non-recurrence of a £615m gain on disposal of Barclays' share of Visa Europe Limited in H116. H117 results were also impacted by the appreciation of average USD and EUR against GBP of 12% and 10% respectively, compared to H116, which positively impacted income and adversely affected impairment and operating expenses

Total income decreased 1% to £10,881m, reflecting a 2% reduction in income in the Core to £11,411m, predominantly in Head Office, partially offset by a 10% reduction in Non-Core negative income to £530m. Income increased 3% in Barclays International, with growth across both CIB and Consumer, Cards and Payments, though decreased 2% in Barclays UK, impacted by the non-recurrence of a gain on disposal of Barclays' share of Visa Europe Limited in H116

Credit impairment charges increased £123m to £1,054m, driven by a 53% increase in Consumer, Cards and Payments, mainly reflecting a change in portfolio mix, an increase in underlying delinquency trends in US Cards and business growth, partially offset by lower impairment in CIB. As a result, the Group loan loss rate increased 10bps to 49bps

Operating expenses were broadly in line at £7,732m (H116: £7,697m), driven by a 10% increase in Core to £7,448m due to charges for PPI, the impact of the change in compensation awards introduced in Q416 and business growth and investment, which more than offset cost efficiencies. Non-Core operating expenses reduced 70% to £284m as the segment continued to be rundown

Other net income increased to £246m (H116: £322m expense) reflecting a gain of £109m on the sale of Barclays' share in VocaLink to MasterCard and a gain of £76m on the sale of a joint venture in Japan. A gain of £189m on the sale of Barclays Bank Egypt was broadly offset by the recycling of £180m of currency translation reserve losses to the income statement

Loss after tax in respect of the Africa Banking discontinued operation of £2,195m (H116: profit of £311m) included a £1,090m impairment of Barclays' holding in BAGL and a £1,435m loss on the sale of 33.7% of BAGL's issued share capital, primarily due to recycling of currency translation reserve losses to the income statement on accounting deconsolidation

RoTE was (4.6%) (H116: 4.8%) and basic loss per share was (6.6p) (H116: earnings of 6.9p). Excluding the impact of the loss on the sale of 33.7% of BAGL's issued share capital, the impairment of Barclays' holding in BAGL and charges for PPI RoTE, was 8.1% and earnings per share were 11.8p

 

Core performance

 

The Core business generated an RoTE of 7.3% (H116: 12.5%), though excluding charges for PPI delivered a double digit RoTE of 10.4%

Profit before tax decreased 25% to £2,988m mainly due to the impact of charges for PPI of £700m (H116: £400m) and the non-recurrence of the gain on disposal of Barclays' share of Visa Europe Limited of £615m in H116

Total income decreased 2% to £11,411m driven by reduced income in Head Office, primarily due to the non-recurrence of own credit gains in H116, and in Barclays UK, mainly due to the non-recurrence of the gain on disposal of Barclays' share of Visa Europe Limited. This was partially offset by 3% growth in Barclays International, with growth across both CIB and Consumer, Cards and Payments

Credit impairment charges increased 17% to £1,024m, driven by increased impairment in Consumer, Cards and Payments mainly reflecting a change in portfolio mix, an increase in underlying delinquency trends in US Cards and business growth. The Core loan loss rate increased 11bps to 54bps

Operating expenses increased 10% to £7,448m driven by charges for PPI, the change in compensation awards introduced in Q416, higher structural reform programme costs and business growth and investment in Consumer, Cards and Payments

Other net income of £49m (H116: £9m expense) reflected a gain of £109m on the sale of Barclays' share in VocaLink to MasterCard and a gain of £76m on the sale of a joint venture in Japan, offset by an expense of £180m on the recycling of the currency translation reserve to the income statement on the sale of Barclays Bank Egypt

 

Barclays UK

 

RoTE reduced to 4.6% (H116: 13.6%) with a 41% decrease in profit before tax to £634m due to charges for PPI of £700m (H116: £400m) and the non-recurrence of the £151m gain on disposal of Barclays' share of Visa Europe Limited in H116

Total income decreased 2% to £3,661m driven by the non-recurrence of the £151m gain on disposal of Barclays' share of Visa Europe Limited in H116 and the impact of the UK base rate reduction in 2016, partially offset by pricing initiatives and deposit growth. The net interest margin increased 10bps to 3.69%

Credit impairment charges increased £32m year-on-year to £398m, reflecting higher charge-offs in Personal Banking and the higher recoveries in H116. Underlying delinquency trends reduced year-on-year, with 30 and 90 day arrears rates in UK Cards improving year-on-year to 2.0% (H116: 2.3%) and 0.9% (H116: 1.2%) respectively

Operating expenses increased 14% to £2,628m, due to charges for PPI of £700m (H116: £400m), the costs of setting up the ring-fenced bank and investment in cyber resilience and technology, partially offset by cost efficiencies

 

Barclays International

 

RoTE of 12.4% (H116: 14.3%) reflected an improved RoTE of 9.7% in CIB (H116: 8.4%) and an RoTE of 28.0% (H116: 50.9%) in Consumer, Cards and Payments

Profit before tax decreased 5% to £2,617m driven by an increase in operating expenses and impairment, partially offset by higher income

Total income increased 3% to £7,748m, including the appreciation of average USD and EUR against GBP, with growth in both CIB and Consumer, Cards and Payments. CIB income increased 3% to £5,346m driven by higher Banking income, partially offset by a decrease in Macro income, while Consumer, Cards and Payments income increased 2% to £2,402m including growth in US Cards

Credit impairment charges increased 23% to £625m driven by Consumer, Cards and Payments, which increased 53% to £575m, due to a change in portfolio mix, an increase in underlying delinquency trends in US Cards, business growth and the appreciation of average USD and EUR against GBP. CIB credit impairment charges reduced 62% to £50m due to the non-recurrence of oil and gas single name charges in H116

Total operating expenses increased 10% to £4,720m, including the appreciation of average USD and EUR against GBP. CIB operating expenses increased 7% to £3,697m reflecting the change in compensation awards introduced in Q416 and higher structural reform programme costs, partially offset by a reduction in restructuring charges and cost efficiencies. Consumer, Cards and Payments operating expenses increased 21% to £1,023m including continued growth and investment

Other net income increased to £214m (H116: £19m) reflecting a gain of £109m on the sale of Barclays' share in VocaLink to MasterCard and a gain of £76m on the sale of a joint venture in Japan

 

Head Office

 

Income reduced £299m to £2m, primarily due to the early adoption of the own credit provisions of IFRS 9 and lower net income from treasury operations. Own credit, which was previously recorded in the income statement (H116: gain of £183m) is now recognised within other comprehensive income

Loss before tax of £263m (H116: profit of £134m) included an expense of £180m on the recycling of the currency translation reserve to the income statement on the sale of Barclays Bank Egypt

 

Non-Core performance

 

Non-Core to close on 1 July 2017, with residual assets and liabilities to be reintegrated into the Core and, as previously guided to, it is expected that risk weighted assets and loss before tax previously associated with Non-Core will continue to reduce in future periods

Progress on the rundown continued with RWAs reduced to £22.8bn (December 2016: £32.1bn), below guidance of approximately £25bn, driven by a £5bn reduction in Derivatives, a £2bn reduction in Businesses and a £1bn reduction in Securities and loans

Loss before tax decreased to £647m (H116: £1,904m) driven by lower operating expenses, favourable fair value movements on the Education, Social Housing and Local Authority (ESHLA) portfolio, the non-recurrence of impairment associated with the valuation of the French retail business in H116 and a £189m gain on the sale of Barclays Bank Egypt

Total income increased £56m to a net expense of £530m driven by increased Securities and loans income primarily due to positive fair value movements on the ESHLA portfolio. This was offset by reduced Derivatives income, reflecting increased cost of exits, and lower Businesses income following the completion of the sale of the Italian retail, Southern European cards and Barclays Bank Egypt businesses

Operating expenses improved 70% to £284m reflecting the completion of the sale of several businesses, a reduction in restructuring charges, and lower litigation and conduct charges

Other net income increased to £197m (H116: £313m expense) reflecting a £189m gain on sale of Barclays Bank Egypt and the non-recurrence of impairment associated with the valuation of the French retail business in H116

 

Group capital and leverage

 

The fully loaded CET1 ratio increased to 13.1% (December 2016: 12.4%) principally due to a reduction in RWAs of £38.2bn to £327.4bn. CET1 capital decreased £2.4bn to £42.8bn

-

Profits relating to continuing operations were largely offset by decreases in other qualifying reserves as a result of the redemption of USD preference shares, the separation payments relating to the BAGL disposal and increased pension deductions. CET1 capital further decreased by £1.8bn as a result of BAGL minority interest no longer being included under proportional consolidation

-

Losses relating to the discontinued operation due to the impairment allocated to the goodwill of Barclays' holding in BAGL and the recycling of the BAGL currency translation reserve losses to the income statement had no impact on CET1 capital

-

The decrease in RWAs principally reflected the £27.9bn reduction as a result of the proportional consolidation of BAGL following the selldown of Barclays' holding, as well as reductions in Non-Core

The average UK leverage ratio increased to 4.8% (December 2016: 4.5%) driven by an increase in the average fully loaded Tier 1 capital to £52.1bn (December 2016: £51.6bn) and a decrease in the average UK leverage exposure to £1,092bn (December 2016: £1,137bn)

Tangible net asset value per share decreased to 284p (December 2016: 290p) primarily due to profit after tax excluding additional charges for PPI being more than offset by the redemption of USD preference shares, dividends paid and reduction in reserves including the currency translation and cash flow hedge reserves

 

Group funding and liquidity

 

The Group continued to maintain surpluses to its internal and regulatory requirements. The liquidity pool increased to £201bn (December 2016: £165bn). The increase in the liquidity pool was driven by a net increase in minimum requirement for own funds and eligible liabilities (MREL) issuance, drawdown from the Bank of England Term Funding Scheme, higher money market balances and deposit growth. The liquidity coverage ratio (LCR) increased to 149% (December 2016: 131%), equivalent to a surplus of £65bn (December 2016: £39bn) to 100%, reflecting our approach to build a conservative liquidity position

Wholesale funding outstanding excluding repurchase agreements was £163bn (December 2016: £158bn). The Group issued £7.6bn equivalent of capital and term senior unsecured debt from Barclays PLC (HoldCo) of which £4.8bn was in public senior unsecured debt, and £2.8bn in capital instruments. In the same period, £4.7bn of Barclays Bank PLC (OpCo) capital and senior public term instruments either matured or were redeemed, including the $1.375bn 7.1% Series 3 USD preference shares

 

Other matters

 

On 1 June 2017, Barclays sold 286 million ordinary shares of BAGL, representing 33.7% of BAGL's issued share capital. The sale resulted in the accounting deconsolidation of BAGL from the Barclays Group. Following the sale, BAGL is accounted for as an Available for Sale (AFS) asset in Barclays' financial statements and is no longer reported as a discontinued operation. The Group's CET1 ratio increased 47bps as a result of the sale and reflecting the proportional consolidation of BAGL for regulatory reporting purposes

As at 30 June 2017, Barclays accounted for 139 million ordinary shares in BAGL, representing 16.4% of BAGL's issued share capital. Barclays had an obligation at this date to contribute 1.5% of BAGL's ordinary shares or the cash equivalent to a Black Economic Empowerment scheme. At 30 September 2017, Barclays will account for 126 million ordinary shares in BAGL, currently representing 14.9% of BAGL's issued share capital

The latest triennial valuation of the UK Retirement Fund (UKRF) with an effective date of 30 September 2016 has been completed and showed a funding deficit of £7.9bn and funding level of 81.5%, versus a £6.0bn funding deficit at the 30 September 2015 update. Amongst other measures, Barclays and the UKRF agreed a recovery plan with revised deficit reduction contributions of £740m in 2017 (of which £620m has been paid in H117), £500m per annum in 2018 to 2020, and £1,000m per annum in 2021 to 2026

Additional charges of £700m (H116: £400m) relating to PPI were recognised in Q217, primarily to reflect higher than expected complaints flow in the year to date. The remaining PPI provision as at June 2017 was £2,109m (December 2016: £1,979m)

Certain legal proceedings and investigations relating to legacy issues remain outstanding. Resolving outstanding legacy issues in an appropriate timeframe will continue to be a priority. Please see Note 19 to the financial statements for details of relevant matters

 

Dividends

 

An interim dividend of 1.0p per share will be paid on 18 September 2017

 

Outlook and financial targets

 

The Group remains focused on cost efficiency, creating capacity to self-fund investment in our businesses, and continues to target a Group cost: income ratio of less than 60% over time

Following the closure of the Non-Core segment on 1 July 2017, the Group's previous returns target of converging Group returns with Core returns is transitioned to a target of achieving a Group RoTE of greater than 10.0% over time, underpinned by a combination of cost focus and redeployment of capital from business lines delivering inadequate returns

The Group expects the dividend for the full year to total 3.0p per share as previously guided. The Group will update the market on its updated capital management framework including the dividend policy at the full year results in February 2018

 

Tushar Morzaria, Group Finance Director

 

Results by Business

Barclays UK

Half year ended

Half year ended

30.06.17

30.06.16

YoY

Income statement information

£m

£m

% Change

Net interest income

3,045

2,977

2

Net fee, commission and other income

616

769

(20)

Total income

3,661

3,746

(2)

Credit impairment charges and other provisions

(398)

(366)

(9)

Net operating income

3,263

3,380

(3)

Operating expenses excluding litigation and conduct

(1,933)

(1,899)

(2)

Litigation and conduct

(695)

(400)

(74)

Operating expenses

(2,628)

(2,299)

(14)

Other net expenses

(1)

(1)

-

Profit before tax

634

1,080

(41)

Attributable profit

185

608

(70)

As at 30.06.17

As at 31.12.16

As at 30.06.16

Balance sheet information

£bn

£bn

£bn

Loans and advances to customers at amortised cost

166.6

166.4

166.0

Total assets

203.4

209.6

204.6

Customer deposits

187.4

189.0

181.7

Risk weighted assets

66.1

67.5

67.1

Half year ended

Half year ended

Key facts

30.06.17

30.06.16

Average LTV of mortgage portfolio1

47%

47%

Average LTV of new mortgage lending1

62%

63%

Number of branches

1,295

1,331

Barclays mobile banking active customers

5.9m

5.1m

30 day arrears rate - Barclaycard Consumer UK

2.0%

2.3%

Performance measures

Return on average allocated tangible equity

4.6%

13.6%

Average allocated tangible equity (£bn)

8.8

9.1

Cost: income ratio

72%

61%

Loan loss rate (bps)

47

43

Loan: deposit ratio

89%

91%

Net interest margin

3.69%

3.59%

 

 

1

Average LTV of mortgage portfolio and new mortgage lending calculated on the balance weighted basis.

 

Analysis of Barclays UK

Half year ended

Half year ended

30.06.17

30.06.16

YoY

Analysis of total income

£m

£m

% Change

Personal Banking

1,877

1,987

(6)

Barclaycard Consumer UK

993

954

4

Wealth, Entrepreneurs & Business Banking

791

805

(2)

Total income

3,661

3,746

(2)

Analysis of credit impairment charges and other provisions

Personal Banking

(106)

(86)

(23)

Barclaycard Consumer UK

(272)

(274)

1

Wealth, Entrepreneurs & Business Banking

(20)

(6)

Total credit impairment charges and other provisions

(398)

(366)

(9)

As at 30.06.17

As at 31.12.16

As at 30.06.16

Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn

Personal Banking

136.5

135.0

134.7

Barclaycard Consumer UK

16.2

16.5

16.2

Wealth, Entrepreneurs & Business Banking

13.9

14.9

15.1

Total loans and advances to customers at amortised cost

166.6

166.4

166.0

Analysis of customer deposits

Personal Banking

138.5

139.3

134.8

Barclaycard Consumer UK

-

-

-

Wealth, Entrepreneurs & Business Banking

48.9

49.7

46.9

Total customer deposits

187.4

189.0

181.7

 

Barclays UK

Income statement - H117 compared to H116

 

Profit before tax decreased 41% to £634m primarily due to charges for PPI of £700m (H116: £400m) and the non-recurrence of the £151m gain on disposal of Barclays' share in Visa Europe Limited in H116

Total income decreased 2% to £3,661m due to the non-recurrence of the £151m gain on disposal of Barclays' share of Visa Europe Limited in H116 and the impact of the UK base rate reduction in 2016, partially offset by pricing initiatives and deposit growth

-

Personal Banking income decreased 6% to £1,877m driven by the non-recurrence of the gain on disposal of Barclays' share of Visa Europe Limited in H116, the impact of the UK base rate reduction in 2016 and asset margin pressure, partially offset by pricing initiatives and deposit growth

-

Barclaycard Consumer UK income increased 4% to £993m reflecting improved margins

-

Wealth, Entrepreneurs & Business Banking (WEBB) decreased 2% to £791m due to the non-recurrence of the gain on disposal of Barclays' share of Visa Europe Limited in H116, partially offset by deposit pricing initiatives and balance growth

-

Net interest income increased 2% to £3,045m due to deposit pricing initiatives and balance growth

-

Net interest margin increased 10bps to 3.69% reflecting higher margins on Personal Banking deposits, partially offset by lower asset margins

-

Net fee, commission and other income decreased 20% to £616m due to the non-recurrence of the gain on disposal of Barclays' share of Visa Europe Limited in H116

Credit impairment charges increased £32m to £398m reflecting higher charge-offs in Personal Banking and higher recoveries in H116. Underlying delinquency trends reduced year-on-year, with 30 day and 90 day arrears rates in UK cards improving year-on-year at 2.0% (H116: 2.3%) and 0.9% (H116: 1.2%) respectively

Total operating expenses increased 14% to £2,628m due to charges for PPI of £700m (H116: £400m), the costs of setting up the ring-fenced bank and investment in cyber resilience and technology, partially offset by cost efficiencies

 

Balance sheet - 30 June 2017 compared to 31 December 2016

 

Loans and advances to customers were broadly in line at £166.6bn (December 2016: £166.4bn)

Total assets decreased 3% to £203.4bn primarily due to a reduction in the allocated liquidity pool

Customer deposits decreased 1% to £187.4bn reflecting the realignment of certain clients between Barclays UK and Barclays International in preparation for structural reform, partially offset by underlying deposit growth

RWAs reduced to £66.1bn (December 2016: £67.5bn) reflecting the realignment of certain clients between Barclays UK and Barclays International in preparation for structural reform

 

Barclays International

Half year ended

Half year ended

30.06.17

30.06.16

YoY

Income statement information

£m

£m

% Change

Net interest income

2,172

2,111

3

Net trading income

2,221

2,375

(6)

Net fee, commission and other income

3,355

3,066

9

Total income

7,748

7,552

3

Credit impairment charges and other provisions

(625)

(509)

(23)

Net operating income

7,123

7,043

1

Operating expenses excluding litigation and conduct

(4,711)

(4,295)

(10)

Litigation and conduct

(9)

(14)

36

Operating expenses

(4,720)

(4,309)

(10)

Other net income

214

19

Profit before tax

2,617

2,753

(5)

Attributable profit

1,656

1,746

(5)

As at 30.06.17

As at 31.12.16

As at 30.06.16

Balance sheet information

£bn

£bn

£bn

Loans and advances to banks and customers at amortised cost1

204.8

211.3

230.6

Trading portfolio assets

83.3

73.2

68.1

Derivative financial instrument assets

108.4

156.2

181.4

Derivative financial instrument liabilities

116.8

160.6

187.5

Reverse repurchase agreements and other similar secured lending

17.2

13.4

19.7

Financial assets designated at fair value

94.1

62.3

68.3

Total assets

681.6

648.5

679.9

Customer deposits2

230.3

216.2

226.5

Risk weighted assets

212.2

212.7

209.3

Half year ended

Half year ended

Performance measures

30.06.17

30.06.16

Return on average allocated tangible equity

12.4%

14.3%

Average allocated tangible equity (£bn)

27.5

25.0

Cost: income ratio

61%

57%

Loan loss rate (bps)

61

44

Loan: deposit ratio

80%

90%

Net interest margin

4.06%

3.90%

 

 

1

As at 30 June 2017 loans and advances included £183.9bn (December 2016: £185.9bn) of loans and advances to customers (including settlement balances of £31.6bn (December 2016: £19.5bn) and cash collateral of £26.9bn (December 2016: £30.1bn)), and £20.9bn (December 2016: £25.4bn) of loans and advances to banks (including settlement balances of £5.7bn (December 2016: £1.7bn) and cash collateral of £5.4bn (December 2016: £6.3bn)). Loans and advances to banks and customers in respect of Consumer, Cards and Payments were £38.5bn (December 2016: £39.7bn).

2

As at 30 June 2017 customer deposits included settlement balances of £29.4bn (December 2016: £16.6bn) and cash collateral of £16.2bn (December 2016: £20.8bn).

 

Analysis of Barclays International

Half year ended

Half year ended

Corporate and Investment Bank

30.06.17

30.06.16

YoY

Income statement information

£m

£m

% Change

Analysis of total income

Credit

695

591

18

Equities

917

919

-

Macro

946

1,185

(20)

Markets

2,558

2,695

(5)

Banking fees

1,400

1,103

27

Corporate lending

547

608

(10)

Transactional banking

802

798

1

Banking

2,749

2,509

10

Other

39

3

Total income

5,346

5,207

3

Credit impairment charges and other provisions

(50)

(132)

62

Operating expenses

(3,697)

(3,465)

(7)

Other net income

116

-

Profit before tax

1,715

1,610

7

As at 30.06.17

As at 31.12.16

As at 30.06.16

Balance sheet information

£bn

£bn

£bn

Risk weighted assets

178.9

178.6

178.4

Half year ended

Half year ended

Performance measures

30.06.17

30.06.16

Return on average allocated tangible equity

9.7%

8.4%

Average allocated tangible equity (£bn)

23.3

21.5

Half year ended

Half year ended

Consumer, Cards and Payments

30.06.17

30.06.16

YoY

Income statement information

£m

£m

% Change

Total income

2,402

2,345

2

Credit impairment charges and other provisions

(575)

(377)

(53)

Operating expenses

(1,023)

(844)

(21)

Other net income

98

19

Profit before tax

902

1,143

(21)

As at 30.06.17

As at 31.12.16

As at 30.06.16

Balance sheet information

£bn

£bn

£bn

Loans and advances to banks and customers at amortised cost

38.5

39.7

35.4

Customer deposits

57.3

50.0

46.9

Risk weighted assets

33.3

34.1

30.9

Half year ended

Half year ended

Key facts

30.06.17

30.06.16

30 day arrears rates - Barclaycard US

2.2%

2.2%

Total number of Barclaycard business clients

364,000

350,000

Value of payments processed

£157bn

£141bn

Performance measures

Return on average allocated tangible equity

28.0%

50.9%

Average allocated tangible equity (£bn)

4.2

3.5

 

Barclays International

Income statement - H117 compared to H116

 

Profit before tax decreased 5% to £2,617m driven by a 10% increase in total operating expenses and a 23% increase in impairment, partially offset by a 3% increase in total income

Total income increased 3% to £7,748m, including the appreciation of average USD and EUR against GBP, as CIB income increased 3% to £5,346m and Consumer, Cards and Payments income increased 2% to £2,402m

-

Markets income decreased 5% to £2,558m

-

Credit income increased 18% to £695m driven by improved performance in the European business and increased municipals income

-

Equities income was broadly in line at £917m (H116: £919m) driven by lower US equity derivatives revenue, offset by improved performance in cash equities and equity financing

-

Macro income decreased 20% to £946m driven by lower market volatility in rates and the impact of exiting energy-related commodities

-

Banking income increased 10% to £2,749m

-

Banking fees income increased 27% to £1,400m, driven by higher debt underwriting, equity underwriting and advisory fees, with fee share up in all products

-

Corporate lending reduced 10% to £547m primarily due to higher losses on fair value hedges, a reduction in work-out gains and reduced balances

-

Transactional banking income increased 1% to £802m as higher deposit balances were partially offset by margin compression in a low base rate environment

-

Consumer, Cards and Payments income increased 2% to £2,402m driven by continued growth, a gain of £192m relating to an asset sale in US cards and a valuation gain on Barclays' preference shares in Visa Inc. of £74m, partially offset by the non-recurrence of the gain on the disposal of Barclays' share of Visa Europe Limited of £464m in H116

Credit impairment charges increased 23% to £625m including the appreciation of average USD and EUR against GBP

-

CIB credit impairment charges reduced 62% to £50m due to the non-recurrence of oil and gas single name charges in H116

-

Consumer, Cards and Payments credit impairment charges increased 53% to £575m primarily driven by a change in portfolio mix, an increase in underlying delinquency trends in US cards and business growth. 30 and 90 days arrears rates within US Cards were broadly stable at 2.2% (H116: 2.2%) and 1.1% (H116: 1.0%) respectively, including a benefit from the Q117 asset sale in US cards

Total operating expenses increased 10% to £4,720m, including the appreciation of average USD and EUR against GBP

-

CIB increased 7% to £3,697m reflecting the change in compensation awards introduced in Q416 and higher structural reform programme costs, partially offset by a reduction in restructuring charges and cost efficiencies

-

Consumer, Cards and Payments increased 21% to £1,023m including continued growth and investment, primarily within the US Cards and merchant acquiring businesses

Other net income increased to £214m (H116: £19m) due to a gain of £109m on the sale of Barclays' share in VocaLink to MasterCard and a gain of £76m on the sale of a joint venture in Japan

 

Balance sheet - 30 June 2017 compared to 31 December 2016

 

Loans and advances to banks and customers at amortised cost decreased £6.5bn to £204.8bn with CIB decreasing £5.3bn to £166.3bn due to a reduction in lending and cash collateral, partially offset by an increase in settlement balances. Consumer, Cards and Payments decreased £1.2bn to £38.5bn due to an asset sale in US cards in Q117, partially offset by the realignment of certain clients from Barclays UK to Barclays International in preparation for structural reform

Trading portfolio assets increased £10.1bn to £83.3bn due to increased activity

Derivative financial instrument assets and liabilities decreased £47.8bn to £108.4bn and £43.8bn to £116.8bn respectively, reflecting the adoption of the Chicago Mercantile Exchange (CME) rulebook change to daily settlement and an increase in major interest rate forward curves and depreciation of USD against GBP

Reverse repurchase agreements and other similar lending increased £3.8bn to £17.2bn primarily due to increased trading desks' funding requirements

Financial assets designated at fair value increased £31.8bn to £94.1bn primarily due to increased matched book trading and trading desks' funding requirements

Customer deposits increased £14.1bn to £230.3bn, with CIB increasing £6.8bn to £173.0bn primarily driven by an increase in settlement balances, partially offset by a decrease in cash collateral and corporate deposits. Consumer, Cards and Payments increased £7.3bn to £57.3bn driven by the realignment of certain clients from Barclays UK to Barclays International in preparation for structural reform

RWAs remained broadly in line at £212.2bn (December 2016: £212.7bn) driven by a reduction due to the depreciation of USD against GBP, an asset sale in US cards in Q117 and credit quality improvement, offset by increased trading portfolio and securities financing transaction volumes

 

Head Office

Half year ended

Half year ended

30.06.17

30.06.16

YoY

Income statement information

£m

£m

% Change

Net interest income

(7)

(6)

(17)

Net fee, commission and other income

9

307

(97)

Total income

2

301

(99)

Credit impairment charges and other provisions

(1)

(1)

-

Net operating income

1

300

Operating expenses excluding litigation and conduct

(89)

(121)

26

Litigation and conduct

(11)

(18)

39

Operating expenses

(100)

(139)

28

Other net expenses

(164)

(27)

(Loss)/profit before tax

(263)

134

Attributable (loss)/profit

(298)

90

As at 30.06.17

As at 31.12.16

As at 30.06.16

Balance sheet information

£bn

£bn

£bn

Total assets

17.3

75.2

87.7

Risk weighted assets1

26.2

53.3

43.2

Half year ended

Half year ended

30.06.17

30.06.16

Performance measures

£bn

£bn

Average allocated tangible equity

8.2

5.8

 

1

Includes Africa Banking risk weighted assets of £9.8bn (December 2016: £42.3bn).

 

Head Office

 

Income statement - H117 compared to H116

 

Loss before tax was £263m (H116: profit of £134m)

Total income reduced £299m to £2m following the early adoption of the own credit provisions of IFRS 9 on 1 January 2017 and lower net income from treasury operations. Own credit, which was previously recorded in the income statement (H116: gain of £183m), is now recognised within other comprehensive income

Other net expenses increased to £164m (H116: £27m) driven by an expense of £180m on the recycling of the currency translation reserve to the income statement on the sale of Barclays Bank Egypt

 

Balance sheet - 30 June 2017 compared to 31 December 2016

 

Total assets decreased to £17.3bn (December 2016: £75.2bn) primarily due to the sale of 33.7% of BAGL's issued share capital resulting in the accounting deconsolidation of BAGL from the Barclays Group

RWAs decreased to £26.2bn (December 2016: £53.3bn) reflecting a £27.9bn reduction as a result of the proportional consolidation of BAGL

 

Barclays Non-Core

Half year ended

Half year ended

30.06.17

30.06.16

YoY

Income statement information

£m

£m

% Change

Net interest income

(112)

136

Net trading income

(488)

(953)

49

Net fee, commission and other income

70

231

(70)

Total income

(530)

(586)

10

Credit impairment charges and other provisions

(30)

(55)

45

Net operating expenses

(560)

(641)

13

Operating expenses excluding litigation and conduct

(256)

(857)

70

Litigation and conduct

(28)

(93)

70

Operating expenses

(284)

(950)

70

Other net income/(expenses)

197

(313)

Loss before tax

(647)

(1,904)

66

Attributable loss

(419)

(1,490)

72

As at 30.06.17

As at 31.12.16

As at 30.06.16

Balance sheet information

£bn

£bn

£bn

Loans and advances to banks and customers at amortised cost1

48.3

51.1

68.5

Derivative financial instrument assets

150.3

188.7

262.8

Derivative financial instrument liabilities

143.0

178.6

253.4

Reverse repurchase agreements and other similar secured lending

-

0.1

0.1

Financial assets designated at fair value

12.1

14.5

15.4

Total assets

233.0

279.7

379.1

Customer deposits2

11.8

12.5

17.4

Risk weighted assets

22.8

32.1

46.7

Half year ended

Half year ended

Performance measures

30.06.17

30.06.16

Average allocated tangible equity (£bn)

4.9

8.5

Period end allocated tangible equity (£bn)

4.0

7.8

Loan loss rate (bps)

12

15

YoY

Analysis of total income

£m

£m

% Change

Businesses

10

377

(97)

Securities and loans

43

(765)

Derivatives

(583)

(198)

Total income

(530)

(586)

10

 

 

1

As at 30 June 2017 loans and advances included £37.1bn (December 2016: £38.5bn) of loans and advances to customers (including settlement balances of £nil (December 2016: £0.1bn) and cash collateral of £15.3bn (December 2016: £17.3bn)), and £11.2bn (December 2016: £12.6bn) of loans and advances to banks (including settlement balances of £nil (December 2016: £0.1bn) and cash collateral of £10.9bn (December 2016: £12.1bn)).

2

As at 30 June 2017 customer deposits included settlement balances of £nil (December 2016 £0.1bn) and cash collateral of £11.4bn (December 2016: £11.9bn).

 

Barclays Non-Core

Income statement - H117 compared to H116

Loss before tax reduced to £647m (H116: £1,904m) driven by lower operating expenses, favourable fair value movements on the ESHLA portfolio, the non-recurrence of impairment associated with the valuation of the French retail business in H116 and a gain on the sale of Barclays Bank Egypt

Total income increased £56m to a net expense of £530m

-

Businesses income reduced to £10m (H116: £377m) primarily due to the completion of the sale of the Italian retail, Southern European cards and Barclays Bank Egypt businesses

-

Securities and loans income increased £808m to net income of £43m primarily driven by fair value gains of £44m (H116: £424m expense) on the ESHLA portfolio and the non-recurrence of the £182m loss associated with the restructure of the ESHLA portfolio loan terms in H116

-

Derivatives income reduced £385m to an expense of £583m reflecting losses on the rundown of the portfolio

Credit impairment charges improved 45% to £30m due to higher recoveries across Europe and investment banking activities

Total operating expenses improved 70% to £284m reflecting the completion of the sale of several businesses, a reduction in restructuring charges, and lower litigation and conduct charges

Other net income of £197m (H116: £313m expense) included a £189m gain on the sale of Barclays Bank Egypt. H116 included a £372m impairment associated with the valuation of the French retail business

 

Balance sheet - 30 June 2017 compared to 31 December 2016

 

Loans and advances to banks and customers at amortised cost decreased 5% to £48.3bn due to a decrease in cash collateral assets, partially offset by the reclassification of £1.5bn of ESHLA loans now recognised at amortised cost, following the restructuring of certain loans within the portfolio

Derivative financial instrument assets and liabilities decreased 20% to £150.3bn and 20% to £143.0bn respectively, due to the continued rundown of the derivative back book and an increase in major interest rate forward curves

Customer deposits decreased 6% to £11.8bn due to a decrease in cash collateral

Total assets decreased 17% to £233.0bn due to lower derivative financial instrument assets

RWAs reduced £9.3bn to £22.8bn including a £5bn reduction in Derivatives, a £2bn reduction in Businesses and a £1bn reduction in Securities and loans

 

Barclays Non-Core closure and reintegration into Core

The Non-Core segment was closed on 1 July 2017 with the residual assets and liabilities, and prospective financial performance to be reintegrated into Barclays UK, Barclays International and Head Office. Financial results up until 30 June 2017 will continue to be reflected in the Non-Core

-

As at 30 June 2017 Non-Core RWAs were £22.8bn. It is estimated that c.£3.5bn will be reintegrated with Barclays UK comprising of ESHLA loans excluding higher education, c.£8.8bn will be reintegrated with Barclays International, primarily relating to derivatives and ESHLA higher education, and c.£10.5bn will be reintegrated with Head Office, primarily relating to Italian mortgages and operational risk

Guidance of a Non-Core loss before tax for 2017 of approximately £1bn is unchanged, with a loss before tax of approximately £300-400m in H217. The H217 loss before tax is anticipated to be split c.10% to Barclays UK, c.40% to Barclays International and c.50% to Head Office

As previously guided to, it is expected that risk weighted assets and loss before tax previously associated with Non-Core will continue to reduce in future periods

 

 

Moves to

Balance sheet information (£bn)1

Barclays Non-Core

Barclays UK

Barclays International

Head Office

Loans and advances to banks and customers at amortised cost

48.3

10.1

28.9

9.3

Derivative financial instrument assets

150.3

-

150.3

-

Derivative financial instrument liabilities

143.0

-

143.0

-

Financial assets designated at fair value

12.1

8.2

3.2

0.7

Total assets

233.0

18.3

200.3

14.4

Customer deposits

11.8

-

11.7

0.1

Risk weighted assets

22.8

3.5

8.8

10.5

Period end allocated tangible equity

4.0

0.7

1.6

1.7

 

 

1

Estimated allocation based on 30.06.17 balance sheet.

 

Discontinued Operation Results

 

Disposal of the shares in BAGL

On 1 March 2016, Barclays announced its intention to reduce the Group's 62.3% interest in BAGL to a level which would permit Barclays to deconsolidate BAGL from a regulatory perspective and, prior to that, from an accounting perspective. From this date, BAGL was treated as a discontinued operation. On 5 May 2016, Barclays sold 12.2% of the Group's interest in BAGL, reducing Barclays' interest to 50.1% of BAGL's issued share capital.

In December 2016, Barclays agreed the terms of the transitional services arrangements and separation payments of £0.7bn, as announced in Barclays' 2016 Annual Report.

Following receipt of the required regulatory approvals, on 1 June 2017 Barclays sold 286 million ordinary shares of BAGL, representing 33.7% of BAGL's issued share capital, of which 7.0% is allocated to the Public Investment Corporation (PIC) who is expected to take receipt of the shares following the necessary regulatory approvals. Following the sale, as at 30 June 2017 Barclays accounted for 139 million ordinary shares in BAGL, representing 16.4% of BAGL's issued share capital. An amount of £1,141m was recognised on the balance sheet at the date of disposal, representing the fair value.

Additionally, as at 30 June 2017 Barclays had an obligation to contribute 1.5% of BAGL's ordinary shares or the cash equivalent to a Black Economic Empowerment (BEE) scheme. As at 30 September 2017, Barclays will account for 126 million ordinary shares in BAGL, currently representing 14.9% of BAGL's issued share capital. A liability for the obligation to the BEE scheme of £105m is reflected on the balance sheet.

Financial performance

The discontinued operation reported a loss before tax of £2,041m in H117, representing (i) a profit before tax on Africa Banking operations for five months to 31 May 2017, excluding impairment of Barclays' holding in BAGL and loss on sale of BAGL, of £484m, (ii) a £60m loss on sale of the 33.7% share of BAGL's issued share capital on 1 June 2017, (iii) a £1,375m loss on recycling of Other Comprehensive Income reserves of which £1,377m relates to the currency translation reserve, owing to the weakening of the ZAR since initial consolidation of BAGL in 2005, and (iv) a £1,090m impairment of Barclays' holding in BAGL, predominantly allocated to acquisition goodwill. The recycling of the currency translation reserve and the impairment of Barclays' holding in BAGL allocated to acquisition goodwill had no effect on the Group's tangible net asset value or CET1 ratio.

Accounting and regulatory treatment

The sale of 33.7% of BAGL's issued share capital resulted in the accounting deconsolidation of BAGL from the Barclays Group, as of 1 June 2017. Barclays' holding in BAGL technically met the requirements to be treated as an Associate, the subsequent revision of its governance rights in July 2017 means that it is treated as an Available for Sale (AFS) asset. Given the immateriality of the differences between the accounting treatments since 1 June it has been determined that it would be appropriate to treat this holding as an AFS asset since 1 June 2017. BAGL is consequently no longer reported as a discontinued operation and the retained investment will be reported in the Head Office segment. Barclays' share of BAGL's dividend will be recognised in the Group's income statement when the right to receive the dividend has been established, and changes in fair value of the asset will be recognised in the AFS reserve.

For regulatory reporting purposes, BAGL is treated at 30 June 2017 on a proportional consolidated basis based on a holding of 23.4%. The Group's CET1 ratio increased 47bps as a result of the sale and reflecting the proportional consolidation of BAGL. Barclays expects to proportionally consolidate BAGL in H217 based on a holding of 14.9%, following the contribution of 1.5% of BAGL's issued share capital to a BEE scheme and the expected delivery of 7.0% of BAGL's issued share capital to PIC. Subject to regulatory approval, Barclays expects to fully deconsolidate BAGL from a regulatory perspective within 18 months. The estimated future accretion to the Group's CET1 ratio is c.26bps in aggregate.

 

Africa Banking

Half year ended

Half year ended

30.06.17

30.06.16

YoY

Income statement information¹

£m

£m

% Change

Net interest income

1,024

982

4

Net fee, commission and other income

762

715

7

Total income

1,786

1,697

5

Credit impairment charges and other provisions

(177)

(244)

27

Net operating income

1,609

1,453

11

Operating expenses excluding impairment of Barclays' holding in BAGL

(1,130)

(1,020)

(11)

Other net income excluding loss on sale of BAGL

5

2

Profit before tax excluding impairment of Barclays' holding in BAGL and loss on sale of BAGL

484

435

11

Impairment of Barclays' holding in BAGL

(1,090)

-

Loss on sale of BAGL

(1,435)

-

(Loss)/profit before tax

(2,041)

435

Tax charge

(154)

(124)

(24)

(Loss)/profit after tax

(2,195)

311

Attributable (loss)/profit

(2,335)

156

As at 30.06.17

As at 31.12.16

As at 30.06.16

Balance sheet information

£bn

£bn

£bn

Total assets

-

65.1

56.0

Risk weighted assets2

9.8

42.3

36.1

 

 

1

The H117 Africa Banking income statement represents five months of results as a discontinued operation to 31 May 2017.

2

Africa Banking (excluding Egypt and Zimbabwe) RWAs are reported in Head Office within Core.

 

 

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information1

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

407

617

626

561

502

480

468

471

Net fee, commission and other income

297

465

441

421

377

338

346

351

Total income

704

1,082

1,067

982

879

818

814

822

Credit impairment charges and other provisions

(71)

(106)

(105)

(96)

(133)

(111)

(93)

(66)

Net operating income

633

976

962

886

746

707

721

756

Operating expenses excluding UK bank levy and impairment of Barclays' holding in BAGL

(477)

(653)

(727)

(598)

(543)

(477)

(501)

(515)

UK bank levy

-

-

(65)

-

-

-

(50)

-

Other net income excluding loss on sale of BAGL

3

2

2

2

1

1

3

1

Profit before tax excluding impairment of Barclays' holding in BAGL and loss on sale of BAGL

159

325

172

290

204

231

173

242

Impairment of Barclays' holding in BAGL

(206)

(884)

-

-

-

-

-

-

Loss on sale of BAGL

(1,435)

-

-

-

-

-

-

-

(Loss)/profit before tax

(1,482)

(559)

172

290

204

231

173

242

(Loss)/profit after tax

(1,537)

(658)

71

209

145

166

101

167

Attributable (loss)/profit

(1,534)

(801)

(52)

85

70

86

25

85

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

-

66.0

65.1

61.1

56.0

52.7

47.9

50.2

Risk weighted assets

9.8

41.3

42.3

39.9

36.1

33.9

31.7

33.8

 

1

The Q217 Africa Banking income statement represents two months of results as a discontinued operation to 31 May 2017.

 

Quarterly Results Summary

Barclays Group

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

2,579

2,519

2,523

2,796

2,530

2,688

2,726

2,692

Net fee, commission and other income

2,479

3,304

2,469

2,650

3,442

2,353

1,722

2,789

Total income

5,058

5,823

4,992

5,446

5,972

5,041

4,448

5,481

Credit impairment charges and other provisions

(527)

(527)

(653)

(789)

(488)

(443)

(554)

(429)

Net operating income

4,531

5,296

4,339

4,657

5,484

4,598

3,894

5,052

Operating expenses excluding UK bank levy and litigation and conduct

(3,398)

(3,591)

(3,812)

(3,581)

(3,425)

(3,747)

(3,547)

(3,552)

UK bank levy

-

-

(410)

-

-

-

(426)

-

Litigation and conduct

(715)

(28)

(97)

(741)

(447)

(78)

(1,722)

(699)

Operating expenses

(4,113)

(3,619)

(4,319)

(4,322)

(3,872)

(3,825)

(5,695)

(4,251)

Other net income/(expenses)

241

5

310

502

(342)

20

(274)

(182)

Profit/(loss) before tax

659

1,682

330

837

1,270

793

(2,075)

619

Tax (charge)/credit

(305)

(473)

50

(328)

(467)

(248)

(164)

(133)

Profit/(loss) after tax in respect of continuing operations

354

1,209

380

509

803

545

(2,239)

486

(Loss)/profit after tax in respect of discontinued operation

(1,537)

(658)

71

209

145

166

101

167

Attributable to:

Ordinary equity holders of the parent

(1,401)

190

99

414

677

433

(2,422)

417

Other equity holders

162

139

139

110

104

104

107

79

Non-controlling interests

56

222

213

194

167

174

177

157

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

1,135.3

1,203.8

1,213.1

1,324.0

1,351.3

1,248.9

1,120.0

1,236.5

Risk weighted assets

327.4

360.9

365.6

373.4

366.3

363.0

358.4

381.9

CRR leverage exposure

1,122.1

1,196.9

1,125.5

1,185.1

1,155.4

1,082.0

1,027.8

1,140.7

Performance measures

Return on average tangible shareholders' equity

(11.0%)

1.8%

1.1%

3.6%

5.8%

3.8%

(20.1%)

3.6%

Average tangible shareholders' equity (£bn)

49.3

49.4

48.9

49.4

48.3

48.3

47.8

47.6

Cost: income ratio

81%

62%

87%

79%

65%

76%

128%

78%

Loan loss rate (bps)

49

47

58

66

41

40

53

37

Basic (loss)/earnings per share

(8.0p)

1.3p

0.8p

2.6p

4.2p

2.7p

(14.4p)

2.6p

Basic earnings/(loss) per share in respect of continuing operations

1.0p

6.1p

1.1p

2.1p

3.8p

2.2p

(14.4p)

2.1p

 

Barclays Core

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

2,702

2,508

2,577

2,718

2,491

2,591

2,555

2,557

Net fee, commission and other income

2,812

3,389

2,834

2,887

3,825

2,692

1,961

2,708

Total income

5,514

5,897

5,411

5,605

6,316

5,283

4,516

5,265

Credit impairment charges and other provisions

(500)

(524)

(606)

(769)

(462)

(414)

(522)

(388)

Net operating income

5,014

5,373

4,805

4,836

5,854

4,869

3,994

4,877

Operating expenses excluding UK bank levy and litigation and conduct

(3,290)

(3,443)

(3,471)

(3,270)

(3,057)

(3,258)

(2,992)

(3,094)

UK bank levy

-

-

(334)

-

-

-

(338)

-

Litigation and conduct

(696)

(19)

(46)

(639)

(420)

(12)

(1,634)

(419)

Operating expenses

(3,986)

(3,462)

(3,851)

(3,909)

(3,477)

(3,270)

(4,964)

(3,513)

Other net income/(expenses)

37

12

164

4

(18)

9

(5)

13

Profit/(loss) before tax

1,065

1,923

1,118

931

2,359

1,608

(975)

1,377

Tax charge

(512)

(548)

(272)

(522)

(696)

(485)

(92)

(299)

Profit/(loss) after tax

553

1,375

846

409

1,663

1,123

(1,067)

1,078

Non-controlling interests

(51)

(70)

(76)

(57)

(80)

(84)

(81)

(54)

Other equity holders

(143)

(121)

(121)

(95)

(89)

(89)

(92)

(63)

Attributable profit/(loss)

359

1,184

649

257

1,494

950

(1,240)

961

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

902.3

954.7

933.4

964.3

972.2

883.6

794.2

862.0

Risk weighted assets

304.6

333.5

333.5

329.5

319.6

312.2

304.1

316.3

Performance measures

Return on average allocated tangible equity

3.6%

11.0%

6.4%

2.7%

15.0%

9.9%

(12.8%)

10.4%

Average allocated tangible equity (£bn)

44.9

44.2

42.4

41.8

40.4

39.3

38.1

37.5

Cost: income ratio

72%

59%

71%

70%

55%

62%

110%

67%

Loan loss rate (bps)

52

53

61

74

45

42

57

39

Basic earnings/(loss) per share contribution

2.3p

7.2p

4.0p

1.7p

9.0p

5.8p

(7.3p)

5.8p

 

Barclays Non-Core

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

(123)

11

(54)

78

40

96

171

135

Net trading income

(411)

(77)

(462)

(288)

(463)

(490)

(398)

(124)

Net fee, commission and other income

78

(8)

97

51

79

152

159

204

Total income

(456)

(74)

(419)

(159)

(344)

(242)

(68)

215

Credit impairment charges and other provisions

(27)

(3)

(47)

(20)

(26)

(29)

(32)

(41)

Net operating (expenses)/income

(483)

(77)

(466)

(179)

(370)

(271)

(100)

174

Operating expenses excluding UK bank levy and litigation and conduct

(108)

(148)

(341)

(311)

(368)

(489)

(555)

(458)

UK bank levy

-

-

(76)

-

-

-

(88)

-

Litigation and conduct

(19)

(9)

(51)

(102)

(27)

(66)

(89)

(279)

Operating expenses

(127)

(157)

(468)

(413)

(395)

(555)

(732)

(737)

Other net income/(expenses)

204

(7)

146

498

(324)

11

(268)

(195)

Loss before tax

(406)

(241)

(788)

(94)

(1,089)

(815)

(1,100)

(758)

Tax credit/(charge)

207

75

322

194

229

237

(72)

166

(Loss)/profit after tax

(199)

(166)

(466)

100

(860)

(578)

(1,172)

(592)

Non-controlling interests

(8)

(9)

(14)

(13)

(12)

(10)

(19)

(21)

Other equity holders

(19)

(18)

(18)

(15)

(15)

(15)

(17)

(15)

Attributable (loss)/profit

(226)

(193)

(498)

72

(887)

(603)

(1,208)

(628)

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to banks and customers at amortised cost

48.3

49.5

51.1

58.7

68.5

55.4

51.8

57.1

Derivative financial instrument assets

150.3

164.2

188.7

253.2

262.8

249.7

213.7

243.3

Derivative financial instrument liabilities

143.0

155.3

178.6

243.0

253.4

239.1

202.1

235.0

Reverse repurchase agreements and other similar secured lending

-

-

0.1

0.1

0.1

0.7

3.1

8.5

Financial assets designated at fair value

12.1

13.4

14.5

15.5

15.4

23.4

21.4

22.8

Total assets

233.0

249.1

279.7

359.8

379.1

365.4

325.8

374.5

Customer deposits

11.8

12.9

12.5

16.0

17.4

19.3

20.9

25.8

Risk weighted assets

22.8

27.4

32.1

43.9

46.7

50.9

54.3

65.6

Performance measures

Average allocated tangible equity (£bn)

4.5

5.2

6.5

7.6

7.9

9.0

9.7

10.2

Period end allocated tangible equity (£bn)

4.0

4.8

5.4

7.2

7.8

8.5

8.5

10.2

Loan loss rate (bps)

22

2

31

13

14

21

25

27

Basic (loss)/earnings per share contribution

(1.3p)

(1.1p)

(2.9p)

0.5p

(5.2p)

(3.6p)

(7.2p)

(3.7p)

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

Businesses

(41)

51

(73)

181

181

196

229

314

Securities and loans

(25)

68

161

(34)

(363)

(402)

(195)

(87)

Derivatives

(390)

(193)

(507)

(306)

(162)

(36)

(102)

(12)

Total income

(456)

(74)

(419)

(159)

(344)

(242)

(68)

215

 

Quarterly Core Results by Business

Barclays UK

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,534

1,511

1,502

1,569

1,476

1,501

1,509

1,499

Net fee, commission and other income

286

330

326

374

467

302

325

375

Total income

1,820

1,841

1,828

1,943

1,943

1,803

1,834

1,874

Credit impairment charges and other provisions

(220)

(178)

(180)

(350)

(220)

(146)

(219)

(154)

Net operating income

1,600

1,663

1,648

1,593

1,723

1,657

1,615

1,720

Operating expenses excluding UK bank levy and litigation and conduct

(974)

(959)

(989)

(904)

(947)

(952)

(920)

(925)

UK bank levy

-

-

(48)

-

-

-

(77)

-

Litigation and conduct

(699)

4

(28)

(614)

(399)

(1)

(1,466)

(76)

Operating expenses

(1,673)

(955)

(1,065)

(1,518)

(1,346)

(953)

(2,463)

(1,001)

Other net (expenses)/income

(1)

-

-

-

(1)

-

1

1

(Loss)/profit before tax

(74)

708

583

75

376

704

(847)

720

Attributable (loss)/profit

(285)

470

383

(163)

141

467

(1,078)

541

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

166.6

164.5

166.4

166.6

166.0

166.2

166.1

166.7

Total assets

203.4

203.0

209.6

209.1

204.6

201.7

202.5

204.1

Customer deposits

187.4

184.4

189.0

185.5

181.7

179.1

176.8

173.4

Risk weighted assets

66.1

66.3

67.5

67.4

67.1

69.7

69.5

71.0

Performance measures

Return on average allocated tangible equity

(12.7%)

21.6%

18.2%

(7.1%)

6.6%

20.5%

(46.5%)

23.3%

Average allocated tangible equity (£bn)

8.7

8.9

8.6

8.7

9.0

9.3

9.2

9.3

Cost: income ratio

92%

52%

58%

78%

69%

53%

134%

53%

Loan loss rate (bps)

52

43

42

82

52

34

51

36

Net interest margin

3.70%

3.69%

3.56%

3.72%

3.56%

3.62%

3.58%

3.54%

 

Analysis of Barclays UK

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

Personal Banking

933

944

934

970

1,068

919

945

938

Barclaycard Consumer UK

495

498

507

561

463

491

505

552

Wealth, Entrepreneurs & Business Banking

392

399

387

412

412

393

384

384

Total income

1,820

1,841

1,828

1,943

1,943

1,803

1,834

1,874

Analysis of credit impairment charges and other provisions

Personal Banking

(56)

(50)

(50)

(47)

(44)

(42)

(39)

(36)

Barclaycard Consumer UK

(149)

(123)

(118)

(291)

(169)

(105)

(176)

(111)

Wealth, Entrepreneurs & Business Banking

(15)

(5)

(12)

(12)

(7)

1

(4)

(7)

Total credit impairment charges and other provisions

(220)

(178)

(180)

(350)

(220)

(146)

(219)

(154)

Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Personal Banking

136.5

134.4

135.0

135.3

134.7

134.7

134.0

134.5

Barclaycard Consumer UK

16.2

16.1

16.5

16.2

16.2

16.0

16.2

15.9

Wealth, Entrepreneurs & Business Banking

13.9

14.0

14.9

15.1

15.1

15.5

15.9

16.3

Total loans and advances to customers at amortised cost

166.6

164.5

166.4

166.6

166.0

166.2

166.1

166.7

Analysis of customer deposits

Personal Banking

138.5

137.3

139.3

137.2

134.8

132.9

131.0

128.4

Barclaycard Consumer UK

-

-

-

-

-

-

-

-

Wealth, Entrepreneurs & Business Banking

48.9

47.1

49.7

48.3

46.9

46.2

45.8

45.0

Total customer deposits

187.4

184.4

189.0

185.5

181.7

179.1

176.8

173.4

 

Barclays International

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,060

1,112

1,046

1,355

1,001

1,110

1,121

1,109

Net trading income

1,039

1,182

1,131

1,074

1,130

1,245

593

817

Net fee, commission and other income

1,511

1,844

1,415

1,422

1,908

1,158

1,254

1,297

Total income

3,610

4,138

3,592

3,851

4,039

3,513

2,968

3,223

Credit impairment charges and other provisions

(279)

(346)

(426)

(420)

(240)

(269)

(303)

(235)

Net operating income

3,331

3,792

3,166

3,431

3,799

3,244

2,665

2,988

Operating expenses excluding UK bank levy and litigation and conduct

(2,276)

(2,435)

(2,497)

(2,337)

(2,074)

(2,221)

(2,007)

(2,059)

UK bank levy

-

-

(284)

-

-

-

(253)

-

Litigation and conduct

4

(13)

(17)

(17)

(10)

(4)

(151)

(302)

Operating expenses

(2,272)

(2,448)

(2,798)

(2,354)

(2,084)

(2,225)

(2,411)

(2,361)

Other net income

202

12

5

8

11

8

8

9

Profit before tax

1,261

1,356

373

1,085

1,726

1,027

262

636

Attributable profit/(loss)

819

837

43

623

1,171

575

(24)

422

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to banks and customers at amortised cost

204.8

226.1

211.3

233.7

230.6

215.9

184.1

220.3

Trading portfolio assets

83.3

83.0

73.2

73.8

68.1

64.3

61.9

72.8

Derivative financial instrument assets

108.4

105.3

156.2

155.6

181.4

150.1

111.5

133.7

Derivative financial instrument liabilities

116.8

112.8

160.6

160.5

187.5

155.4

119.0

142.0

Reverse repurchase agreements and other similar secured lending

17.2

17.6

13.4

17.3

19.7

19.1

24.7

68.0

Financial assets designated at fair value

94.1

81.3

62.3

72.0

68.3

59.6

46.8

5.6

Total assets

681.6

677.2

648.5

681.9

679.9

618.4

532.2

596.1

Customer deposits

230.3

241.0

216.2

224.1

226.5

213.1

185.6

207.0

Risk weighted assets

212.2

214.3

212.7

214.6

209.3

202.2

194.8

204.0

Performance measures

Return on average allocated tangible equity

12.4%

12.5%

1.0%

10.0%

19.2%

9.5%

(0.2%)

7.0%

Average allocated tangible equity (£bn)

27.4

27.7

26.6

25.7

24.8

25.1

24.9

24.7

Cost: income ratio

63%

59%

78%

61%

52%

63%

81%

73%

Loan loss rate (bps)

54

62

78

71

41

50

65

42

Net interest margin

4.07%

4.06%

3.91%

4.21%

3.92%

3.78%

3.79%

3.85%

 

Analysis of Barclays International

Corporate and Investment Bank

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Analysis of total income

Credit

296

399

261

333

269

322

195

191

Equities

455

462

410

461

406

513

319

416

Macro

456

490

505

614

612

573

382

487

Markets

1,207

1,351

1,176

1,408

1,287

1,408

896

1,094

Banking fees

674

726

650

644

622

481

458

501

Corporate lending

278

269

303

284

312

296

312

377

Transactional banking

404

398

401

458

390

408

415

419

Banking

1,356

1,393

1,354

1,386

1,324

1,185

1,185

1,297

Other

1

38

1

1

-

3

16

(17)

Total income

2,564

2,782

2,531

2,795

2,611

2,596

2,097

2,374

Credit impairment releases/(charges) and other provisions

1

(51)

(90)

(38)

(37)

(95)

(83)

(75)

Operating expenses

(1,756)

(1,941)

(2,287)

(1,872)

(1,665)

(1,800)

(1,962)

(1,940)

Other net income

116

-

1

-

-

-

-

(1)

Profit before tax

925

790

155

885

909

701

52

358

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Risk weighted assets

178.9

180.6

178.6

182.5

178.4

172.6

167.3

177.4

Performance measures

Return on average allocated tangible equity

11.1%

8.2%

(1.2%)

9.2%

9.5%

7.3%

(2.5%)

4.5%

Average allocated tangible equity (£bn)

23.3

23.5

22.6

21.9

21.3

21.6

21.8

21.7

Consumer, Cards and Payments

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Total income

1,046

1,356

1,061

1,056

1,428

917

871

849

Credit impairment charges and other provisions

(280)

(295)

(336)

(382)

(203)

(174)

(219)

(160)

Operating expenses

(516)

(507)

(511)

(482)

(419)

(425)

(449)

(421)

Other net income

86

12

4

8

11

8

8

10

Profit before tax

336

566

218

200

817

326

210

278

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to banks and customers at amortised cost

38.5

38.7

39.7

36.8

35.4

32.9

32.1

30.6

Customer deposits

57.3

57.6

50.0

48.3

46.9

44.2

41.8

39.8

Risk weighted assets

33.3

33.7

34.1

32.1

30.9

29.6

27.5

26.6

Performance measures

Return on average allocated tangible equity

19.4%

36.4%

13.2%

14.8%

77.9%

23.4%

15.3%

24.7%

Average allocated tangible equity (£bn)

4.1

4.2

4.0

3.7

3.5

3.4

3.2

3.1

 

Head Office

Q217

Q117

Q416

Q316

Q216

Q116

Q415

Q315

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

108

(115)

29

(206)

14

(20)

(75)

(51)

Net fee, commission and other income1

(24)

33

(38)

17

320

(13)

(210)

220

Total income

84

(82)

(9)

(189)

334

(33)

(285)

169

Credit impairment (charges)/releases and other provisions

(1)

-

-

1

(2)

1

-

1

Net operating income/(expenses)

83

(82)

(9)

(188)

332

(32)

(285)

170

Operating expenses excluding UK bank levy and litigation and conduct

(40)

(49)

15

(29)

(36)

(85)

(64)

(110)

UK bank levy

-

-

(2)

-

-

-

(8)

-

Litigation and conduct

(1)

(10)

(1)

(8)

(11)

(7)

(17)

(42)

Operating expenses

(41)

(59)

12

(37)

(47)

(92)

(89)

(152)

Other net (expenses)/income

(164)

-

159

(4)

(28)

1

(14)

2

(Loss)/profit before tax

(122)

(141)

162

(229)

257

(123)

(388)

20

Attributable (loss)/profit

(175)

(123)

223

(203)

182

(92)

(140)

(1)

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

17.3

74.5

75.2

73.3

87.7

63.4

59.4

61.8

Risk weighted assets2

26.2

52.9

53.3

47.5

43.2

40.3

39.7

41.3

Performance measures

Average allocated tangible equity (£bn)

8.8

7.6

7.2

7.4

6.6

5.0

3.9

3.4

 

1

Following the early adoption of the own credit provisions of IFRS 9 on 1 January 2017, own credit, which was previously reported in Net fee, commission and other income is now recognised within other comprehensive income from Q117.

2

Includes Africa Banking RWAs.

 

Performance Management

 

Margins and balances

Half year ended 30.06.17

Half year ended 30.06.16

Net interest income

Average customer assets

Net interest margin

Net interest income

Average customer assets

Net interest margin

£m

£m

%

£m

£m

%

Barclays UK

3,045

166,200

3.69

2,977

166,944

3.59

Barclays International1

2,185

108,486

4.06

2,016

103,934

3.90

Total Barclays UK and Barclays International

5,230

274,686

3.84

4,993

270,878

3.71

Other2

(132)

225

Total net interest income

5,098

5,218

 

 

1

Barclays International margins include interest earning lending balances within the investment banking business.

2

Other includes Head Office, Barclays Non-Core and non-lending related investment banking balances.

Total Barclays UK and Barclays International net interest income increased 5% to £5,230m due to:

 

An increase in average customer assets to £274.7bn (H116: £270.9bn) predominantly driven by growth in Barclays International

Net interest margin increased 13bps to 3.84% primarily driven by higher margins on Personal Banking and Consumer, Cards and Payments deposits, partially offset by lower asset margins. Group net interest income decreased 2% to £5.1bn including net structural hedge contributions of £0.7bn (H116: £0.7bn)

Net interest margin by business reflects movements in the Group's internal funding rates which are based on the cost to the Group of alternative funding in wholesale markets. The internal funding rate prices intra-group funding and liquidity to appropriately give credit to businesses with net surplus liquidity and to charge those businesses in need of alternative funding at a rate that is driven by prevailing market rates and includes a term premium.

 

 

Quarterly analysis for Barclays UK and Barclays International

Three months ended 30.06.17

Net interest income

Average customer assets

Net interest margin

£m

£m

%

Barclays UK

1,534

166,345

3.70

Barclays International1

1,064

104,899

4.07

Total Barclays UK and Barclays International

2,598

271,244

3.84

Three months ended 31.03.17

Barclays UK

1,511

166,065

3.69

Barclays International1

1,121

112,060

4.06

Total Barclays UK and Barclays International

2,632

278,125

3.84

Three months ended 31.12.16

Barclays UK

1,502

167,935

3.56

Barclays International1

1,110

112,936

3.91

Total Barclays UK and Barclays International

2,612

280,871

3.70

Three months ended 30.09.16

Barclays UK

1,569

167,713

3.72

Barclays International1

1,149

108,571

4.21

Total Barclays UK and Barclays International

2,718

276,284

3.91

Three months ended 30.06.16

Barclays UK

1,476

166,891

3.56

Barclays International1

1,021

104,707

3.92

Total Barclays UK and Barclays International

2,497

271,598

3.70

 

1

Barclays International margins include interest earning lending balances within the investment banking business.

 

Risk Management

Risk management and principal risks

The roles and responsibilities of the business groups, Risk and Compliance, in the management of risk in the firm are defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the firm, the process by which the firm sets its appetite for these risks in its business activities, and the consequent limits which it places on related risk taking. The framework identifies eight Principal Risks: Credit Risk; Market Risk; Treasury and Capital Risk; Operational Risk; Conduct Risk; Reputation Risk; Model Risk; and Legal Risk. Further detail on these risks and how they are managed is available in the 2016 Annual Report or online at home.barclays.com/annualreport. There have been no significant changes to these principal risks in the period nor are any expected for the remaining six months of the financial year.

The following section gives an overview of Credit Risk, Market Risk and Treasury and Capital Risk for the period.

Credit Risk

Analysis of loans and advances to customers and banks

 

Loans and advances at amortised cost net of impairment allowances, by industry sector and geography

United Kingdom

Europe

Americas

Africa and Middle East

Asia

Total

As at 30.06.17

£m

£m

£m

£m

£m

£m

Banks

7,337

14,454

9,256

2,183

3,878

37,108

Other financial institutions

28,590

20,985

41,978

401

5,027

96,981

Home loans

131,962

11,659

578

382

125

144,706

Cards, unsecured loans and other personal lending

29,082

4,263

20,541

372

93

54,351

Construction and property

21,613

1,014

1,546

133

122

24,428

Other

48,346

8,297

9,680

1,005

2,210

69,538

Net loans and advances to customers and banks

266,930

60,672

83,579

4,476

11,455

427,112

Impairment allowance

2,678

562

1,184

102

30

4,556

Gross loans and advances to customers and banks

269,608

61,234

84,763

4,578

11,485

431,668

Loans and advances at fair value

10,239

984

1,195

-

6

12,424

As at 31.12.16

Banks

7,458

12,674

16,894

1,778

4,447

43,251

Other financial institutions

22,209

19,800

45,189

425

4,189

91,812

Home loans

131,801

11,918

594

354

98

144,765

Cards, unsecured loans and other personal lending

29,606

4,003

22,513

493

114

56,729

Construction and property

21,276

1,042

1,669

89

125

24,201

Other

48,860

10,287

11,080

1,728

3,322

75,277

Net loans and advances to customers and banks

261,210

59,724

97,939

4,867

12,295

436,035

Impairment allowance

2,544

686

1,247

89

54

4,620

Gross loans and advances to customers and banks

263,754

60,410

99,186

4,956

12,349

440,655

Loans and advances at fair value

9,130

772

525

27

65

10,519

 

 

Analysis of retail and wholesale loans and advances and impairment

Gross loans and advances

Impairment allowance

Loans and advances net of impairment

Credit

risk loans

CRLs % of gross loans and advances

Loan impairment charges1

Loan loss rates

As at 30.06.17

£m

£m

£m

£m

%

£m

bps

Barclays UK

155,040

1,585

153,455

1,980

1.3

380

49

Barclays International

30,801

1,505

29,296

1,247

4.0

578

378

Barclays Core

185,841

3,090

182,751

3,227

1.7

958

104

Barclays Non-Core

9,804

285

9,519

716

7.3

30

62

Total Group retail

195,645

3,375

192,270

3,943

2.0

988

102

Barclays UK

15,126

307

14,819

616

4.1

19

25

Barclays International

176,233

718

175,515

1,227

0.7

46

5

Head Office

5,702

-

5,702

-

-

-

-

Barclays Core

197,061

1,025

196,036

1,843

0.9

65

7

Barclays Non-Core

38,962

156

38,806

273

0.7

(1)

(1)

Total Group wholesale

236,023

1,181

234,842

2,116

0.9

64

5

Total loans and advances at amortised cost

431,668

4,556

427,112

6,059

1.4

1,052

49

Traded loans

3,942

n/a

3,942

n/a

Loans and advances designated at fair value

12,424

n/a

12,424

n/a

Loans and advances held at fair value

16,366

n/a

16,366

n/a

Total loans and advances

448,034

4,556

443,478

6,059

As at 31.12.16

Barclays UK

155,729

1,519

154,210

2,044

1.3

866

56

Barclays International

33,485

1,492

31,993

1,249

3.7

1,085

324

Barclays Core

189,214

3,011

186,203

3,293

1.7

1,951

103

Barclays Non-Core

10,319

385

9,934

838

8.1

102

99

Total Group retail

199,533

3,396

196,137

4,131

2.1

2,053

103

Barclays UK

15,204

282

14,922

591

3.9

30

20

Barclays International

180,102

748

179,354

1,470

0.8

258

14

Head Office

4,410

-

4,410

-

-

-

-

Barclays Core

199,716

1,030

198,686

2,061

1.0

288

14

Barclays Non-Core

41,406

194

41,212

299

0.7

11

3

Total Group wholesale

241,122

1,224

239,898

2,360

1.0

299

12

Total loans and advances at amortised cost

440,655

4,620

436,035

6,491

1.5

2,352

53

Traded loans

2,975

n/a

2,975

n/a

Loans and advances designated at fair value

10,519

n/a

10,519

n/a

Loans and advances held at fair value

13,494

n/a

13,494

n/a

Total loans and advances

454,149

4,620

449,529

6,491

1

Excluding impairment charges on available for sale investments and reverse repurchase agreements. H117 impairment charges represent 6 months charge, whereas December 2016 impairment charges represent 12 months charge.

 

Total loans and advances decreased £6bn to £448bn driven by a decrease in lending to banks and customers, partially offset by an increase in net settlement and cash collateral balances.

 

Credit risk loans (CRLs) and the ratio of CRLs to gross loans and advances decreased £0.4bn to £6.1bn and 0.1% to 1.4% respectively.

 

Analysis of forbearance programmes

Balances

Impairment allowance

Allowance coverage

As at

As at

As at

As at

As at

As at

30.06.17

31.12.16

30.06.17

31.12.16

30.06.17

31.12.16

£m

£m

£m

£m

%

%

Barclays UK

841

926

197

237

23.4

25.6

Barclays International

218

243

84

57

38.5

23.5

Barclays Core

1,059

1,169

281

294

26.5

25.1

Barclays Non-Core

201

211

11

9

5.5

4.3

Total retail

1,260

1,380

292

303

23.2

22.0

Barclays UK

590

589

57

62

9.7

10.5

Barclays International

2,399

2,044

300

257

12.5

12.6

Barclays Core

2,989

2,633

357

319

11.9

12.1

Barclays Non-Core

201

269

54

50

26.9

18.5

Total wholesale

3,190

2,902

411

369

12.9

12.7

Group total

4,450

4,282

703

672

15.8

15.7

Retail balances decreased 9% to £1.3bn primarily due to continued improvement in the residential mortgage and Barclaycard portfolios within Barclays UK.

 

Barclays UK: Forbearance balances decreased 9% to £841m following a continued improvement in mortgage and card portfolios driven by the benign economic environment

Barclays International: Balances decreased primarily in US cards due to stricter forbearance criteria whereas impairment allowance increased as a result of a strengthened impairment methodology

 

Wholesale balances increased 10% to £3.2bn primarily due to an increase in forborne balances in Barclays International slightly offset by a reduction in Barclays Non-Core portfolios.

 

Barclays UK: Forbearance balances remained stable at £590m (December 2016 : £589m)

Barclays International: Balances increased £355m to £2.4bn as consistent forbearance methodologies were introduced across CIB

 

Analysis of specific portfolios and asset types

Secured home loans

The UK home loan portfolio primarily comprises first lien mortgages and accounts for 99%1 (2016: 98%) of total home loans in the Group's retail core portfolios.

Home loans principal portfolios2

Barclays UK

As at

As at

30.06.17

31.12.16

Gross loans and advances (£m)

128,966

129,136

>90 day arrears, excluding recovery book (%)

0.2

0.2

Non-performing proportion of outstanding balances (%)

0.5

0.6

Annualised gross charge-off rates (%)

0.2

0.3

Recovery book proportion of outstanding balances (%)

0.3

0.4

Recovery book impairment coverage ratio (%)

9.8

9.1

 

1

Remaining balance represents Wealth portfolio.

2

Gross loans and advances include loans and advances to customers and banks. Risk metrics based on exposures to customers only.

 

Barclays UK: Arrears and charge-off rates remained stable reflecting the continuing low base rate environment. The recovery book impairment coverage ratio increased as a result of a reduction in the recovery book without a corresponding release in the impairment provision. Balance weighted LTV reduced to 47.4% (2016: 47.7%) as average house prices increased. This increase also contributed to a 4% reduction in home loans with LTV >100% to £229m (2016: £239m)

Within the UK home loans portfolio:

 

Owner-occupied interest-only home loans comprised 29.5% (2016: 30.8%) of total balances. The average balance weighted LTV on these loans reduced to 40.7% (2016: 41.7%) as house prices improved across core regions and >90 day arrears was stable at 0.2% (2016: 0.2%)

Buy-to-let (BTL) home loans comprised 9.8% (2016: 9.1%) of total balances with the increase driven by strong performance in this segment. The average balance weighted LTV increased marginally to 52.9% (2016: 52.6%) while the >90 day arrears remained stable at 0.1% (2016: 0.1%)

 

Home loans principal portfolios-distribution of balances by LTV1

Distribution of balances

Impairment coverage ratio

Non-performing proportion of outstanding balances

Non-performing balances impairment coverage ratio

Recovery book proportion of outstanding balances

Recovery book impairment coverage ratio

As at

30.06.17

31.12.16

30.06.17

31.12.16

30.06.17

31.12.16

30.06.17

31.12.16

30.06.17

31.12.16

30.06.17

31.12.16

Barclays UK

%

%

%

%

%

%

%

%

%

%

%

%

91.5

91.8

0.1

0.1

0.5

0.6

4.0

4.2

0.3

0.4

6.1

5.9

>75% and

4.0

3.5

0.2

0.2

0.6

0.6

16.9

17.1

0.4

0.4

23.2

22.1

>80% and

2.3

2.1

0.2

0.2

0.6

0.8

15.8

20.4

0.4

0.6

20.3

25.0

>85% and

1.2

1.3

0.3

0.3

0.7

0.7

25.4

23.0

0.5

0.6

32.6

25.4

>90% and

0.6

0.8

0.4

0.4

1.0

1.1

30.8

28.3

0.8

0.8

35.1

33.7

>95% and

0.2

0.3

1.0

0.7

2.6

1.9

29.7

23.4

1.9

1.5

36.5

27.0

>100%

0.2

0.2

3.7

3.1

6.5

5.7

41.0

38.6

5.5

5.0

45.6

40.9

 

1

Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest house price index available as at 30 June 2017.

 

Home loans principal portfolios - average LTV

Barclays UK

As at

As at

30.06.17

31.12.16

Portfolio marked to market LTV:

Balance weighted (%)

47.4

47.7

Valuation weighted (%)

35.2

35.6

For > 100% LTVs:

Balances (£m)

229

239

Marked to market collateral (£m)

203

210

Average LTV: balance weighted (%)

124.8

118.4

Average LTV: valuation weighted (%)

117.6

113.1

% of balances in recovery book

5.5

5.0

 

Home loans principal portfolios - new lending

Barclays UK

Half year

Half year

ended

ended

30.06.17

30.06.16

New home loan bookings (£m)

10,025

9,990

New home loans proportion above 85% LTV (%)

4.7

8.7

Average LTV on new home loans: balance weighted (%)

62.4

63.2

Average LTV on new home loans: valuation weighted (%)

54.6

54.8

 

 

Barclays UK: New lending remained stable at £10.0bn (H116: £10.0bn). The decrease in mortgages with LTV > 85% to 4.7% (H116 8.7%) reflects an increased focus on remortgage business, which is typically lower LTV, and the closure of the Help to Buy 2 scheme that supported owner occupied home purchase loans where maximum LTV was 95%.

Credit cards and unsecured loans

The principal portfolios listed below accounted for 92% (2016: 94%) of the Group's total credit cards and unsecured loans.

 

Principal portfolios

 

Gross loans and advances1

30 day

arrears, excluding recovery book

90 day

arrears, excluding recovery book

Annualised gross

charge-off

rates

Recovery book

proportion of

outstanding balances

Recovery book impairment coverage ratio

As at 30.06.17

£m

%

%

%

%

%

Barclays UK

UK cards2

17,528

2.0

0.9

5.0

3.7

83.6

UK personal loans

6,254

2.2

1.0

3.5

4.7

78.6

Barclays International

US cards2

21,413

2.2

1.1

5.3

2.9

84.4

Barclays Partner Finance

3,857

1.4

0.5

2.7

2.4

81.0

Germany cards

1,912

2.9

1.1

3.7

2.7

79.8

As at 31.12.16

Barclays UK

UK cards2

17,833

1.9

0.9

5.5

3.0

83.8

UK personal loans

6,076

2.1

0.9

3.1

4.7

77.2

Barclays International

US cards2

23,915

2.6

1.3

4.5

2.4

83.6

Barclays Partner Finance

4,041

1.5

0.6

2.5

2.6

81.5

Germany cards

1,812

2.6

1.0

3.7

2.7

79.0

1

Gross loans and advances include loans and advances to customers and banks. Risk metrics based on exposures to customers.

2

For UK and US cards, outstanding recovery book balances for acquired portfolios recognised at fair value (which have no related impairment allowance) have been excluded from the recovery book impairment coverage ratio. Losses have been recognised where related to additional spend from acquired accounts in the period post acquisition.

UK cards: In 2017, both early and late stage arrears remained broadly stable. Charge-off rates reduced in the first half of 2017 following the non-recurrence of one-off accelerated charge-offs. However, recovery book proportion of outstanding balances was higher due to accelerated charge-off of certain forbearance plans since the beginning of the year.

US cards: Arrears rates improved principally due to a one-off portfolio sale. The higher charge-off rate is a result of accelerating the timeframe in which settlements and bankrupt clients are charged off to align with US industry standards. The increase in impairment coverage ratio for recovery book was due to a model enhancement providing a more accurate representation of future recovery expectations.

 

Market Risk

Analysis of management VaR

 

The table below shows the total management VaR on a diversified basis by risk factor. Total management VaR includes all trading positions in CIB, Non-Core and Head Office and it is calculated with one day holding period

Limits are applied against each risk factor VaR as well as total Management VaR, which are then cascaded further by risk managers to each business

 

Management VaR (95%) by asset class1

Half year ended

30.06.17

31.12.16

30.06.16

Average

High2

Low2

Average

High2

Low2

Average

High2

Low2

£m

£m

£m

£m

£m

£m

£m

£m

£m

Credit risk

13

18

10

16

24

13

15

23

9

Interest rate risk

7

15

4

8

13

5

6

10

4

Equity risk

8

14

4

7

11

4

6

10

4

Basis risk

5

6

4

6

9

5

5

6

3

Spread risk

4

6

3

4

5

3

3

5

2

Foreign exchange risk

3

5

2

3

5

2

3

4

2

Commodity risk

2

3

1

2

3

2

2

4

1

Inflation risk

2

4

1

2

3

2

2

3

2

Diversification effect

(24)

-

-

(26)

-

-

(22)

-

-

Total management VaR

20

26

17

22

29

15

20

29

13

 

 

1

Including BAGL.

2

The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table.

 

Average total management VaR decreased 9% to £20m. Credit Risk VaR reduced by 19% to £13m primarily driven by reduction in counterparty risk trading as Barclays CDS spread tightened and a decrease in loan commitment hedging.

Treasury and Capital Risk

The Group has a comprehensive Key Risk Control Framework for managing the Group's liquidity risk. The Liquidity Framework meets the PRA's standards and is designed to ensure the Group maintains liquidity resources that are sufficient in amount and quality, and a funding profile that is appropriate to meet the liquidity risk appetite. The Liquidity Framework is delivered via a combination of policy formation, review and governance, analysis, stress testing, limit setting and monitoring.

Funding and liquidity

Whilst Barclays has a comprehensive framework for managing the Group's liquidity risks, liquidity risk is managed separately at Barclays Africa Group Limited (BAGL) due to local currency and funding requirements. All liquidity related disclosures treat BAGL on a fully deconsolidated basis.

Liquidity stress testing

Barclays manages the Group's liquidity position against the Group's internally defined Liquidity Risk Appetite (LRA) and regulatory metrics such as CRD IV Liquidity Coverage Ratio (LCR). As at June 2017, the Group held eligible liquid assets well in excess of 100% of net stress outflows for both the 30 day Barclays-specific LRA and the LCR.

 

 

Compliance with internal and regulatory stress tests

Barclays' LRA (30 day Barclays specific requirement)1

CRD IV

LCR2

£bn

£bn

Eligible liquidity buffer

201

199

Net stress outflows

(129)

(134)

Surplus

71

65

Liquidity pool as a percentage of anticipated net outflows as at 30 June 2017

155%

149%

Liquidity pool as a percentage of anticipated net outflows as at 31 December 2016

120%

131%

 

 

1

Of the three stress scenarios monitored as part of the LRA, the 30 day Barclays specific scenario results in the lowest ratio at 155% (December 2016: 120%). This compares to 177% (December 2016: 134%) under the 90 day market-wide scenario and 190% (December 2016: 144%) under the 30 day combined scenario.

 

Barclays manages the Group's liquidity position against the Group's internally defined Liquidity Risk Appetite (LRA) and regulatory metrics, such as CRD IV Liquidity Coverage Ratio (LCR). As at 30 June 2017, the Group held eligible liquid assets significantly in excess of 100% of net stress outflows for both the 30 day Barclays-specific LRA and the LCR.

LRA buffer duration as of 30 June 2017 was observed at in excess of 90 days (December 2016: in excess of 90 days).

 

Composition of the Group liquidity pool

Liquidity pool

Liquidity pool of which interim CRD IV LCR-eligible

Liquidity pool

30.06.17

Cash

Level 1

Level 2A

31.12.16

£bn

£bn

£bn

£bn

£bn

Cash and deposits with central banks1

146

141

-

-

103

Government bonds

AAA to AA-

39

-

39

-

34

A+ to A-

-

-

-

-

3

BBB+ to BBB-

1

-

1

-

1

Other LCR Ineligible government bonds

-

-

-

-

1

Total government bonds

40

-

40

-

39

Other

Government Guaranteed Issuers, PSEs and GSEs

8

-

7

1

12

International Organisations and MDBs

5

-

5

-

6

Covered bonds

1

-

1

-

1

Other

1

-

-

-

4

Total other

15

-

13

1

23

Total as at 30 June 2017

201

141

53

1

Total as at 31 December 2016

165

101

55

3

 

 

1

Of which over 98% (December 2016: over 98%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.

 

Barclays manages the liquidity pool on a centralised basis. The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. As at 30 June 2017, 94% (December 2016: 91%) of the liquidity pool was located in Barclays Bank PLC and was available to meet liquidity needs across the Barclays Group. The residual liquidity pool is held predominantly within Barclays Capital Inc. The portion of the liquidity pool outside of Barclays Bank PLC is held primarily against entity-specific stressed outflows and regulatory requirements.

 

 

Deposit funding

As at 30.06.17

As at 31.12.16

Funding of loans and advances to customers

Loans and advances to customers

Customer deposits

Loan to deposit ratio

Loan to deposit ratio

£bn

£bn

%

%

Barclays UK

167

187

Barclays International1

94

159

Non-Core1

20

-

Total retail and corporate funding1

281

346

81%

83%

Barclays International and Head Office2

109

91

Total

390

437

89%

93%

 

 

1

Excluding the investment banking businesses.

2

Including the investment banking businesses.

 

Barclays UK and Barclays International (excluding the investment banking balances) are largely funded by customer deposits. The loan to deposit ratio for these businesses was 81% (December 2016: 83%).

The loan to deposit ratio for the Group was 89% (December 2016: 93%).

 

Wholesale funding

 

Funding of other assets as at 30 June 2017

Assets

£bn

Liabilities

£bn

Trading portfolio assets

56

Repurchase agreements

121

Reverse repurchase agreements

65

Reverse repurchase agreements

40

Trading portfolio liabilities

40

Derivative financial instruments

260

Derivative financial instruments

261

Liquidity pool1

136

Less than 1 year wholesale debt

72

Other assets2

95

Greater than 1 year wholesale debt and equity

158

 

 

1

The portion of the liquidity pool estimated to be funded by wholesale funds.

2

Predominantly available for sale investments, trading portfolio assets, financial assets designated at fair value and loans and advances to banks.

 

Repurchase agreements fund reverse repurchase agreements and trading portfolio assets. Trading portfolio liabilities are settled by the remainder of reverse repurchase agreements.

Derivative liabilities and assets are largely matched. A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are largely offset once netted against cash collateral received and paid.

Wholesale debt, along with the surplus of customer deposits to loans and advances to customers, is used to fund the liquidity pool. Term wholesale debt and equity largely fund other assets.

 

Composition of wholesale funding1

As the Group progresses to a Single Point of Entry resolution model, Barclays continues to issue debt capital and term senior unsecured funding from Barclays PLC, the holding company, replacing maturing debt in Barclays Bank PLC.

 

 

Maturity profile of wholesale funding

month

1-3 months

3-6 months

6-12 months

year

1-2 years

2-3 years

3-4 years

4-5 years

>5

years

Total

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Barclays PLC

Senior unsecured (public benchmark)

 -

 -

 -

0.8

0.8

0.1

2.3

2.8

4.5

9.9

20.4

Senior unsecured (privately placed)

 -

 -

 -

 -

 -

0.1

 -

0.1

0.1

0.5

0.8

Subordinated liabilities

 -

 -

 -

 -

 -

 -

 -

1.1

 -

4.2

5.3

Barclays Bank PLC

Deposits from banks

10.6

5.6

1.0

0.8

18.0

0.1

 -

0.2

 -

 -

18.3

Certificates of deposit and commercial paper

0.6

6.4

10.4

8.5

25.9

0.7

0.9

0.5

0.4

0.1

28.5

Asset backed commercial paper

2.7

3.4

1.4

0.2

7.7

 -

 -

 -

 -

 -

7.7

Senior unsecured (public benchmark)

 -

 -

 -

 -

 -

1.4

1.9

0.6

0.1

1.1

5.1

Senior unsecured (privately placed)2

1.0

1.6

1.7

5.2

9.5

7.8

5.8

2.0

2.3

12.1

39.5

Covered bonds

 -

1.5

 -

1.0

2.5

 -

2.8

1.0

2.4

1.3

10.0

Asset backed securities

 -

 -

0.6

0.7

1.3

0.6

2.3

 -

0.1

1.3

5.6

Subordinated liabilities

 -

 -

1.2

3.1

4.3

 -

 -

5.9

1.4

7.0

18.6

Other3

1.3

0.5

0.1

0.3

2.2

0.2

0.1

0.2

 -

0.5

3.2

Total as at 30 June 2017

16.2

19.0

16.4

20.6

72.2

11.0

16.1

14.4

11.3

38.0

163.0

Of which secured

2.7

4.9

2.0

2.0

11.6

0.6

5.1

1.0

2.5

2.6

23.4

Of which unsecured

13.5

14.1

14.4

18.6

60.6

10.4

11.0

13.4

8.8

35.4

139.6

Total as at 31 December 2016

16.6

17.3

16.4

20.0

70.3

14.3

14.4

8.6

14.1

36.1

157.8

Of which secured

3.7

5.6

3.4

2.3

15.0

1.8

3.2

0.4

1.0

4.4

25.8

Of which unsecured

12.9

11.7

13.0

17.7

55.3

12.5

11.2

8.2

13.1

31.7

132.0

 

 

1

The composition of wholesale funds comprises the balance sheet reported Deposits from Banks, Financial liabilities at Fair Value, Debt Securities in Issue and Subordinated Liabilities, excluding cash collateral and settlement balances. It does not include participation in the Bank of England's Term Funding Scheme.

2

Includes structured notes of £30.1bn, £8.2bn of which matures within one year.

3

Primarily comprised of fair value deposits £2.1bn and secured financing of physical gold £0.3bn.

 

Outstanding wholesale funding includes £40.3bn (December 2016: £37.6bn) of privately placed senior unsecured notes in issue. These notes are issued through a variety of distribution channels including intermediaries and private banks. Although not a requirement, the liquidity pool exceeded wholesale funding maturing in less than one year by £128.8bn (December 2016: £94.7bn).

Term financing

 

The Group issued £7.6bn equivalent of capital and term senior unsecured debt from Barclays PLC (HoldCo) of which £4.8bn was in public senior unsecured debt and £2.8bn was in capital instruments. In the same period, £4.7bn of Barclays Bank PLC (OpCo) capital and senior public term instruments either matured or were redeemed, including the $1.375bn 7.1% Series 3 USD preference shares.

 

In addition, Barclays has £8.6bn of term funding maturing in the remainder of 2017 and £11.2bn in 2018.

 

The Group expects to continue issuing public wholesale debt in 2017 from Barclays PLC, in order to ensure compliance with new prospective loss absorbency requirements and maintain a stable and diverse funding base by type, currency and distribution channel.

 

Credit ratings

 

In addition to monitoring and managing key metrics related to the financial strength of the Group, Barclays also solicits independent credit ratings by Standard & Poor's (S&P), Moody's, Fitch and Rating and Investment Information (R&I). These ratings assess the creditworthiness of the Group, its subsidiaries and branches, and are based on reviews of a broad range of business and financial attributes including risk management processes and procedures, capital strength, earnings, funding, asset quality, liquidity, accounting and governance.

 

 

Barclays Bank PLC

Standard & Poor's

Moody's

Fitch

Long-term

A- (Negative)

A1 (Negative)

A (Stable)

Short-term

A-2

P-1

F1

Standalone rating1

bbb+

baa2

a

Barclays PLC

Standard & Poor's

Moody's

Fitch

Long-term

BBB (Negative)

Baa2 (Negative)

A (Stable)

Short-term

A-2

P-3

F1

 

 

1

Refers to Standard & Poor's Stand-Alone Credit Profile (SACP), Moody's Baseline Credit Assessment (BCA) and Fitch's Viability Rating (VR).

 

As at 30 June 2017, all solicited ratings with all agencies remained unchanged since 31 December 2016. S&P affirmed Barclays' ratings in May 2017 as part of their periodic review.

Barclays' ratings outlooks for Moody's and S&P remain negative following the outcome of the EU referendum in June 2016, which were part of a wider review which saw the two agencies place several UK banks on negative outlooks whilst affirming the ratings. The ratings continue to carry a stable outlook with Fitch.

Barclays also solicits issuer ratings from R&I for local issuances purposes in Japan and the ratings of A for Barclays Bank PLC and A- for Barclays PLC and were affirmed in July 2017 with stable outlooks.

CRD IV capital

Barclays' current regulatory requirement is to meet a fully loaded CET1 ratio comprising the required 4.5% Pillar 1 minimum CET1 requirement and, phased in from 2016, a Combined Buffer Requirement. This currently comprises a Capital Conservation Buffer (CCB) and a Global Systemically Important Institution (G-SII) buffer determined by the PRA in line with guidance from the Financial Stability Board (FSB). Both buffers are subject to phased implementation at 25% per annum from 2016 with full effect from 2019. The CCB has been set at 2.5% with 1.25% applicable for 2017. The G-SII buffer for 2017 has been set at 2% with 1% applicable for 2017. On 21 November 2016 the FSB confirmed that the G-SII buffer for 2018 will be 1.5% with 1.1% applicable for 2018.

 

The Combined Buffer Requirement also includes a Counter-Cyclical Capital Buffer (CCyB) and a Systemic Risk Buffer (SRB). On 27 June 2017 the Financial Policy Committee (FPC) increased the UK CCyB rate from 0% to 0.5% applicable from 27 June 2018. Other national authorities also determine the appropriate CCyBs that should be applied to exposures in their jurisdiction. CCyBs have started to apply for Barclays' exposures to other jurisdictions; however based on current exposures these are not material. No SRB has been set to date.

 

In addition, Barclays' Pillar 2A requirement as per the PRA's Individual Capital Guidance (ICG) for 2017 based on a point in time assessment is 4.2% of which 56% needs to be met in CET1 form, equating to approximately 2.3% of RWAs. The Pillar 2A requirement is subject to at least annual review.

 

For regulatory reporting purposes, BAGL is treated on a proportional consolidated basis based on a Barclays' holding in BAGL of 23.4%.

 

As at 30 June 2017 Barclays' CET1 ratio was 13.1% which exceeds the 2017 transitional minimum requirement of 9.1% including the minimum 4.5% CET1 ratio requirement, 2.3% of Pillar 2A, a 1.25% CCB buffer, a 1% G-SII buffer and a 0% CCyB.

 

Capital ratios

As at

As at

As at

30.06.17

31.03.17

31.12.16

Fully loaded CET11,2

13.1%

12.5%

12.4%

PRA Transitional Tier 13,4

16.6%

15.8%

15.6%

PRA Transitional Total Capital3,4

20.7%

19.6%

19.6%

Capital resources

£m

£m

£m

Shareholders' equity (excluding non-controlling interests) per the balance sheet

63,866

65,536

64,873

Less: other equity instruments (recognised as AT1 capital)

(7,694)

(7,690)

(6,449)

Adjustment to retained earnings for foreseeable dividends

(303)

(519)

(388)

Minority interests (amount allowed in consolidated CET1)

-

1,864

1,825

Other regulatory adjustments and deductions:

Additional value adjustments (PVA)

(1,494)

(1,618)

(1,571)

Goodwill and intangible assets

(7,756)

(8,142)

(9,054)

Deferred tax assets that rely on future profitability excluding temporary differences

(346)

(421)

(494)

Fair value reserves related to gains or losses on cash flow hedges

(1,576)

(1,956)

(2,104)

Excess of expected losses over impairment

(1,179)

(1,286)

(1,294)

Gains or losses on liabilities at fair value resulting from own credit

58

(28)

86

Defined-benefit pension fund assets

(542)

(753)

(38)

Direct and indirect holdings by an institution of own CET1 instruments

(50)

(50)

(50)

Deferred tax assets arising from temporary differences (amount above 10% threshold)

(115)

(39)

(183)

Other regulatory adjustments

(35)

40

45

Fully loaded CET1 capital

42,834

44,938

45,204

  

Additional Tier 1 (AT1) capital

Capital instruments and related share premium accounts

7,694

7,690

6,449

Qualifying AT1 capital (including minority interests) issued by subsidiaries

3,843

4,576

5,445

Other regulatory adjustments and deductions

(130)

(131)

(130)

Transitional AT1 capital5

11,407

12,135

11,764

PRA Transitional Tier 1 capital

54,241

57,073

56,968

Tier 2 (T2) capital

Capital instruments and related share premium accounts

5,198

3,724

3,769

Qualifying T2 capital (including minority interests) issued by subsidiaries

8,486

10,153

11,366

Other regulatory adjustments and deductions

(252)

(257)

(257)

PRA Transitional total regulatory capital

67,673

70,693

71,846

 

 

1

The transitional regulatory adjustments to CET1 capital are no longer applicable resulting in CET1 capital on a fully loaded basis being equal to that on a transitional basis.

2

The CRD IV CET1 ratio (FSA October 2012 transitional statement) as applicable to Barclays' Tier 2 Contingent Capital Notes was 13.7% based on £44.8bn of transitional CRD IV CET1 capital and £327bn of RWAs.

3

The PRA transitional capital is based on the PRA Rulebook and accompanying supervisory statements.

4

As at 30 June 2017, Barclays' fully loaded Tier 1 capital was £50,398m, and the fully loaded Tier 1 ratio was 15.4%. Fully loaded total regulatory capital was £64,709m and the fully loaded total capital ratio was 19.8%. The fully loaded Tier 1 capital and total capital measures are calculated without applying the transitional provisions set out in CRD IV and assessing compliance of AT1 and T2 instruments against the relevant criteria in CRD IV.

5

Of the £11.4bn transitional AT1 capital, fully loaded AT1 capital used for the leverage ratio comprises the £7.7bn capital instruments and related share premium accounts and £0.1bn capital deductions. It excludes legacy Tier 1 capital instruments issued by subsidiaries that are subject to grandfathering.

 

Movement in CET1 capital

Three months

Half year

ended

ended

30.06.17

30.06.17

£m

£m

Opening CET1 capital

44,938

45,204

Loss for the period attributable to equity holders

(1,239)

(910)

Own credit relating to derivative liabilities

64

79

Dividends paid and foreseen

(241)

(473)

Decrease in retained regulatory capital generated from earnings

(1,416)

(1,304)

Net impact of share schemes

272

(163)

Available for sale reserves

(7)

58

Currency translation reserves

947

705

Other reserves

(372)

(934)

Increase/(decrease) in other qualifying reserves

840

(334)

Retirement benefit reserve

(416)

(29)

Defined-benefit pension fund asset deduction

211

(504)

Net impact of pensions

(205)

(533)

Minority interests

(1,864)

(1,825)

Additional value adjustments (PVA)

124

77

Goodwill and intangible assets

386

1,298

Deferred tax assets that rely on future profitability excluding those arising from temporary differences

75

148

Excess of expected loss over impairment

107

115

Deferred tax assets arising from temporary differences (amount above 10% threshold)

(76)

68

Other regulatory adjustments

(75)

(80)

Decrease in regulatory capital due to adjustments and deductions

(1,323)

(199)

Closing CET1 capital

42,834

42,834

 

 

CET1 capital decreased £2.4bn to £42.8bn (December 2016: £45.2bn) due to the following:

A £0.9bn loss for the period attributable to equity holders. £1.4bn profit after tax in respect of continuing operations was more than offset by losses in discontinued operation of £2.3bn. These losses, resulting from the impairment of Barclays' holding in BAGL allocated to goodwill and the recycling of BAGL currency translation reserve losses to the income statement, had no impact on CET1 capital with offsetting movements in the goodwill and intangible assets deduction and other qualifying reserves

A £0.5bn decrease for dividends paid and foreseen

A £0.7bn increase in the currency translation reserve largely due to the £1.4bn recycling of losses in BAGL to the income statement which were offset by a £0.6bn decrease due to the appreciation of GBP against USD and JPY

A £0.9bn decrease in other qualifying reserves which included a £0.5bn decrease as a result of USD preference share redemptions, and £0.4bn separation payments in relation to the partial BAGL disposal

A £0.5bn decrease net of tax as a result of movements relating to pensions. The pension asset capital deduction increased due to the UKRF, which is the Group's main pension scheme, moving from a small deficit in December 2016 to a £0.7bn surplus largely due to contributions in the period

A £1.8bn decrease due to BAGL minority interests which are no longer eligible under proportional consolidation

A £1.3bn increase due to the goodwill and a decrease in the intangible assets deduction largely as a result of the impairment of Barclays' holding in BAGL allocated to goodwill

 

Risk weighted assets (RWAs) by risk type and business

Credit risk

Counterparty credit risk

Market risk

Operational risk

Total RWAs

Std

IRB

Std

IRB

Settle-ment Risk

CVA

Std

IMA

As at 30.06.17

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Barclays UK

3,768

49,979

3

-

-

31

-

-

12,338

66,119

Barclays International

49,382

81,109

15,456

13,962

32

2,205

11,100

11,460

27,538

212,244

Head Office1

2,612

7,891

68

535

-

207

146

1,876

12,871

26,206

Barclays Core

55,762

138,979

15,527

14,497

32

2,443

11,246

13,336

52,747

304,569

Barclays Non-Core

2,627

9,102

874

4,072

-

590

294

1,373

3,913

22,845

Barclays Group

58,389

148,081

16,401

18,569

32

3,033

11,540

14,709

56,660

327,414

As at 31.03.17

Barclays UK

4,629

49,330

-

-

1

43

-

-

12,338

66,341

Barclays International

50,609

83,643

15,942

14,007

77

2,251

10,481

9,716

27,538

214,264

Head Office1

9,182

25,660

99

1,040

-

851

567

2,716

12,746

52,861

Barclays Core

64,420

158,633

16,041

15,047

78

3,145

11,048

12,432

52,622

333,466

Barclays Non-Core

4,036

9,396

1,034

5,106

-

638

337

2,827

4,038

27,412

Barclays Group

68,456

168,029

17,075

20,153

78

3,783

11,385

15,259

56,660

360,878

As at 31.12.16

Barclays UK

5,592

49,591

47

-

-

-

-

-

12,293

67,523

Barclays International

53,201

82,327

13,515

13,706

30

3,581

9,343

9,460

27,538

212,701

Head Office1

9,048

27,122

77

1,157

-

927

482

2,323

12,156

53,292

Barclays Core

67,841

159,040

13,639

14,863

30

4,508

9,825

11,783

51,987

333,516

Barclays Non-Core

4,714

9,945

1,043

6,081

37

2,235

477

2,928

4,673

32,133

Barclays Group

72,555

168,985

14,682

20,944

67

6,743

10,302

14,711

56,660

365,649

 

 

 

Movement analysis of RWAs

Credit risk

Counterparty credit risk

Market risk

Operational risk

Total RWAs

£bn

£bn

£bn

£bn

£bn

As at 01.01.17

241.5

42.4

25.0

56.7

365.6

Book size

(2.1)

(2.6)

2.8

-

(1.9)

Acquisitions and disposals

(27.7)

(1.3)

(1.5)

-

(30.5)

Book quality

(1.3)

0.1

0.1

-

(1.1)

Model updates

(1.4)

-

-

-

(1.4)

Methodology and policy

0.1

(0.6)

(0.2)

-

(0.7)

Foreign exchange movements2

(2.6)

-

-

-

(2.6)

As at 30.06.17

206.5

38.0

26.2

56.7

327.4

 

 

1

Includes Africa Banking RWAs.

2

Foreign exchange movement does not include FX for counterparty risk or market risk.

 

RWAs decreased £38.2bn to £327.4bn, primarily driven by a £27.9bn reduction as a result of the proportional consolidation of BAGL, as well as portfolio rundowns and disposals in Non-Core.

 

Leverage ratio and exposures

Barclays is subject to a leverage ratio requirement that is implemented on a phased basis, with a transitional requirement of 3.4% as at 30 June 2017; this comprises of the 3% minimum requirement, a transitional G-SII additional leverage ratio buffer (G-SII ALRB) and a countercyclical leverage ratio buffer (CCLB). Based on both future and proposed requirements the expected end point leverage requirement is 4.0%. Additionally, the CRR fully loaded leverage requirement is currently expected at 3%, although this may be impacted by the Basel Consultation on the Leverage Framework.

Barclays is required to disclose a UK leverage ratio which is based on capital and exposure measures on the last day of the quarter; as well as an average UK leverage ratio based on the last day of each month in the quarter. Both approaches exclude qualifying cash at central banks from the calculation of leverage exposure. There is also a CRR leverage ratio disclosure requirement, which is based on the end point CRR definition of Tier 1 capital and the CRR definition of leverage exposure.

At 30 June 2017, Barclays' UK leverage ratio was 5.0% (December 2016: 5.0%) and the average UK leverage ratio was 4.8% (December 2016: 4.5%), which exceeds the transitional leverage requirement for Barclays of 3.4%, and expected end point leverage requirement of 4.0%. The CRR leverage ratio was 4.5% (December 2016: 4.6%).

 

 

UK leverage ratio

As at 30.06.17

As at 31.03.17

As at 31.12.16

£bn

£bn

£bn

Average UK leverage exposure

1,092

1,130

1,137

Fully loaded Tier 1 capital (quarterly month end average)

52.1

52.3

51.6

Average UK leverage ratio

4.8%

4.6%

4.5%

UK leverage ratio

5.0%

4.8%

5.0%

 

CRR leverage ratio

Accounting assets

Derivative financial instruments

260

271

347

Cash collateral

58

60

67

Reverse repurchase agreements and other similar secured lending

17

18

13

Financial assets designated at fair value1

107

96

79

Loans and advances and other assets

693

759

707

Total IFRS assets

1,135

1,204

1,213

Regulatory consolidation adjustments

10

(4)

(6)

Derivatives adjustments

Derivatives netting

(235)

(244)

(313)

Adjustments to cash collateral

(47)

(51)

(50)

Net written credit protection

12

13

12

Potential Future Exposure (PFE) on derivatives

127

137

136

Total derivatives adjustments

(143)

(145)

(215)

Securities financing transactions (SFTs) adjustments

24

35

29

Regulatory deductions and other adjustments

(13)

(14)

(15)

Weighted off-balance sheet commitments

109

121

119

CRR leverage exposure

1,122

1,197

1,125

Fully loaded CET 1 capital

42.8

44.9

45.2

Fully loaded AT1 capital

7.6

8.0

6.8

Fully loaded Tier 1 capital

50.4

53.0

52.0

CRR leverage ratio

4.5%

4.4%

4.6%

 

1

Included within financial assets designated at fair value reverse repurchase agreements designated at fair value of £88bn (December 2016: £63bn).

 

The average UK leverage exposure as at 30 June 2017, which excludes qualifying central bank claims, was £1,092bn (December 2016: £1,137bn), resulting in an average UK leverage ratio of 4.8% (December 2016: 4.5%). The CET1 capital held against the 0.35% transitional G-SII ALRB was £3.5bn. The impact of CCLB is currently nil.

 

The CRR leverage ratio decreased to 4.5% (December 2016: 4.6%) primarily driven by a £1.6bn decrease in fully loaded Tier 1 capital to £50.4bn (December 2016: £52.0bn):

 

Loans and advances and other assets decreased by £14bn to £693bn. This was driven primarily by a £67bn decrease in assets held for sale mainly due to the disposal of Barclays' holding in BAGL; £44bn increase in cash and balances at central banks mainly due to an increase in the cash contributions to the Group liquidity pool; £17bn increase in settlement balances; £17bn decrease in lending for Barclays International and a £10bn increase in trading portfolio assets due to client activity

Reverse repurchase agreements increased £29bn to £105bn, primarily due to an increase in matched book trading

Net derivative leverage exposures, excluding net written credit protection and PFE on derivatives, decreased £15bn to £36bn due to a decrease in cash collateral and a reduction in IFRS derivatives mainly due to decrease in interest rate derivatives, continued rundown of Non-Core assets and decrease in foreign exchange derivatives

Regulatory consolidation adjustments increased £16bn to £10bn primarily due to the proportional consolidation of BAGL for regulatory purposes

Potential future exposure on derivatives decreased £9bn to £127bn primarily due to portfolio rundown in Non-Core

 

The difference between the average UK leverage ratio and the CRR leverage ratio was primarily driven by the exemption of qualifying central bank claims partially offset by higher positions for April and May within assets held for sale prior to the BAGL disposal, trading portfolio assets and settlement balances.

 

Additional Barclays' regulatory disclosures prepared in accordance with the EBA Guidelines on materiality, proprietary and confidentiality and on disclosure frequency under Articles 432(1), 432(2) and 433 of Regulation (EU) No 575/2013 (EBA/GL/2014/14) and EBA Guidelines on disclosure requirements under Part Eight of Regulation (EU) No 575/2013 will be disclosed on 25th August 2017, available at home.barclays/results.

 

Statement of Directors' Responsibilities

Each of the Directors (the names of whom are set out below) confirm that to the best of their knowledge, the condensed consolidated interim financial statements set out on pages 52 to 57 have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union, and that the interim management report herein includes a fair review of the information required by Disclosure and Transparency Rules 4.2.7R and 4.2.8R namely:

 

an indication of important events that have occurred during the six months ended 30 June 2017 and their impact on the condensed consolidated interim financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year

any related party transactions in the six months ended 30 June 2017 that have materially affected the financial position or performance of Barclays during that period and any changes in the related party transactions described in the last Annual Report that could have a material effect on the financial position or performance of Barclays in the six months ended 30 June 2017.

 

Signed on behalf of the Board by

 

James E Staley Tushar Morzaria

Group Chief Executive Group Finance Director

 

Barclays PLC Board of Directors:

 

Chairman

John McFarlane

Executive Directors

James E Staley (Group Chief Executive)

Tushar Morzaria (Group Finance Director)

 

Non-executive Directors

Mike Ashley

Tim Breedon CBE

Sir Ian Cheshire

Mary Francis CBE

Crawford Gillies

Sir Gerry Grimstone

Reuben Jeffery III

Dambisa Moyo

Diane Schueneman

 

Independent Review Report to Barclays PLC

Independent review report to Barclays PLC

 

Conclusion

We have been engaged by the company to review the condensed set of financial statements in the Results Announcement for the six months ended 30 June 2017 which comprises:

the condensed consolidated income statement and condensed consolidated statement of comprehensive income for the period then ended;

the condensed consolidated balance sheet as at 30 June 2017;

the condensed consolidated statement of changes in equity for the period then ended;

the condensed consolidated cash flow statement for the period then ended; and

the related explanatory notes.

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the Results Announcement for the six months ended 30 June 2017 is not prepared, in all material respects, in accordance with IAS 34 Interim Financial Reporting as adopted by the EU and the Disclosure Guidance and Transparency Rules ("the DTR") of the UK's Financial Conduct Authority ("the UK FCA").

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. We read the other information contained in the Results Announcement and consider whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Directors' responsibilities

The Results Announcement is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the Results Announcement in accordance with the DTR of the UK FCA.

As disclosed in note 1, the annual financial statements of the group are prepared in accordance with International Financial Reporting Standards as adopted by the EU. The directors are responsible for preparing the condensed set of financial statements included in the Results Announcement in accordance with IAS 34 as adopted by the EU.

Our responsibility

Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the Results Announcement based on our review.

The purpose of our review work and to whom we owe our responsibilities

This report is made solely to the company in accordance with the terms of our engagement to assist the company in meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusions we have reached.

 

KPMG LLP

Chartered Accountants

15 Canada Square

London, E14 5GL

 

27 July 2017

 

Condensed Consolidated Financial Statements

 

 Condensed consolidated income statement (unaudited)

Half year ended

Half year ended

30.06.17

30.06.16

Continuing operations

Notes1

£m

£m

Net interest income

5,098

5,218

Net fee and commission income

3,550

3,299

Net trading income

1,667

1,545

Net investment income

528

914

Other income

38

37

Total income

10,881

11,013

Credit impairment charges and other provisions

(1,054)

(931)

Net operating income

9,827

10,082

Staff costs

2

(4,460)

(4,601)

Administration and general expenses

3

(3,272)

(3,096)

Operating expenses

(7,732)

(7,697)

Profit/(loss) on disposal of undertakings and share of results of associates and joint ventures

246

(322)

Profit before tax

2,341

2,063

Tax

5

(778)

(715)

Profit after tax in respect of continuing operations

1,563

1,348

(Loss)/profit after tax in respect of discontinued operation

4

(2,195)

311

(Loss)/profit after tax

(632)

1,659

Attributable to:

Ordinary equity holders of the parent

(1,211)

1,110

Other equity holders2

301

208

Total equity holders2

(910)

1,318

Profit attributable to non-controlling interests in respect of continuing operations

6

138

186

Profit attributable to non-controlling interests in respect of discontinued operation

6

140

155

(Loss)/profit after tax

(632)

1,659

Earnings per share

p

p

Basic (loss)/earnings per ordinary share2

7

(6.6)

6.9

Basic earnings per ordinary share in respect of continuing operations

7

7.1

6.0

Basic (loss)/earnings per ordinary share in respect of discontinued operation

7

(13.7)

0.9

Diluted (loss)/earnings per ordinary share2

7

(6.5)

6.8

Diluted earnings per ordinary share in respect of continuing operations

7

7.0

5.9

 

 

1

For notes to the Financial Statements see pages 58 to 93.

2

The profit after tax attributable to other equity holders of £301m (H116: £208m) is offset by a tax credit recorded in reserves of £82m (H116: £58m). The net amount of £219m (H116: £150m), along with non-controlling interests (NCI) is deducted from profit after tax in order to calculate earnings per share and return on average shareholders' equity.

 

Condensed consolidated statement of comprehensive income (unaudited)

Half year ended

Half year ended

30.06.17

30.06.16

Notes1

£m

£m

(Loss)/profit after tax

(632)

1,659

Profit after tax in respect of continuing operations

1,563

1,348

(Loss)/profit after tax in respect of discontinued operation

(2,195)

311

Other comprehensive (loss)/income that may be recycled to profit or loss from continuing operations:

Currency translation reserve

17

(635)

1,789

Available for sale reserve

17

69

(311)

Cash flow hedge reserve

17

(531)

1,747

Other

15

(2)

Other comprehensive (loss)/income that may be recycled to profit or loss from continuing operations

(1,082)

3,223

Other comprehensive loss not recycled to profit or loss from continuing operations:

Retirement benefit measurements

14

(29)

(759)

Own credit2

22

-

Other comprehensive loss not recycled to profit or loss from continuing operations

(7)

(759)

Other comprehensive (loss)/income for the period from continuing operations

(1,089)

2,464

Other comprehensive income for the period from discontinued operation

1,301

985

Total comprehensive (loss)/income for the period:

Total comprehensive income for the period, net of tax from continuing operations

474

3,812

Total comprehensive (loss)/income for the period, net of tax from discontinued operation

(894)

1,296

Total comprehensive (loss)/income for the period

(420)

5,108

Attributable to:

Equity holders of the parent

(666)

4,358

Non-controlling interests

246

750

Total comprehensive (loss)/income for the period

(420)

5,108

 

 

1

For notes to the Financial Statements see pages 58 to 93.

2

As a result of the early adoption of the own credit provisions of IFRS 9 on 1 January 2017, own credit which was previously recorded in the income statement is now recognised within other comprehensive income. The cumulative unrealised own credit net loss of £175m has therefore been reclassified from retained earnings to a separate own credit reserve, within Other reserves. During H117 a £22m gain on own credit has been booked in the reserve.

 

Condensed consolidated balance sheet (unaudited)

As at

As at

30.06.17

31.12.16

Assets

Notes1

£m

£m

Cash and balances at central banks

146,063

102,353

Items in the course of collection from other banks

1,226

1,467

Trading portfolio assets

90,698

80,240

Financial assets designated at fair value

107,197

78,608

Derivative financial instruments

10

259,851

346,626

Financial investments

9

61,771

63,317

Loans and advances to banks

37,108

43,251

Loans and advances to customers

390,004

392,784

Reverse repurchase agreements and other similar secured lending

17,209

13,454

Current and deferred tax assets

5

4,901

5,430

Prepayments, accrued income and other assets

3,072

2,893

Investments in associates and joint ventures

715

684

Goodwill and intangible assets

7,724

7,726

Property, plant and equipment

2,749

2,825

Retirement benefit assets

14

709

14

Assets included in disposal groups classified as held for sale

4

4,319

71,454

Total assets

1,135,316

1,213,126

Liabilities

Deposits from banks

48,887

48,214

Items in the course of collection due to other banks

778

636

Customer accounts

436,863

423,178

Repurchase agreements and other similar secured borrowing

38,578

19,760

Trading portfolio liabilities

40,470

34,687

Financial liabilities designated at fair value

125,348

96,031

Derivative financial instruments

10

260,765

340,487

Debt securities in issue2

76,664

75,932

Subordinated liabilities

12

23,879

23,383

Accruals, deferred income and other liabilities

6,533

8,871

Current and deferred tax liabilities

5

371

766

Provisions

13

3,930

4,134

Retirement benefit liabilities

14

329

390

Liabilities included in disposal groups classified as held for sale

4

5,658

65,292

Total liabilities

1,069,053

1,141,761

Equity

Called up share capital and share premium

15

21,998

21,842

Other reserves

17

6,148

6,051

Retained earnings

28,026

30,531

Shareholders' equity attributable to ordinary shareholders of parent

56,172

58,424

Other equity instruments

16

7,694

6,449

Total equity excluding non-controlling interests

63,866

64,873

Non-controlling interests

6

2,397

6,492

Total equity

66,263

71,365

Total liabilities and equity

1,135,316

1,213,126

 

 

1

For notes to the Financial Statements see pages 58 to 93.

2

Debt securities in issue include covered bonds of £10.0bn (December 2016: £12.4bn).

 

Condensed consolidated statement of changes in equity (unaudited)

Called up share capital and share premium1

Other equity instruments1

Other reserves1

Retained earnings

Total

Non-controlling interests2

Total equity

Half year ended 30.06.17

£m

£m

£m

£m

£m

£m

£m

Balance as at 31 December 2016

21,842

6,449

6,051

30,531

64,873

6,492

71,365

Effects of changes in accounting policies3

-

-

(175)

175

-

-

-

Balance as at 1 January 2017

21,842

6,449

5,876

30,706

64,873

6,492

71,365

Profit after tax

-

301

-

1,124

1,425

138

1,563

Currency translation movements

-

-

(634)

-

(634)

(1)

(635)

Available for sale investments

-

-

69

-

69

-

69

Cash flow hedges

-

-

(531)

-

(531)

-

(531)

Retirement benefit remeasurements

-

-

-

(29)

(29)

-

(29)

Own credit

-

-

22

-

22

-

22

Other

-

-

-

15

15

-

15

Total comprehensive income net of tax from continuing operations

-

301

(1,074)

1,110

337

137

474

Total comprehensive income net of tax from discontinued operation

-

-

1,332

(2,335)

(1,003)

109

(894)

Total comprehensive income for the period

-

301

258

(1,225)

(666)

246

(420)

Issue of new ordinary shares

107

-

-

-

107

-

107

Issue of shares under employee share schemes

49

-

-

284

333

-

333

Issue and exchange of other equity instruments

-

1,245

-

-

1,245

-

1,245

Coupons paid on other equity instruments

-

(301)

-

82

(219)

-

(219)

Redemption of preference shares

-

-

-

(473)

(473)

(657)

(1,130)

Treasury shares

-

-

14

(617)

(603)

-

(603)

Dividends paid

-

-

-

(339)

(339)

(307)

(646)

Net equity impact of partial BAGL disposal

-

-

-

(359)

(359)

(3,443)

(3,802)

Other movements

-

-

-

(33)

(33)

66

33

Balance as at 30 June 2017

21,998

7,694

6,148

28,026

63,866

2,397

66,263

Half year ended 31.12.16

Balance as at 1 July 2016

21,763

5,314

5,695

30,082

62,854

6,566

69,420

Profit after tax

-

249

-

480

729

160

889

Currency translation movements

-

-

1,234

-

1,234

1

1,235

Available for sale investments

-

-

(76)

-

(76)

-

(76)

Cash flow hedges

-

-

(949)

-

(949)

-

(949)

Retirement benefit remeasurements

-

-

-

(221)

(221)

-

(221)

Other

-

-

-

15

15

-

15

Total comprehensive income net of tax from continuing operations

-

249

209

274

732

161

893

Total comprehensive income net of tax from discontinued operation

-

-

116

27

143

672

815

Total comprehensive income for the period

-

249

325

301

875

833

1,708

Issue of new ordinary shares

40

-

-

-

40

-

40

Issue of shares under employee share schemes

39

-

-

442

481

-

481

Issue and exchange of other equity instruments

-

1,132

-

-

1,132

-

1,132

Coupons paid on other equity instruments

-

(249)

-

70

(179)

-

(179)

Redemption of preference shares

-

-

-

(164)

(164)

(620)

(784)

Treasury shares

-

-

31

(31)

-

-

-

Dividends paid

-

-

-

(169)

(169)

(295)

(464)

Net equity impact of partial BAGL disposal

-

-

-

-

-

-

-

Other movements

-

3

-

-

3

8

11

Balance as at 31 December 2016

21,842

6,449

6,051

30,531

64,873

6,492

71,365

 

1

Details of Called up share capital and share premium, Other equity instruments and Other reserves are shown on pages 78 to 79.

2

Details of Non-controlling interests are shown on page 63.

3

As a result of the early adoption of the own credit provisions of IFRS 9 on 1 January 2017, own credit which was previously recorded in the income statement is now recognised within other comprehensive income. The cumulative unrealised own credit net loss of £175m has therefore been reclassified from retained earnings to a separate own credit reserve, within Other reserves. During H117 a £22m gain on own credit has been booked in the reserve.

 

Condensed consolidated statement of changes in equity (unaudited)

Called up share capital and share premium1

Other equity instruments1

Other reserves1

Retained earnings

Total

Non-controlling interests2

Total equity

Half year ended 30.06.16

£m

£m

£m

£m

£m

£m

£m

Balance as at 1 January 2016

21,586

5,305

1,898

31,021

59,810

6,054

65,864

Profit after tax

-

208

-

954

1,162

186

1,348

Currency translation movements

-

-

1,788

-

1,788

1

1,789

Available for sale investments

-

-

(311)

-

(311)

-

(311)

Cash flow hedges

-

-

1,747

-

1,747

-

1,747

Retirement benefit remeasurements

-

-

-

(759)

(759)

-

(759)

Other

-

-

-

(3)

(3)

1

(2)

Total comprehensive income net of tax from continuing operations

-

208

3,224

192

3,624

188

3,812

Total comprehensive income net of tax from discontinued operation

-

-

578

156

734

562

1,296

Total comprehensive income for the period

-

208

3,802

348

4,358

750

5,108

Issue of new ordinary shares

28

-

-

-

28

-

28

Issue of shares under employee share schemes

149

-

-

226

375

-

375

Coupons paid on other equity instruments

-

(208)

-

58

(150)

-

(150)

Redemption of preference shares

-

-

-

(253)

(253)

(550)

(803)

Treasury shares

-

-

(5)

(384)

(389)

-

(389)

Dividends paid

-

-

-

(588)

(588)

(280)

(868)

Net equity impact of partial BAGL disposal

-

-

-

(349)

(349)

601

252

Other movements

-

9

-

3

12

(9)

3

Balance as at 30 June 2016

21,763

5,314

5,695

30,082

62,854

6,566

69,420

 

 

 

1

Details of Called up share capital and share premium, Other equity instruments and Other reserves are shown on pages 78 to 79.

2

Details of Non-controlling interests are shown on page 63.

 

Condensed consolidated cash flow statement (unaudited)

Half year ended

Half year ended

30.06.17

30.06.16

Notes1

£m

£m

Continuing operations

Profit before tax

2,341

2,063

Adjustment for non-cash items

1,041

(8,913)

Changes in operating assets and liabilities

32,088

25,129

Corporate income tax paid

(530)

(394)

Net cash from operating activities

34,940

17,885

Net cash from investing activities

2,043

14,376

Net cash from financing activities

287

(1,709)

Effect of exchange rates on cash and cash equivalents

(1,092)

6,897

Net increase in cash and cash equivalents from continuing operations

36,178

37,449

Net cash from discontinued operation

4

101

371

Net increase in cash and cash equivalents

36,279

37,820

Cash and cash equivalents at beginning of the period

144,110

86,556

Cash and cash equivalents at end of the period

180,389

124,376

 

1

For notes to the Financial Statements see pages 58 to 93.

 

Financial Statement Notes

 

1. Basis of preparation

These condensed consolidated interim financial statements for the six months ended 30 June 2017 have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority and with IAS 34, 'Interim Financial Reporting', as published by the IASB and adopted by the European Union. The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2016, which have been prepared in accordance with IFRSs as adopted by the European Union.

The accounting policies and methods of computation used in these condensed consolidated interim financial statements are the same as those used in the Barclays 2016 Annual Report, except for the option in IFRS 9 to recognise changes in own credit in other comprehensive income, which Barclays has applied from 1 January 2017 as detailed in Note 17. This will have no effect on net assets, and any changes due to own credit in prior periods have not been restated. Any realised and unrealised amounts recognised in other comprehensive income will not be reclassified to the income statement in future periods.

 

Future accounting developments

IFRS 9 - Financial instruments

IFRS 9 Financial Instruments which will replace IAS 39 Financial Instruments: Recognition and Measurement is effective for periods beginning on or after 1 January 2018 and was endorsed by the EU in November 2016. IFRS 9, in particular the impairment requirements, will lead to significant changes in the accounting for financial instruments. Barclays will not restate comparatives on initial application of IFRS 9 on 1 January 2018 but will provide detailed transition disclosures in accordance with the amended requirements of IFRS 7.

Barclays has a jointly accountable Risk and Finance IFRS 9 implementation programme with representation from all impacted departments.

In respect of the impairment and classification and measurement implementation programmes for financial assets, work has continued to prepare for adoption on 1 January 2018, with the focus during 2017 on quantifying impact, model validation and finalising processes, governance and controls.

As permitted by IFRS 9, Barclays will continue applying the IAS 39 hedge accounting requirements but will provide the new hedge accounting disclosures required by the amended IFRS 7.

Since the publication of the 2016 Annual Report, the IASB has issued an Exposure Draft potentially impacting financial assets with prepayment features with negative compensation. Such prepayment features are present in some fixed rate corporate and investment bank loans. If such loans are concluded to be measured at fair value through profit or loss, the potential impact on opening equity and profit or loss would depend on their fair values compared to their carrying amounts, and the future changes in fair value. The IASB is currently considering comments received on the proposals.

Barclays will disclose the financial impact estimates when the implementation programme, validation and testing is further advanced, which is expected to be no later than the Barclays Annual Report 2017.

For further information on this and other new standards refer to the Barclays 2016 Annual Report.

 

Going concern

Having reassessed the principal risks, the directors considered it appropriate to adopt the going concern basis of accounting in preparing the interim financial information.

 

2. Staff costs

 

Half year ended

Half year ended

30.06.17

30.06.16

Compensation costs

£m

£m

Current year bonus charges

558

393

Deferred bonus charge

340

369

Commissions and other incentives1

58

35

Performance costs

956

797

Salaries

1,968

2,056

Social security costs

297

303

Post-retirement benefits

253

245

Other compensation costs

189

179

Total compensation costs

3,663

3,580

Other resourcing costs

Outsourcing

579

460

Redundancy and restructuring

23

266

Temporary staff costs

167

250

Other

28

45

Total other resourcing costs

797

1,021

Total staff costs

4,460

4,601

Group compensation as % of income

37

36

 

 

1

Amounts previously included in 2016 as commitments are now included in current and deferred bonus charges for consistency with 2017.

 

Total staff costs decreased 3% to £4,460m, principally reflecting:

 

A decrease in other resourcing costs of 22% to £797m mainly due to a decrease in redundancy and restructuring costs following the non-recurrence of costs relating to strategic initiatives within the CIB in the previous year

An increase in Group performance costs of 20% to £956m due to changes in the granting of incentives awards to more closely align to the income statement charge as announced in the Barclays 2016 Results Announcement

 

No awards have yet been granted in relation to the 2017 bonus pool as decisions regarding incentive awards are not taken by the Remuneration Committee until the performance for the full year can be assessed. The current year bonus charge for the first six months represents an accrual for estimated costs in accordance with accounting requirements.

 

3. Administration and general expenses

 

Half year

ended

Half year

ended

30.06.17

30.06.16

£m

£m

Infrastructure costs

Property and equipment

671

562

Depreciation of property, plant and equipment

228

242

Operating lease rentals

198

235

Amortisation of intangible assets

342

301

Impairment of property, equipment and intangible assets

23

82

Total infrastructure costs

1,462

1,422

Other costs

Consultancy, legal and professional fees

535

539

Subscriptions, publications, stationery and communications

284

333

Marketing, advertising and sponsorship

189

207

Travel and accommodation

74

68

Charges for PPI

700

400

Other administration and general expenses

28

127

Total other costs

1,810

1,674

Total administration and general expenses

3,272

3,096

 

 

4. Held for sale assets and discontinued operation

The Group applies IFRS 5 Non-current Assets Held for Sale and Discontinued Operations.

On 1 March 2016, Barclays announced its intention to reduce the Group's 62.3% interest in BAGL. On 5 May 2016, Barclays sold 12.2% of the Group's interest in BAGL. On 1 June 2017, Barclays reduced its shareholding by a further 33.7%. As a result, Barclays accounts for a holding of 16.4% with an obligation to contribute to a BEE scheme leaving a residual holding of 14.9%. This resulted in accounting deconsolidation of BAGL from the Group as of 1 June 2017, with the holding recognised as an available for sale investment valued at £1,146m in Barclays' financial statements.

Prior to the sale of shares on 1 June 2017, impairment of £1,090m was recognised under IFRS 5 against the net assets of BAGL. Impairment under IFRS 5 is calculated as the difference between fair value less disposal costs and the carrying value of the disposal group. The fair value is determined by reference to the quoted market price for BAGL and the opening foreign exchange rate for ZAR/GBP as at 1 June 2017. Payments of £0.7bn have been made following execution of separation agreements and the completion of the sale. As at 30 June 2017, a liability for the obligation to the BEE scheme of £105m is reflected on the balance sheet.

The remaining balance in held for sale predominantly relates to the disposal of the French retail and Zimbabwean businesses which are intended for disposal early in the second half of 2017.

 

As at

As at

30.06.17

31.12.16

Assets included in disposal groups classified as held for sale

£m

£m

Cash and balances at central banks

204

2,930

Items in the course of collection from other banks

17

570

Trading portfolio assets

-

3,084

Financial assets designated at fair value

1,365

6,984

Derivative financial instruments

-

1,992

Financial investments

1,915

7,737

Loans and advances to banks

172

1,666

Loans and advances to customers

1,020

43,504

Current and deferred tax assets

2

149

Prepayments, accrued income and other assets

8

696

Investments in associates and joint ventures

11

87

Goodwill and intangible assets

3

1,567

Property, plant and equipment

41

954

Retirement benefit assets

-

33

Total

4,758

71,953

Balance of impairment unallocated under IFRS 5

(439)

(499)

Total assets classified as held for sale

4,319

71,454

Liabilities included in disposal groups classified as held for sale

Deposits from banks

18

2,149

Items in the course of collection due to other banks

24

373

Customer accounts

2,477

42,431

Repurchase agreements and other similar secured borrowing

-

597

Trading portfolio liabilities

-

388

Financial liabilities designated at fair value

3,013

7,325

Derivative financial instruments

-

1,611

Debt securities in issue

-

7,997

Subordinated liabilities

-

934

Accruals, deferred income and other liabilities

79

1,180

Current and deferred tax liabilities

-

162

Provisions

14

103

Retirement benefit liabilities

33

42

Total liabilities classified as held for sale

5,658

65,292

Net (liabilities)/assets classified as held for sale

(1,339)

6,162

Expected contribution to BAGL

-

866

Disposal group post contribution

(1,339)

7,028

 

Prior to the sale of shares on 1 June 2017, BAGL met the requirements for presentation as a discontinued operation. As such, the results, which have been presented as the profit after tax and non-controlling interest in respect of the discontinued operation on the face of the Group income statement, are analysed in the income statement below. The income statement, statement of other comprehensive income and cash flow statement below represent five months of results as a discontinued operation to 31 May 2017, compared to the half year ended 30 June 2016.

Half year ended

Half year ended

Barclays Africa disposal group income statement

30.06.17

30.06.16

£m

£m

Net interest income

1,024

982

Net fee and commission income

522

479

Net trading income

149

130

Net investment income

30

21

Net premiums from insurance contracts

161

164

Other income

(16)

8

Total income

1,870

1,784

Net claims and benefits incurred on insurance contracts

(84)

(87)

Total income net of insurance claims

1,786

1,697

Credit impairment charges and other provisions

(177)

(244)

Net operating income

1,609

1,453

Staff costs

(586)

(522)

Administration and general expenses1

(1,634)

(498)

Operating expenses

(2,220)

(1,020)

Share of post-tax results of associates and joint ventures

5

2

(Loss)/profit before tax

(606)

435

Tax

(154)

(124)

(Loss)/profit after tax

(760)

311

Attributable to:

Equity holders of the parent

(900)

156

Non-controlling interests

140

155

(Loss)/profit after tax2

(760)

311

 

1

Includes impairment of £1,090m (H116: £nil).

2

Total loss in respect of the discontinued operation was £2,195m which includes £60m loss on sale and £1,375m loss on recycling of other comprehensive loss on reserves.

 

Half year ended

Half year ended

Statement of other comprehensive income from discontinued operation

30.06.17

30.06.16

£m

£m

Available for sale assets

(3)

1

Currency translation reserves

(38)

534

Cash flow hedge reserves

19

43

Other comprehensive (loss)/income, net of tax from discontinued operation

(22)

578

 

Half year ended

Half year ended

Cash flows from discontinued operation

30.06.17

30.06.16

£m

£m

Net cash flows from operating activities

540

(507)

Net cash flows from investing activities

(245)

459

Net cash flows from financing activities

 (165)

(108)

Effect of exchange rates on cash and cash equivalents

(29)

527

Net increase in cash and cash equivalents

101

371

 

5. Tax

 

Assets

Liabilities

As at

30.06.17

As at

31.12.16

As at

30.06.17

As at

31.12.16

Current and deferred tax assets and liabilities

£m

£m

£m

£m

Current tax

411

561

(324)

(737)

Deferred tax

4,490

4,869

(47)

(29)

Total

4,901

5,430

(371)

(766)

 

 

The deferred tax asset of £4,490m (December 2016: £4,869m) includes £3,658m (December 2016: £3,973m) related to amounts in the US, with the majority of the remaining £832m (December 2016: £896m) related to amounts in the UK. Of the total deferred tax asset, £362m (December 2016: £503m) related to tax losses and £4,128m (December 2016: £4,366m) related to temporary differences.

 

 

The tax charge for H117 was £778m (H116: £715m), representing an effective tax rate of 33.2% (H116: 34.7%). The effective tax rate is higher than the UK statutory tax rate of 19.25% (2016: 20%) primarily due to profits outside the UK taxed at higher local statutory tax rates, charges for PPI being non-deductible for tax purposes, the tax surcharge of 8% that applies to banks' UK profits, non-deductible expenses and non-creditable taxes. These factors, which have each increased the effective tax rate, are partially offset by the impact of non-taxable gains and income.

 

 

6. Non-controlling interests

 

 

Profit attributable to non-controlling interests

Equity attributable to non-controlling interests

Half year ended

Half year ended

As at

As at

30.06.17

30.06.16

30.06.17

31.12.16

£m

£m

£m

£m

Barclays Bank PLC Issued:

- Preference shares

134

182

2,041

2,698

- Upper Tier 2 instruments

2

2

272

272

Barclays Africa Group Limited

140

155

-

3,507

Other non-controlling interests

2

2

84

15

Total

278

341

2,397

6,492

 

 

Equity attributable to non-controlling interests decreased by £4,095m to £2,397m as at 30 June 2017 driven by Barclays' sale of 33.7% of BAGL's issued share capital, which resulted in accounting deconsolidation of BAGL from the Group, and by the redemption of $1.375bn Barclays Bank PLC 7.1% Series 3 non-cumulative callable preference shares on 15 March 2017.

 

 

7. Earnings per share

 

Half year ended

Half year ended

30.06.17

30.06.16

£m

£m

(Loss)/profit attributable to ordinary equity holders of the parent from continuing and discontinued operations

(1,211)

1,110

Tax credit on profit after tax attributable to other equity holders

82

58

Total (loss)/profit attributable to ordinary equity holders of the parent from continuing and discontinued operations

(1,129)

1,168

Continuing operations

Profit attributable to ordinary equity holders of the parent from continuing operations

1,124

954

Tax credit on profit after tax attributable to other equity holders

82

58

Profit attributable to equity holders of the parent from continuing operations

1,206

1,012

Discontinued operation

(Loss)/profit attributable to ordinary equity holders of the parent from discontinued operation

(2,335)

156

Dilutive impact of convertible options from discontinued operation

-

(2)

(Loss)/profit attributable to equity holders of the parent from discontinued operation including dilutive impact on convertible options

(2,335)

154

(Loss)/profit attributable to equity holders of the parent from continuing and discontinued operations including dilutive impact on convertible options

(1,129)

1,166

Half year ended

Half year ended

30.06.17

30.06.16

m

m

Basic weighted average number of shares in issue

16,989

16,859

Number of potential ordinary shares

304

182

Diluted weighted average number of shares

17,293

17,041

p

p

Basic (loss)/earnings per ordinary share1

(6.6)

6.9

Basic earnings per ordinary share in respect of continuing operations

7.1

6.0

Basic (loss)/earnings per ordinary share in respect of discontinued operation

(13.7)

0.9

Diluted (loss)/earnings per ordinary share

(6.5)

6.8

Diluted earnings per ordinary share in respect of continuing operations

7.0

5.9

Diluted (loss)/earnings per ordinary share in respect of discontinued operation

(13.5)

0.9

 

 

1

The profit after tax attributable to other equity holders of £301m (H116: £208m) is offset by a tax credit recorded in reserves of £82m (H116: £58m). The net amount of £219m (H116: £150m), along with non-controlling interests (NCI) is deducted from profit after tax in order to calculate earnings per share.

 

 

8. Dividends on ordinary shares

It is Barclays' policy to declare and pay dividends on a semi-annual basis. An interim dividend for 2017 of 1.0p (H116: 1.0p) per ordinary share will be paid on 18 September 2017 to shareholders on the Share Register on 11 August 2017.

 

 

Half year ended 30.06.17

Half year ended 30.06.16

Per share

Total

Per share

Total

Dividends paid during the period

p

£m

p

£m

Final dividend paid during period

2.0

339

3.5

588

 

For qualifying US and Canadian resident ADR holders, the interim dividend of 1.0p per ordinary share becomes 4.0p per ADS (representing four shares). The ADR depositary will post the interim dividend on 18 September 2017 to ADR holders on the record at close of business on 11 August 2017.

 

9.  Financial investments

 

 

As at

As at

30.06.17

31.12.16

£m

£m

Available for sale debt securities and other eligible bills

55,082

57,703

Available for sale equity securities

1,547

438

Held to maturity debt securities

5,142

5,176

Financial investments

61,771

63,317

 

10. Derivative financial instruments

Contract Notional

Amount

Fair Value

Assets

Liabilities

As at 30.06.17

£m

£m

£m

Foreign exchange derivatives

4,619,552

61,638

(61,512)

Interest rate derivatives

32,817,795

167,317

(159,504)

Credit derivatives

889,924

15,338

(14,452)

Equity and stock index and commodity derivatives

883,443

15,125

(24,280)

Derivative assets/(liabilities) held for trading

39,210,714

259,418

(259,748)

Derivatives in hedge accounting relationships

Derivatives designated as cash flow hedges

172,316

195

(35)

Derivatives designated as fair value hedges

111,170

198

(963)

Derivatives designated as hedges of net investments

3,227

40

(19)

Derivative assets/(liabilities) designated in hedge accounting relationships

286,713

433

(1,017)

Total recognised derivative assets/(liabilities)

39,497,427

259,851

(260,765)

As at 31.12.16

Foreign exchange derivatives

4,229,796

79,260

(78,248)

Interest rate derivatives

30,011,026

228,133

(219,298)

Credit derivatives

947,800

16,273

(15,085)

Equity and stock index and commodity derivatives

997,198

21,958

(27,015)

Derivative assets/(liabilities) held for trading

36,185,820

345,624

(339,646)

Derivatives in hedge accounting relationships

Derivatives designated as cash flow hedges

188,863

669

(33)

Derivatives designated as fair value hedges

141,575

301

(744)

Derivatives designated as hedges of net investments

6,086

32

(64)

Derivative assets/(liabilities) designated in hedge accounting relationships

336,524

1,002

(841)

Total recognised derivative assets/(liabilities)

36,522,344

346,626

(340,487)

 

 

Derivative assets decreased by £87bn to £260bn primarily due to interest rate derivatives reflecting the adoption of a CME rulebook change to daily settlement, continued rundown of the Non-Core derivative back book and an increase in major interest rate forward curves and foreign exchange derivatives due to depreciation of USD against GBP as at the reporting date.

 

The IFRS netting posted against derivative assets was £13bn including £1bn of cash collateral netted (December 2016: £12bn including £1bn cash collateral netted) and £12bn for liabilities (December 2016: £11bn) with no cash collateral netted. Derivative asset exposures would be £238bn (December 2016: £315bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds cash collateral of £34bn (December 2016: £42bn). Similarly, derivative liabilities would be £238bn (December 2016: £317bn) lower reflecting counterparty netting and cash collateral placed of £34bn (December 2016: £44bn). In addition, non cash collateral of £6bn (December 2016: £8bn) was held in respect of derivative assets and £2bn (December 2016: £4bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on balance sheet exposure so as to not include over-collateralisation.

 

Of the £34bn cash collateral held, £22bn (December 2016: £27bn) was included in deposits from banks and £12bn (December 2016: £15bn), was included in customer accounts. Of the £34bn cash collateral placed, £15bn (December 2016: £18bn) was included in loans and advances to banks and £19bn (December 2016: £26bn) was included in loans and advances to customers.

 

11. Fair value of financial instruments

 

This section should be read in conjunction with Note 18 Fair value of financial instruments of the 2016 Annual Report, which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used.

 

 

Valuation

The following table shows the Group's assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification:

 

 

Valuation technique using

Quoted market prices

Observable inputs

Significant unobservable inputs

(Level 1)

(Level 2)

(Level 3)

Total

As at 30.06.17

£m

£m

£m

£m

Trading portfolio assets

45,457

42,996

2,245

90,698

Financial assets designated at fair value

5,641

92,495

9,061

107,197

Derivative financial assets

3,850

248,129

7,872

259,851

Available for sale investments

25,324

30,957

348

56,629

Investment property

-

-

141

141

Assets included in disposal groups classified as held for sale1

-

-

4,319

4,319

Total assets

80,272

414,577

23,986

518,835

Trading portfolio liabilities

(25,352)

(15,108)

(10)

(40,470)

Financial liabilities designated at fair value

(67)

(124,598)

(683)

(125,348)

Derivative financial liabilities

(3,270)

(250,621)

(6,874)

(260,765)

Liabilities included in disposal groups classified as held for sale1

-

-

(5,658)

(5,658)

Total liabilities

(28,689)

(390,327)

(13,225)

(432,241)

As at 31.12.16

Trading portfolio assets

41,550

36,625

2,065

80,240

Financial assets designated at fair value

4,031

64,630

9,947

78,608

Derivative financial assets

5,261

332,819

8,546

346,626

Available for sale investments

21,218

36,551

372

58,141

Investment property

-

-

81

81

Assets included in disposal groups classified as held for sale1

6,754

8,511

6,009

21,274

Total assets

78,814

479,136

27,020

584,970

Trading portfolio liabilities

(20,205)

(14,475)

(7)

(34,687)

Financial liabilities designated at fair value

(70)

(95,121)

(840)

(96,031)

Derivative financial liabilities

(5,051)

(328,265)

(7,171)

(340,487)

Liabilities included in disposal groups classified as held for sale1

(397)

(5,224)

(6,201)

(11,822)

Total liabilities

(25,723)

(443,085)

(14,219)

(483,027)

 

 

1

Disposal groups held for sale and measured at fair value less cost to sell are included in the fair value table. For disposal groups measured at carrying amount, the underlying financial assets and liabilities measured at fair value are included in the fair value disclosures on pages 67 to 74 and items measured at amortised costs are included on page 75.

 

The following table shows the Group's assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and product type:

 

 

Assets

Liabilities

Valuation technique using

Valuation technique using

Quoted

market prices

(Level 1)

Observable

inputs

(Level 2)

Significant

unobservable

inputs

(Level 3)

Quoted

market prices

(Level 1)

Observable

inputs

(Level 2)

Significant

unobservable

inputs

(Level 3)

As at 30.06.17

£m

£m

£m

£m

£m

£m

Interest rate derivatives

-

162,322

5,389

-

(156,153)

(4,349)

Foreign exchange derivatives

-

61,556

122

-

(61,424)

(107)

Credit derivatives

-

14,041

1,297

-

(14,175)

(277)

Equity derivatives

3,133

7,859

1,059

(2,568)

(16,179)

(2,141)

Commodity derivatives

717

2,351

5

(702)

(2,690)

-

Government and government sponsored debt

35,575

50,426

40

(13,822)

(10,411)

-

Corporate debt

-

10,759

963

(14)

(1,169)

(10)

Certificates of deposit, commercial paper and other money market instruments

-

1,517

-

-

(6,439)

(257)

Reverse repurchase and repurchase agreements

-

88,273

-

-

(82,581)

-

Non-asset backed loans

-

6,116

7,392

-

-

-

Asset backed securities

-

2,098

486

-

(348)

-

Commercial real estate loans

-

-

1,127

-

-

-

Issued debt

-

-

-

-

(37,764)

(227)

Equity cash products

40,770

6,266

130

(11,516)

(681)

-

Funds and fund linked products

-

615

202

-

(113)

(9)

Private equity investments

10

-

796

-

(17)

(15)

Assets and liabilities held for sale

-

-

4,319

-

-

(5,658)

Other1

67

378

659

(67)

(183)

(175)

Total

80,272

414,577

23,986

(28,689)

(390,327)

(13,225)

As at 31.12.16

Interest rate derivatives

-

222,892

5,759

-

(215,213)

(4,860)

Foreign exchange derivatives

-

79,612

132

-

(78,263)

(51)

Credit derivatives

-

14,662

1,611

-

(14,844)

(241)

Equity derivatives

4,210

11,842

1,037

(4,058)

(15,808)

(2,007)

Commodity derivatives

1,052

3,809

8

(991)

(4,138)

(13)

Government and government sponsored debt

31,203

49,834

3

(12,761)

(11,454)

-

Corporate debt

46

11,921

969

(27)

(1,907)

(5)

Certificates of deposit, commercial paper and other money market instruments

-

994

-

-

(6,936)

(319)

Reverse repurchase and repurchase agreements

-

63,162

-

-

(55,710)

-

Non-asset backed loans

-

2,888

8,767

-

-

-

Asset backed securities

-

1,956

515

-

(256)

-

Commercial real estate loans

-

-

442

-

-

-

Issued debt

-

-

-

-

(31,973)

(298)

Equity cash products

35,399

6,478

150

(7,416)

(934)

(2)

Funds and fund linked products

53

137

273

-

(170)

(37)

Private equity investments

23

110

856

-

(18)

(12)

Assets and liabilities held for sale

6,754

8,511

6,009

(397)

(5,224)

(6,201)

Other1

74

328

489

(73)

(237)

(173)

Total

78,814

479,136

27,020

(25,723)

(443,085)

(14,219)

 

 

1

Other includes asset backed loans, investment properties and physical commodities.

 

Assets and liabilities reclassified between Level 1 and Level 2

There were no material transfers between Level 1 and 2 (December 2016: £2,340m government bonds assets transferred from Level 2 to Level 1).

 Level 3 movement analysis

The following table summarises the movements in the Level 3 balance during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the year.

Assets and liabilities included in disposal groups classified as held for sale are not included as these are measured at fair value on a non-recurring basis.

Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant.

During the period, £1.7bn of non-asset backed loans were derecognised due to a substantial modification of terms on a subset of the ESHLA loans. The new restructured loans are measured on an amortised cost basis.

 

 Level 3 movement analysis

 

 

Sales

Issues

Settlements

Total gains and losses in the period recognised in the income statement

Total gains or losses recognised in OCI

Transfers

As at 30.06.17

As at 01.01.17

Purchases

Trading income

Other income

In

Out

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Government and government sponsored debt

3

37

 -

 -

 -

 -

 -

 -

 -

 -

40

Corporate debt

969

56

(71)

 -

(2)

14

 -

 -

27

(30)

963

Non-asset backed loans

151

369

(87)

 -

(21)

(2)

 -

 -

 -

(7)

403

Asset backed securities

515

46

(69)

 -

(9)

3

 -

 -

 -

 -

486

Funds and fund linked products

273

 -

(28)

 -

(24)

(8)

 -

 -

11

(22)

202

Equity cash products

77

32

(7)

-

-

(13)

-

-

2

-

91

Other

77

2

(12)

-

-

1

-

-

-

(8)

60

Trading portfolio assets

2,065

542

(274)

 -

(56)

(5)

 -

 -

40

(67)

2,245

Non-asset backed loans

8,616

 -

 -

 -

(1,706)

79

-

 -

 -

 -

6,989

Commercial real estate loans

442

1,905

(1,215)

 -

(29)

34

(10)

 -

 -

 -

1,127

Private equity investments

562

31

(106)

 -

 -

(3)

36

 -

28

(58)

490

Other

327

108

(50)

 -

(30)

(10)

110

 -

-

 -

455

Financial assets designated at fair value

9,947

2,044

(1,371)

 -

(1,765)

100

136

 -

28

(58)

9,061

Private equity investments

294

 -

(45)

 -

 -

 -

(2)

23

34

 -

304

Equity cash products

73

-

-

-

-

-

2

1

6

(42)

40

Other

5

 -

(1)

 -

(1)

 -

-

1

 -

 -

4

Available for sale investments

372

 -

(46)

 -

(1)

 -

-

25

40

(42)

348

Investment property

81

62

 -

 -

 -

 -

(2)

 -

 -

 -

141

Corporate debt

(7)

 -

(4)

 -

1

 -

 -

 -

 -

 -

(10)

Trading portfolio liabilities

(7)

 -

(4)

 -

1

 -

 -

 -

 -

 -

(10)

Certificates of deposit,

commercial paper and other

money market instruments

(319)

 -

 -

 -

 -

 -

1

 -

(31)

92

(257)

Issued debt

(298)

 -

 -

 -

71

 -

 -

 -

 -

 -

(227)

Other

(223)

 -

 -

 -

27

 -

(3)

 -

 -

 -

(199)

Financial liabilities

designated at fair value

(840)

 -

 -

 -

98

 -

(2)

 -

(31)

92

(683)

Interest rate derivatives

899

27

12

 -

15

(130)

 -

 -

419

(202)

1,040

Foreign exchange derivatives

81

 -

 -

 -

(16)

2

5

 -

(3)

(54)

15

Credit derivatives

1,370

 -

3

 -

(19)

(263)

 -

 -

(71)

 -

1,020

Equity derivatives

(970)

67

(222)

 -

11

78

 -

 -

(45)

(1)

(1,082)

Commodity derivatives

(5)

 -

 -

 -

 -

3

 -

 -

 -

7

5

Net derivative financial

Instruments1

1,375

94

(207)

 -

(9)

(310)

5

 -

300

(250)

998

Assets and liabilities held for sale

574

 -

(574)

 -

 -

 -

 -

 -

 -

 -

 -

Total

13,567

2,742

(2,476)

 -

(1,732)

(215)

137

25

377

(325)

12,100

Net liabilities held for sale measured at fair value on non-recurring basis

(1,339)

Total

10,761

 

 

1

The derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets are £7,872m (H116: £6,771m) and derivative financial liabilities are £6,874m (H116: £6,306m).

 

Level 3 movement analysis

 

 

Sales

Issues

Settlements

Total gains and losses in the period recognised in the income statement

Total gains or losses recognised in OCI

Transfers

As at 30.06.16

As at 01.01.16

Purchases

Trading income

Other income

In

Out

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Government and government sponsored debt

320

 -

(34)

 -

 -

(1)

 -

 -

 -

 -

285

Corporate debt

2,843

66

(20)

 -

(65)

367

 -

 -

18

(11)

3,198

Non-asset backed loans

507

116

(275)

 -

 -

(29)

 -

 -

18

(3)

334

Asset backed securities

743

56

(230)

 -

(12)

71

 -

 -

43

 -

671

Funds and fund linked products

340

 -

(47)

 -

(286)

296

 -

 -

 -

(13)

290

Equity cash products

121

3

(2)

-

-

(1)

-

-

1

(32)

90

Other

34

4

(20)

-

(68)

11

-

-

-

(7)

(46)

Trading portfolio assets

4,908

245

(628)

 -

(431)

714

 -

 -

80

(66)

4,822

Non-asset backed loans

15,963

 -

(4)

 -

(8,111)

1,695

 -

 -

82

 -

9,625

Commercial real estate loans

543

785

(773)

 -

(10)

45

 -

 -

 -

 -

590

Private equity investments

457

21

(49)

 -

(1)

5

85

 -

4

 -

522

Equity cash products

26

-

(26)

-

-

-

-

-

-

-

-

Other

308

24

(178)

 -

(22)

2

110

 -

70

(38)

276

Financial assets designated at fair value

17,297

830

(1,030)

 -

(8,144)

1,747

195

 -

156

(38)

11,013

Private equity investments

877

11

(514)

 -

(9)

 -

3

37

4

(5)

404

Equity cash products

24

-

(14)

-

-

-

3

3

-

(1)

15

Other

20

7

-

 -

(14)

 -

-

1

26

(1)

39

Available for sale investments

921

18

(528)

 -

(23)

 -

6

41

30

(7)

458

Investment property

82

 -

 -

 -

 -

 -

4

 -

 -

 -

86

Trading portfolio liabilities

 -

 -

 -

 -

 -

 -

 -

 -

 -

 -

 -

Certificates of deposit, commercial paper and other money market instruments

(272)

 -

 -

(128)

114

 -

(19)

 -

(29)

62

(272)

Issued debt

(538)

 -

 -

(27)

203

8

 -

 -

 -

 -

(354)

Other

(244)

 -

 -

(110)

113

(26)

(2)

 -

(61)

38

(292)

Financial liabilities designated at fair value

(1,054)

 -

 -

(265)

430

(18)

(21)

 -

(90)

100

(918)

Interest rate derivatives

418

(36)

(22)

 -

(179)

(77)

 -

 -

(187)

(26)

(109)

Foreign exchange derivatives

(104)

 -

 -

 -

(41)

11

 -

 -

20

75

(39)

Credit derivatives

1,685

10

(4)

 -

(12)

264

 -

 -

(3)

 -

1,940

Equity derivatives

(857)

61

 -

(82)

53

(131)

 -

 -

(50)

26

(980)

Commodity derivatives

(506)

5

 -

 -

48

61

 -

 -

25

20

(347)

Net derivative financial instruments1

636

40

(26)

(82)

(131)

128

 -

 -

(195)

95

465

Assets and liabilities held for sale

424

12

 -

248

(52)

 -

(1)

 -

 -

 -

631

Total

23,214

1,145

(2,212)

(99)

(8,351)

2,571

183

41

(19)

84

16,557

Net liabilities held for sale measured at fair value on non-recurring basis

(1,732)

Total

14,825

 

 

1

The derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets are £7,872m (H116: £6,771m) and derivative financial liabilities are £6,874m (H116: £6,306m).

 

 

Unrealised gains and losses on Level 3 financial assets and liabilities

The following table discloses the unrealised gains and losses recognised in the year arising on Level 3 financial assets and liabilities held at the period end.

 

Half year ended 30.06.17

Half year ended 30.06.16

Income statement

Other compre- hensive income

Total

Income statement

Other compre- hensive income

Total

Trading income

Other income

Trading income

Other income

£m

£m

£m

£m

£m

£m

£m

£m

Trading portfolio assets

(25)

-

-

(25)

400

-

-

400

Financial assets designated at fair value

73

102

-

175

764

166

-

930

Available for sale investments

-

-

25

25

-

33

41

74

Investment property

-

-

-

-

-

3

-

3

Financial liabilities designated at fair value

45

(2)

-

43

(24)

(17)

-

(41)

Net derivative financial instruments

(305)

-

-

(305)

110

-

-

110

Assets and Liabilities held for sale

-

-

-

-

-

-

-

-

Total

(212)

100

25

(87)

1,250

185

41

1,476

 

Valuation techniques and sensitivity analysis

 

Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative models.

 

Current year valuation and sensitivity methodologies are consistent with those described within Note 18 Fair value of financial instruments in the 2016 Annual Report.

 

 

Sensitivity analysis of valuations using unobservable inputs

Fair value

Favourable changes

Unfavourable changes

Total

assets

Total

liabilities

Income

statement

Equity

Income

statement

Equity

As at 30.06.17

£m

£m

£m

£m

£m

£m

Interest rate derivatives

5,389

(4,349)

127

-

(152)

-

Foreign exchange derivatives

122

(107)

9

-

(9)

-

Credit derivatives

1,297

(277)

128

-

(117)

-

Equity derivatives

1,059

(2,141)

160

-

(160)

-

Commodity derivatives

5

-

5

-

(3)

-

Government and government sponsored debt

40

-

-

-

-

-

Corporate debt

963

(10)

4

-

(4)

-

Certificates of deposit, commercial paper and other money market instruments

-

(257)

-

-

-

-

Non-asset backed loans

7,392

-

254

-

(570)

-

Asset backed securities

486

-

1

-

(1)

-

Commercial real estate loans

1,127

-

1

-

(1)

-

Issued debt

-

(227)

-

-

-

-

Equity cash products

130

-

11

23

(10)

(23)

Funds and fund linked products

202

(9)

5

-

(5)

-

Private equity investments

796

(15)

90

20

(90)

(20)

Assets and liabilities held for sale

4,319

(5,658)

-

-

-

-

Other1

659

(175)

1

-

-

-

Total

23,986

(13,225)

796

43

(1,122)

(43)

As at 31.12.16

Interest rate derivatives

5,759

(4,860)

209

-

(249)

-

Foreign exchange derivatives

132

(51)

15

-

(15)

-

Credit derivatives

1,611

(241)

127

-

(133)

-

Equity derivatives

1,037

(2,007)

163

-

(164)

-

Commodity derivatives

8

(13)

5

-

(5)

-

Government and government sponsored debt

3

-

-

-

-

-

Corporate debt

969

(5)

7

-

(2)

-

Certificates of deposit, commercial paper and other money market instruments

-

(319)

-

-

(1)

-

Non-asset backed loans

8,767

-

462

-

(597)

-

Asset backed securities

515

-

1

-

(1)

-

Commercial real estate loans

442

-

2

-

(2)

-

Issued debt

-

(298)

-

-

-

-

Equity cash products

150

(2)

12

26

(11)

(26)

Funds and fund linked products

273

(37)

6

-

(6)

-

Private equity investments

856

(12)

104

18

(104)

(21)

Assets and liabilities held for sale

699

(125)

3

-

(3)

-

Other1

489

(173)

147

-

(105)

-

Total

21,710

(8,143)

1,263

44

(1,398)

(47)

 

1

Other includes asset backed loans and investment property.

 

The effect of stressing unobservable inputs to a range of reasonably possible alternatives alongside considering the impact of using alternative models, would be to increase fair values by up to £0.8bn (December 2016: £1.3bn) or to decrease fair values by up to £1.2bn (December 2016: £1.4bn) with substantially all the potential effect impacting profit and loss rather than reserves.

 

 

 

 

Significant unobservable inputs

The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 are consistent with Note 18 Fair value of financial instruments in the 2016 Annual Report. The description of the significant unobservable inputs and the sensitivity of fair value measurement of the instruments categorised as Level 3 assets or liabilities to increases in significant unobservable inputs is also found in Note 18 Fair value of financial instruments of the 2016 Annual Report. Assets and liabilities included in disposal groups classified as held for sale are not included as these are measured at fair value on a non-recurring basis.

 

Fair value adjustments

 

Key balance sheet valuation adjustments are quantified below:

 

 

As at

30.06.17

As at

31.12.16

£m

£m

Exit price adjustments derived from market bid-offer spreads

(409)

(475)

Uncollateralised derivative funding

(47)

(82)

Derivative credit valuation adjustments

(121)

(237)

Derivative debit valuation adjustments

131

242

 

 

Exit price adjustments decreased £66m to £409m primarily due to tightening in the market bid offer spreads

Uncollateralised derivative funding decreased £35m to £47m as a result of tightening in funding spreads and unwinds of derivative exposures

Credit Valuation Adjustments (CVA) decreased £116m to £121m as a result of tightening in credit spreads and unwinds of derivative exposures

Debit Valuation Adjustments (DVA) decreased £111m to £131m as a result of tightening in credit spreads

 

 Portfolio exemption

 

The Group uses the portfolio exemption in IFRS 13 Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date.

Unrecognised gains as a result of the use of valuation models using unobservable inputs

 

The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, is £120m (2016: £179m). There are additions of £14m (2016: £29m) and £73m (2016: £37m) of amortisation and releases.

 

Third party credit enhancements

 

Structured and brokered certificates of deposit issued by Barclays Group are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IAS 39 fair value option includes this third party credit enhancement. The on balance sheet value of these brokered certificates of deposit amounted to £3,203m (December 2016: £3,905m).

 

Comparison of carrying amounts and fair values for assets and liabilities not held at fair value

 

Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost are consistent with the 2016 Annual Report disclosure.

 

The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group's balance sheet:

 

 

As at 30.06.17

As at 31.12.16

Carrying amount

Fair Value

Carrying amount

Fair Value

Financial assets

£m

£m

£m

£m

Held to maturity

5,142

5,228

5,176

5,347

Loans and advances to banks

37,108

37,101

43,251

43,228

Loans and advances to customers:

-Home loans

144,706

142,212

144,765

141,155

-Credit cards, unsecured and other retail lending

55,423

55,347

57,808

57,699

-Finance lease receivables

1,554

1,554

1,602

1,598

-Corporate loans

188,321

187,261

188,609

186,715

Reverse repurchase agreements and other similar secured lending

17,209

17,209

13,454

13,454

Assets included in disposal groups classified as held for sale1

-

-

43,593

44,838

Financial liabilities

Deposits from banks

(48,887)

(48,887)

(48,214)

(48,212)

Customer accounts:

-Current and demand accounts

(140,614)

(140,614)

(138,204)

(138,197)

-Savings accounts

(133,219)

(133,223)

(133,344)

(133,370)

-Other time deposits

(163,029)

(163,029)

(151,630)

(151,632)

Debt securities in issue

(76,664)

(78,289)

(75,932)

(76,971)

Repurchase agreements and other similar secured borrowing

(38,578)

(38,578)

(19,760)

(19,760)

Subordinated liabilities

(23,879)

(25,419)

(23,383)

(24,547)

Liabilities included in disposal groups classified as held for sale1

-

-

(51,775)

(51,788)

 

 

 

 

1

Disposal groups held for sale and measured at fair value less cost to sell are included in the fair value table. For disposal groups measured at carrying amount, the underlying financial assets and liabilities measured at fair value are included in the fair value disclosures on page 67-74 and items measured at amortised costs are included on page 75.

 

 

12. Subordinated liabilities

As at

As at

30.06.17

31.12.16

£m

£m

Opening balance as at 1 January

23,383

21,467

Issuances

1,547

1,457

Redemptions

(140)

(1,142)

Other

(911)

1,601

Total dated and undated subordinated liabilities as at period end

23,879

23,383

 

 

Subordinated liabilities increased 2% to £23,879m (December 2016: £23,383m). There was one issuance of 4.836% Fixed Rate Subordinated Notes of £1,547m. Redemptions totalling £140m include £133m 6.375% Undated Subordinated Notes. Other movements of £911m decreased largely due to the appreciation of GBP against USD and JPY.

 

13. Provisions

As at

As at

30.06.17

31.12.16

£m

£m

UK Customer Redress

Payment Protection Insurance redress

2,109

1,979

Other customer redress

543

712

Legal, competition and regulatory matters

351

455

Redundancy and restructuring

154

206

Undrawn contractually committed facilities and guarantees

66

67

Onerous contracts

279

385

Sundry provisions

428

330

Total

3,930

4,134

 

 

Payment Protection Insurance Redress

As at 30 June 2017, Barclays had recognised cumulative provisions totalling £9.1bn (December 2016: £8.4bn) against the cost of Payment Protection Insurance (PPI) redress and associated processing costs with utilisation of £7.0bn (December 2016: £6.5bn), leaving a residual provision of £2.1bn (December 2016: £2.0bn).

Through to 30 June 2017, 2.0m (December 2016: 1.8m) customer initiated claims1 had been received and processed. The volume of claims received during H117 increased 32%2 from H216 (increased by 15% from H116).

The current provision reflects the estimate of costs of PPI redress primarily relating to customer initiated complaints and on-going remediation programmes. This also includes liabilities managed by third parties arising from portfolios previously sold where Barclays remains liable.

An additional charge of £0.7bn has been recognised to reflect an updated estimated cost of PPI redress, primarily relating to an increase in expected future volume of claims.

As at 30 June 2017, the provision of £2.1bn represents Barclays' best estimate of expected PPI redress. However, it is possible the eventual outcome may differ from the current estimate. We will continue to review the adequacy of provision level in respect of the on-going level of complaints. The FCA marketing campaign commences on 29 August 2017 covering the period until the FCA's deadline for the bringing the claims in August 2019. The impact of the marketing campaign on Barclays' provision is uncertain but has been considered in Barclays' provision estimate.

The PPI provision is calculated using a number of key assumptions which continue to involve significant management judgement and modelling:

 

Customer initiated claim volumes - claims received but not yet processed plus an estimate of future claims initiated by customers where the volume is anticipated to cease after August 2019

Average claim redress - the expected average payment to customers for upheld claims based on the type and age of the policy/policies

Processing cost per claim - the cost to Barclays of assessing and processing each valid claim

 

These assumptions remain subjective, in particular due to the uncertainty associated with future claims levels, which include complaints driven by CMC activity.

The current provision represents Barclays' revised best estimate of all future expected costs of PPI redress based on the information available at the end of H117.

The following table details actual data through to 30 June 2017, key forecast assumptions used in the provision calculation and a sensitivity analysis illustrating the impact on the provision if the future expected assumptions prove too high or too low.

 

 

Assumption

Cumulative

actual to

30.06.17

Future

expected

Sensitivity analysis increase/decrease

in provision

Customer initiated claims received and processed1

2,000k

740k

50k = £105m

Average uphold rate per claim3

87%

87%

1% = £17m

Average redress per valid claim4

£2,268

£1,932

£100 = £77m

Processing cost per claim5

£386

£283

£10 = £7m

 

 

1

Total claims received directly by Barclays to date, including those received via CMCs but excluding those for which no PPI policy exists and excluding responses to proactive mailing.

2

Gross volumes received including no PPI.

3

Average uphold rate per customer initiated claims received directly by Barclays and proactive mailings, excluding those for which no PPI policy exists.

4

Average redress stated on a per policy basis for future customer initiated complaints received directly by Barclays and proactive mailings.

5

Processing cost per claim is based on customer initiated claims received and processed.

 

 14. Retirement benefits

As at 30 June 2017, the Group's IAS19 pension surplus across all schemes was £0.4bn (December 2016: £0.4bn deficit). The UK Retirement Fund (UKRF), which is the Group's main scheme, had a surplus of £0.7bn (December 2016: £27m deficit). The movement for the UKRF was driven by payment of deficit reduction contributions over the last six months, with changes in market conditions largely being neutral.

Triennial valuation

The latest triennial actuarial valuation of the UKRF with an effective date of 30 September 2016 has been completed. This valuation showed a funding deficit of £7.9bn and a funding level of 81.5%, versus £6.0bn funding deficit at the 30 September 2015 update. The increase in funding deficit over that period was mainly driven by the increase in liabilities due to changes in financial conditions, namely from falls in gilt yields and the lower outlook for future investment returns, offset by favourable asset returns over the year and payment of deficit reduction contributions.

The Bank and UKRF Trustee have agreed a revised scheme-specific funding target, statement of funding principles, schedule of contributions, a recovery plan to seek to eliminate the deficit relative to the funding target and some additional support measures. The agreement with the UKRF Trustee also takes into account the changes to the Group structure that will be implemented as a result of ring-fencing1. The UKRF will remain in Barclays Bank PLC (BBPLC).

The main differences between the funding and IAS 19 assumptions were a different approach to setting the discount rate and a more conservative longevity assumption for funding.

The deficit reduction contributions agreed with the UKRF Trustee as part of the 30 September 2016 valuation recovery plan are shown alongside the deficit recovery contributions agreed in 2014 for the prior 30 September 2013 valuation.

 

 

Year

Deficit contributions30 September 2016 valuation

£m

Deficit contributions30 September 2013 valuation

£m

2017

740 2

1,240 3

2018

500

740

2019

500

740

2020

500

740

2021

1,000

240 3

2022 to 2026

1,000 each year

-

 

 

 

The deficit reduction contributions are in addition to the regular contributions to meet the Group's share of the cost of benefits accruing over each year. The next funding valuation of the UKRF is due to be completed in 2020 with an effective date of 30 September 2019.

Other measures agreed at the same time as the Valuation

Collateral - The UKRF Trustee and BBPLC have entered into an arrangement whereby a collateral pool has been put in place to provide security for 88.5% of the UKRF funding deficit as it increases or decreases over time, and associated deficit recovery contributions, with a cap of £9.0bn. The collateral pool is currently made up of government securities and high quality securitisations of credit cards, mortgages and corporate loans. The arrangement provides the UKRF Trustee with dedicated access to the pool of assets in the event of BBPLC not paying a deficit reduction contribution to the UKRF or in the event of BBPLC's insolvency.

Support from Barclays PLC (BPLC) - In the event of BBPLC not paying a deficit reduction contribution payment required under the 2016 valuation recovery plan by a specified pre-payment date, BPLC has entered into an arrangement whereby it will be required to use, in first priority, dividends received from the UK Ring-Fenced Bank (RFB) (if any) to invest the proceeds in BBPLC (up to the maximum amount of the deficit reduction contribution unpaid by BBPLC). The proceeds of the investment will be used to discharge BBPLC's unpaid deficit reduction contribution.

Participation - As permitted under the Financial Services and Markets Act 2000 (Banking Reform) (Pensions) Regulations 2015, RFB will participate as an employer in the UKRF during a transitional phase until the end of 2025. RFB will make contributions for the future service of its employees who are currently Afterwork members and, in the event of BBPLC's insolvency during this period, RFB would step in as principal employer of the UKRF.

 

1

Refer to page 236 of the Barclays PLC 2016 Annual Report for further information on structural reform.

2

£620m of the £740m for 2017 had been paid to the UKRF by 30 June 2017.

3

The 2017 contribution included up to £500m payable if the deficit in 2017 exceeded a certain level. If it was paid, the additional amount would be deducted from the 2021 payment due.

 

 

15.  Called up share capital

Called up share capital comprises 17,034m (December 2016: 16,963m) ordinary shares of 25p each. The increase was largely due to the issuance of shares under employee share schemes and the Barclays PLC Scrip Dividend Programme.

 

 

16.  Other equity instruments

Other equity instruments of £7,694m (December 2016: £6,449m) include Additional Tier 1 (AT1) securities issued by Barclays PLC. The increase was primarily due to the issuance of a GBP AT1 security, with a principal amount of £1,250m.

The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under CRD IV.

 

 

17. Other reserves

As at

As at

30.06.17

31.12.16

£m

£m

Currency translation reserve

3,756

3,051

Available for sale reserve

(16)

(74)

Cash flow hedging reserve

1,578

2,105

Own credit reserve

(153)

-

Other

983

969

Total

6,148

6,051

 

Currency translation reserve

The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group's net investment in foreign operations, net of the effects of hedging.

As at 30 June 2017, there was a credit balance of £3,756m (December 2016: £3,051m credit) in the currency translation reserve. The £705m credit movement principally reflected the £1,377m credit movement driven by recycling of the accumulated currency translation losses into the income statement resulting from the partial disposal of BAGL. This credit movement was partially offset by debit movements driven by the weakening of USD against GBP.

Available for sale reserve

The available for sale reserve represents the unrealised change in the fair value of available for sale investments since initial recognition.

As at 30 June 2017, there was a debit balance of £16m (December 2016: £74m debit) in the available for sale reserve. The increase of £58m (2016: £391m decrease) was primarily due to £218m of net gains from changes in fair value on Government Bonds predominantly held in the liquidity pool and the related hedging. There were also £165m of net gains transferred to net profit and a tax charge of £49m was recognised in the period relating to these items.

Cash flow hedging reserve

The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss.

As at 30 June 2017, there was a credit balance of £1,578m (December 2016: £2,105m credit) in the cash flow hedging reserve. The decrease of £527m (2016: £844m increase) principally reflected a £413m decrease in the fair value of interest rate swaps held for hedging purposes as interest rate forward curves increased and £321m gains transferred to net profit, partially offset by a tax credit of £205m.

 

Own credit reserve

As a result of the early adoption of the own credit provisions of IFRS 9 on 1 January 2017, own credit which was previously recorded in the income statement is now recognised within other comprehensive income. Changes in own credit in respect of debt instruments are recognised at fair value through the income statement.

As at 30 June 2017, the amount of own credit recognised in the Group's other comprehensive income was a debit balance of £153m (December 2016: £nil). Upon adoption of IFRS 9, an opening debit balance of £175m was recognised. The increase of £22m (2016: £nil) principally reflected amortisation movements of £32m and a widening of Barclays own credit spreads of £6m, partially offset by tax of £13m and foreign exchange of £3m.

Other reserves and treasury shares

As at 30 June 2017, there was a credit balance of £1,011m (December 2016: £1,011m credit) in other reserves relating to redeemed ordinary and preference shares issued by the Group.

There was a debit balance of £28m (December 2016: £42m debit) in other reserves relating to treasury shares. During the period £294m (2016: £140m) net purchases of treasury shares were made, principally reflecting the increase in shares held for the purposes of employee share schemes, and £308m (2016: £166m) was transferred to retained earnings reflecting the vesting of deferred share based payments.

 

 

18. Contingent liabilities and commitments

As at

As at

30.06.17

31.12.16

£m

£m

Guarantees and letters of credit pledged as collateral security

15,971

15,303

Performance guarantees, acceptances and endorsements

4,664

4,636

Total contingent liabilities

20,635

19,939

Documentary credits and other short-term trade related transactions

966

1,005

Forward starting reverse repurchase agreements

133

24

Standby facilities, credit lines and other commitments

297,339

302,657

Total commitments

298,438

303,686

 

 

Further details on contingent liabilities relating to legal, competition and regulatory matters can be found in Note 19.

 

19. Legal, competition and regulatory matters

 

Barclays PLC, Barclays Bank PLC and the Group face legal, competition and regulatory challenges, many of which are beyond our control. The extent of the impact on Barclays PLC, Barclays Bank PLC and the Group of these matters cannot always be predicted but may materially impact our operations, financial results, condition and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both, depending on the relevant facts and circumstances. The Group has not disclosed an estimate of the potential financial effect on the Group of contingent liabilities where it is not currently practicable to do so.

 

Investigations into certain advisory services agreements and other matters and civil action

The UK Serious Fraud Office (SFO), the Financial Conduct Authority (FCA), the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) have been conducting investigations into certain advisory services agreements entered into by Barclays Bank PLC.

 

Background Information

Barclays Bank PLC entered into two advisory services agreements with Qatar Holding LLC (Qatar Holding) in June and October 2008 (the Agreements). The FCA commenced an investigation into whether the Agreements may have related to Barclays PLC's capital raisings in June and November 2008 (the Capital Raisings). The existence of the June 2008 advisory services agreement was disclosed, but the entry into the advisory services agreement in October 2008 and the fees payable under the Agreements, which amounted to a total of £322m payable over a period of five years, were not disclosed in the announcements or public documents relating to the Capital Raisings. The SFO also commenced an investigation into the Agreements and into a $3bn loan (the Loan) provided by Barclays Bank PLC in November 2008 to the State of Qatar.

 

SFO Proceedings

In June 2017, the SFO charged Barclays PLC with two offences of conspiring with certain former senior officers and employees of Barclays to commit fraud by false representations relating to the Agreements and one offence of unlawful financial assistance contrary to section 151 of the Companies Act 1985 in relation to the Loan (the Charges). The SFO has informed Barclays that it has not made a decision as to whether it will also bring a charge against Barclays Bank PLC in respect of the Loan. The trial of the Charges has been scheduled to begin in January 2019. 

 

FCA Proceedings and other investigations

In September 2013, the FCA issued warning notices (the Notices) finding that while, Barclays PLC and Barclays Bank PLC believed at the time of the execution of the Agreements that there should be at least some unspecified and undetermined value to be derived from them, the primary purpose of the Agreements was not to obtain advisory services but to make additional payments, which would not be disclosed, for the Qatari participation in the Capital Raisings. The Notices concluded that Barclays PLC and Barclays Bank PLC were in breach of certain disclosure-related listing rules and Barclays PLC was also in breach of Listing Principle 3 (the requirement to act with integrity towards holders and potential holders of the Company's shares). In this regard, the FCA considers that Barclays PLC and Barclays Bank PLC acted recklessly. The financial penalty provided in the Notices against the Group is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. A stay of the FCA action has been lifted. It is possible that the stay may be reimposed due to the SFO proceedings.

 

In addition, the DOJ and the SEC have been conducting investigations relating to the Agreements.

 

Civil Action

In January 2016, PCP Capital Partners LLP and PCP International Finance Limited (PCP) served a claim on Barclays Bank PLC seeking damages of £721.4m plus interest and costs for fraudulent misrepresentation and deceit, arising from alleged statements made by Barclays Bank PLC to PCP in relation to the terms on which securities were to be issued to potential investors, allegedly including PCP, in the November 2008 capital raising. Barclays Bank PLC is defending the claim.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period. PCP has made a claim against Barclays Bank PLC totalling £721.4m plus interest and costs. This amount does not necessarily reflect Barclays Bank PLC's potential financial exposure if a ruling were to be made against it in that matter.

Investigations into certain business relationships

In 2012, the DOJ and SEC commenced investigations in relation to whether certain relationships with third parties who assist Barclays PLC to win or retain business are compliant with the US Foreign Corrupt Practices Act. Various regulators in other jurisdictions are also being briefed on the investigations. Separately, the Group is cooperating with the DOJ and SEC in relation to an investigation into certain of its hiring practices in Asia and elsewhere and is keeping certain regulators in other jurisdictions informed.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

Investigations relating to whistleblowing systems and controls

The FCA and PRA are conducting investigations in relation to the Group Chief Executive Officer (CEO) and Barclays Bank PLC in connection with certain whistleblowing issues.

 

Background Information

In April 2017, the FCA and PRA commenced investigations into the CEO as to his individual conduct and senior manager responsibilities relating to Barclays' whistleblowing programme and to his attempt in 2016 to identify the author of a letter that was treated by Barclays Bank PLC as a whistleblow; and Barclays Bank PLC, as to its responsibilities relating to the attempt by the CEO to identify the author of the letter, as well as Barclays' systems and controls and culture relating to whistleblowing.

 

The attempt to identify the author of the letter first came to the attention of the Barclays PLC Board (Board) early in 2017. The Board instructed an external law firm to conduct a focussed investigation into the matter and also notified the FCA and PRA and other relevant authorities. The investigation found, and the Board concluded, that the CEO honestly, but mistakenly, believed that it was permissible to identify the author. However, the Board concluded that the CEO made an error in becoming involved with, and not applying appropriate governance around the matter, and in taking action to attempt to identify the author of the letter. The Board has commissioned independent reviews of Barclay's relevant processes and controls, including its whistleblowing programme. 

 

Barclays and the CEO are cooperating fully with the FCA and PRA investigations. Barclays is also providing information to, and cooperating with, authorities in the United States with respect to these matters.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

Investigation relating to retail structured deposits

The FCA has been conducting an enforcement investigation in relation to structured deposits provided by Barclays Bank PLC and Woolwich Plan Managers Limited, a wholly owned subsidiary of Barclays Bank PLC.

 

Background Information

In 2015, the FCA commenced an enforcement investigation into the design, manufacture and sale of structured deposit products by Barclays from November 2009 to the present.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the action described on the Group or what effect that it might have upon the Group's operating results, cash flows or financial position in any particular period.

 

Investigation into Americas Wealth & Investment Management advisory business

The SEC has carried out an investigation into certain practices in Barclays' former Wealth Americas investment advisory business relating to certain due diligence failures, fee and billing practices and mutual fund fee waivers and related disclosures. In May 2017, the SEC announced a settlement pursuant to which Barclays Capital Inc. (BCI) agreed to resolve this matter for US$97m, consisting of a penalty of US$30m (to be paid to the SEC) and US$67m (to be paid to the clients) in remediation and disgorgement.

 

Investigation into suspected money laundering related to foreign exchange transactions in South African operation

Absa Bank Limited, a subsidiary of Barclays Africa Group Limited, identified potentially fraudulent activity by certain of its customers using advance payments for imports in 2014 and 2015 to effect foreign exchange transfers from South Africa to beneficiary accounts located in East Asia, UK, Europe and the US. As a result, the Group conducted a review of relevant activity, processes, systems and controls. The Group is continuing to provide information to relevant authorities as part of the Group's ongoing cooperation.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

Investigations into LIBOR and other benchmarks

Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have been conducting investigations relating to Barclays Bank PLC's involvement in manipulating certain financial benchmarks, such as LIBOR and EURIBOR.

 

Background Information

In 2012, Barclays Bank PLC announced that it had reached settlements with the Financial Services Authority (FSA) (as predecessor to the FCA), the US Commodity Futures Trading Commission (CFTC) and the DOJ in relation to their investigations concerning certain benchmark interest rate submissions, and Barclays Bank PLC paid total penalties of £290m. The settlement with the DOJ was made by entry into a Non-Prosecution Agreement (NPA) which has now expired. Barclays PLC, Barclays Bank PLC and BCI have reached settlements with certain other regulators and law enforcement agencies. Barclays Bank PLC continues to respond to requests for information from the SFO in relation to its ongoing LIBOR investigation, including in respect of Barclays Bank PLC. The investigation by the prosecutor's office in Trani, Italy also remains pending.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

LIBOR and other benchmark civil actions 

A number of individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to LIBOR and/or other benchmarks.

 

Background Information

Following settlement of the investigations referred to above in 'Investigations into LIBOR and other Benchmarks' various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group. While certain cases have been dismissed or settled subject to approval from the court (and in the case of class actions, the right of class members to opt-out of the settlement and to seek to file their own claims), other actions remain pending and their ultimate impact is unclear.

 

USD LIBOR Cases in MDL Court

The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes before a single judge in the SDNY (MDL Court).

 

The complaints are substantially similar and allege, amongst other things, that Barclays Bank PLC and the other banks individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO) and various state laws by manipulating USD LIBOR rates.

 

The proposed class actions purported to be brought on behalf of (amongst others) plaintiffs that (i) engaged in USD LIBOR-linked over-the-counter transactions (OTC Class); (ii) purchased USD LIBOR-linked financial instruments on an exchange (Exchange-Based Class); (iii) purchased USD LIBOR-linked debt securities (Debt Securities Class); (iv) purchased adjustable-rate mortgages linked to USD LIBOR (Homeowner Class); or (v) issued loans linked to USD LIBOR (Lender Class).

 

The lawsuits seek unspecified damages with the exception of five lawsuits, in which the plaintiffs are seeking a combined total in excess of $1.25bn in actual damages against all defendants, including Barclays Bank PLC, plus punitive damages. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO.

 

Between 2013 and 2016, the MDL Court issued a series of decisions effectively dismissing the majority of claims, including antitrust claims, against Barclays Bank PLC and other foreign defendants in both class actions and individual actions. In May 2016, the appeal court reversed the MDL Court's holding that plaintiffs in certain class actions and individual actions had not suffered an antitrust injury and remanded the antitrust claims to the MDL Court for further consideration. Following further consideration, the MDL Court dismissed the majority of antitrust claims against foreign defendants, including Barclays Bank PLC, for lack of personal jurisdiction. Plaintiffs in a number of individual actions and class actions are appealing the MDL Court's personal jurisdiction ruling.

 

In 2014, the MDL Court granted preliminary approval for the settlement of the Exchange-Based Class claims for $20m, of which $5m was paid. The balance of the settlement amount will be paid following final approval of the settlement by the court. Final approval of the settlement is awaiting plaintiff's submission of a plan for allocation of the settlement proceeds acceptable to the MDL Court and will be subject to the right of class members to opt-out of the settlement and to seek to file their own claims.

 

In 2015, the OTC Class claims were settled for $120m. The settlement was preliminarily approved by the MDL court in December 2016 but remains subject to final approval and the right of class members to opt-out of the settlement and to seek to file their own claims. Payment of $120m was made in June 2017.

 

In November 2016, $7.1m was paid in settlement of the Debt Securities Class claims. The settlement has been preliminarily approved by the court but remains subject to final approval and the right of class members to opt-out of the settlement and seek to file their own claims.

 

EURIBOR Case in the SDNY

In 2015, $94m was paid in settlement of a EURIBOR-related class action. The settlement has been preliminarily approved by the court but remains subject to final approval and the right of class members to opt-out of the settlement and to seek to file their own claims.

 

Additional USD LIBOR Case in the SDNY

In 2015, an individual action against Barclays Bank PLC and other panel bank defendants was dismissed by the SDNY. The plaintiff alleged that the panel bank defendants conspired to increase USD LIBOR, which caused the value of bonds pledged as collateral for a loan to decrease, ultimately resulting in the sale of the bonds at a low point in the market. The plaintiff's motion to file a further amended complaint is pending.

 

Sterling LIBOR Case in SDNY

In 2015, a putative class action was filed in the SDNY against Barclays Bank PLC and other Sterling LIBOR panel banks by a plaintiff involved in exchange-traded and over-the-counter derivatives that were linked to Sterling LIBOR. The complaint alleges, among other things, that defendants manipulated the Sterling LIBOR rate between 2005 and 2010 and, in so doing, committed CEA, Antitrust Act, and RICO violations. In early 2016, this class action was consolidated with an additional putative class action making similar allegations against Barclays Bank PLC and BCI and other Sterling LIBOR panel banks. Defendants have filed a motion to dismiss.

 

Japanese Yen LIBOR Cases in SDNY

In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a plaintiff involved in exchange-traded derivatives. The complaint also names members of the Japanese Bankers Association's Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel, of which Barclays Bank PLC is not a member. The complaint alleges, amongst other things, manipulation of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and Antitrust Act between 2006 and 2010. In 2014, the court dismissed the plaintiff's antitrust claims in full, but sustained the plaintiff's CEA claims, which are pending. Discovery is ongoing.

 

In March 2017, a second putative class action concerning Yen LIBOR filed in the SDNY against Barclays PLC, Barclays Bank PLC and BCI was dismissed in full. The complaint makes similar allegations to the 2012 class action. Plaintiffs have appealed the dismissal.

 

SIBOR/SOR Case in the SDNY

A putative class action filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI, and other defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR) was dismissed by the court in relation to claims against Barclays for failure to state a claim. The court indicated that plaintiffs will be allowed to amend their complaint.

 

Non-US Benchmarks Cases

In addition to US actions, legal proceedings have been brought or threatened against the Group in connection with alleged manipulation of LIBOR and EURIBOR in a number of jurisdictions. The number of such proceedings in non-US jurisdictions, the benchmarks to which they relate and the jurisdictions in which they may be brought have increased over time.

 

Claimed Amounts/Financial Impact

Aside from the settlements discussed above, it is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

Foreign Exchange investigations 

Various regulatory and enforcement authorities across multiple jurisdictions have been investigating a range of issues associated with Foreign Exchange sales and trading, including electronic trading.

 

Background Information

In 2015 the Group reached settlements with the CFTC, the DOJ, the New York State Department of Financial Services (NYDFS), the Board of Governors of the Federal Reserve System (Federal Reserve) and the FCA (together, the 2015 Resolving Authorities) in relation to investigations into certain sales and trading practices in the Foreign Exchange market. In connection with these settlements, the Group paid total penalties of approximately $2.38bn and agreed to undertake certain remedial actions. 

 

Under the plea agreement with the DOJ, in addition to a criminal fine, Barclays PLC agreed to a term of probation of three years during which Barclays PLC must, amongst other things, (i) commit no crime whatsoever in violation of the federal laws of the United States, (ii) implement and continue to implement a compliance program designed to prevent and detect the conduct that gave rise to the plea agreement and agreement, (iii) report credible allegations of violations of US antitrust or fraud laws to the relevant U.S. authority, and (iv) strengthen its compliance and internal controls as required by relevant regulatory or enforcement agencies. In January 2017, the US District Court for the District of Connecticut accepted the plea agreement and in accordance with the agreement sentenced Barclays PLC to pay $650m as a fine and $60m for violating the NPA (which amounts are part of the $2.38bn referred to above) and to serve three years of probation from the date of the sentencing order. The Group also continues to provide relevant information to certain of the 2015 Resolving Authorities.

 

The full text of the DOJ plea agreement, the orders of the CFTC, NYDFS and Federal Reserve, and the Final Notice issued by the FCA related to the settlements referred to above are publicly available on the 2015 Resolving Authorities' respective websites.

 

The European Commission (Commission) is one of several authorities conducting an investigation into certain trading practices in the Foreign Exchange market.

 

The DOJ is also conducting an investigation into conduct relating to certain trading activities in connection with certain transactions during 2011 and 2012. Barclays is providing information to the DOJ and other relevant authorities reviewing this conduct.

 

In February 2017 the South African Competition Commission (SACC) referred Barclays Bank PLC, BCI and Absa Bank Limited, a subsidiary of Barclays Africa Group Limited, among other banks, to the Competition Tribunal to be prosecuted for breaches of South African antitrust law related to Foreign Exchange trading of South African Rand. The SACC found from its investigation that between 2007 and 2013 the banks had engaged in various forms of collusive behaviour. Barclays was the first to bring the conduct to the attention of the SACC under its leniency programme and has cooperated with, and will continue to cooperate with, the SACC in relation to this matter. The SACC is therefore not seeking an order from the Tribunal to impose any fine on Barclays Bank PLC, BCI or Absa Bank Limited.

 

Claimed Amounts/Financial Impact

Aside from the settlements discussed above, it is not currently practicable to provide an estimate of any further financial impact of the actions described on the Group or what effect they might have on the Group's operating results, cash flows or financial position in any particular period.

 

Civil actions in respect of Foreign Exchange 

A number of individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to Foreign Exchange.

 

Background Information

Following settlement of certain investigations referred to above in 'Foreign Exchange Investigations' a number of individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to Foreign Exchange or may do so in future. Certain of these cases have been dismissed or have been settled subject to final approval from the relevant court (and in the case of class actions, the right of class members to opt-out of the settlement and to seek to file their own claims).

 

Consolidated FX Action

In 2014, a number of civil actions filed in the SDNY on behalf of proposed classes of plaintiffs alleging manipulation of Foreign Exchange markets under the Antitrust Act and New York state law and naming several international banks as defendants, including Barclays Bank PLC, were combined into a single consolidated action (Consolidated FX Action). In 2015, Barclays Bank PLC and BCI settled the Consolidated FX Action and paid $384m. The settlement itself is subject to final court approval and the right of class members to opt-out of the settlement and to seek to file their own claims.

 

ERISA FX Action

Since 2015, several civil actions have been filed in the SDNY on behalf of proposed classes of plaintiffs purporting to allege different legal theories of injury (other than those alleged in the Consolidated FX Action) related to alleged manipulation of Foreign Exchange rates and naming several international banks as defendants, including Barclays PLC, Barclays Bank PLC and BCI. One such consolidated action asserts claims under the US Employee Retirement Income Security Act (ERISA) statute (ERISA Claims) and includes allegations of conduct that are duplicative of allegations in the other cases, as well as additional allegations about ERISA plans. The Court ruled that the ERISA allegations concerning collusive manipulation of FX rates are covered by the settlement agreement in the Consolidated FX Action, but did not rule on whether allegations characterised by the ERISA plaintiffs as non-collusive manipulation of FX rates are likewise covered by the agreement. In September 2016, the Court dismissed all ERISA Claims (based on both alleged collusive and non-collusive conduct) against Barclays and all other defendants as a matter of law. The ERISA plaintiffs have appealed this decision.

 

Retail Basis Action

A putative action was filed in the Northern District of California (and subsequently transferred to the SDNY) against several international banks, including Barclays PLC and BCI, on behalf of a putative class of individuals that exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The Court has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently dismissed all Retail Basis Claims against Barclays and all other defendants. Plaintiffs have requested the Court's permission to file an amended complaint.

 

Last Look Actions

In 2015, two putative class actions were filed in the SDNY on behalf of proposed classes of plaintiffs alleging injuries based on Barclays' purported improper rejection of customer trades through Barclays Last Look functionality in Barclays' FX e-trading platforms In 2016, Barclays Bank PLC and BCI paid $50m and settled one of the actions on a class-wide basis. (The other action was voluntarily dismissed.) The deadline for opting out of the class has expired (a small number of class members have opted out), but the Court has not yet granted final approval of the settlement.

 

State Law FX Action

In 2016, a putative class action was filed in the SDNY under federal, New York and California law on behalf of proposed classes of stockholders of Exchange Traded Funds and others who supposedly were indirect investors in FX Instruments. The defendants (including Barclays) moved to dismiss the action. Plaintiffs also filed a complaint on behalf of a proposed class of investors under federal and various state laws who traded FX Instruments through FX dealers or brokers not alleged to have manipulated Foreign Exchange Rates. A different group of plaintiffs subsequently filed another action based on the same theories and asserted substantively similar claims. These two actions have been consolidated and a consolidated complaint was filed in June 2017. Defendants (including Barclays) will move to dismiss the action.

 

Canadian FX Action

Civil actions similar to the Consolidated FX Action have been filed in Canadian courts on behalf of proposed classes of plaintiffs containing similar factual allegations of manipulation of Foreign Exchange rates and of damages resulting from such manipulation, in violation of Canadian law. The parties have reached a settlement in principle for $14.8m which has been preliminary approved by the Court. Payment of $14.8m was made in July 2017.

 

Claimed Amounts/Financial Impact

Aside from the settlements discussed above, the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period is currently uncertain.

 

Civil actions in respect of ISDAFIX

In 2014, a number of ISDAFIX related civil actions were filed in the SDNY on behalf of proposed class of plaintiffs, alleging that Barclays Bank PLC, a number of other banks and one broker violated the Antitrust Act and several state laws by engaging in a conspiracy to manipulate the USD ISDAFIX. In 2016, Barclays Bank PLC and BCI entered into a settlement agreement with plaintiffs to resolve the consolidated action and paid $30m, fully resolving all ISDAFIX-related claims that were or could have been brought by the class. The court has preliminarily approved the settlement, which remains subject to final approval and to the right of class members to opt-out of the settlement and to seek to file their own claims.

 

Claimed Amounts/Financial Impact

The principal financial impact of the actions described on the Group is reflected in the settlement described above.

Metals investigations

Barclays Bank PLC has been providing information to the DOJ, the CFTC and other authorities in connection with investigations into metals and metals-based financial instruments.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

Civil actions in respect of the gold and silver fix

Various civil actions have been filed against Barclays Bank PLC and others alleging manipulation of the prices of gold and silver.

 

Background Information

A number of civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the prices of gold and gold derivative contracts in violation of the CEA, the Antitrust Act, and state antitrust and consumer protection laws.

 

Civil actions have been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc., BCI and Barclays Capital PLC on behalf of proposed classes of plaintiffs containing similar factual allegations of the manipulation of the prices of gold in violation of Canadian law.

 

In the US, a proposed class of plaintiffs has filed an amended complaint in an existing class action relating to silver, adding several non-silver fixing banks, including Barclays Bank PLC, BCI and Barclays Capital Services Ltd. alleging manipulation of the price of silver in violation of CEA and the antitrust laws. 

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

US residential and commercial mortgage-related activity and litigation

There have been various investigations and civil litigation relating to secondary market trading of US residential mortgage-backed securities (RMBS) and US commercial mortgage-backed securities (CMBS).

 

Background Information

The Group's activities within the US residential mortgage sector during the period from 2005 through 2008 included:

 

sponsoring and underwriting of approximately $39bn of private-label securitisations;

economic underwriting exposure of approximately $34bn for other private-label securitisations;

sales of approximately $0.2bn of loans to government sponsored enterprises (GSEs);

sales of approximately $3bn of loans to others; and

sales of approximately $19.4bn of loans (net of approximately $500m of loans sold during this period and subsequently repurchased) that were originated and sold to third parties by mortgage originator affiliates of an entity that the Group acquired in 2007 (Acquired Subsidiary).

 

DOJ Civil Action

In December 2016, the DOJ filed a civil complaint against Barclays Bank PLC, Barclays PLC, BCI., Barclays Group US Inc., Barclays US LLC, BCP LLC, Securitized Asset Backed Receivables LLC and Sutton Funding LLC, as well as two former employees, in the US District Court in the Eastern District of New York (EDNY) containing a number of allegations, including mail and wire fraud, relating to mortgage-backed securities sold between 2005 and 2007. The DOJ complaint seeks, amongst other relief, unspecified monetary penalties. Barclays is defending the complaint and has filed a motion to dismiss. 

 

RMBS Repurchase Requests

The Group was the sole provider of various loan-level representations and warranties (R&Ws) with respect to:

 

approximately $5bn of Group sponsored securitisations;

approximately $0.2bn of sales of loans to GSEs; and

approximately $3bn of loans sold to others.

 

In addition, the Acquired Subsidiary provided R&Ws on all of the $19.4bn of loans it sold to third parties.

 

R&Ws on the remaining Group sponsored securitisations were primarily provided by third-party originators directly to the securitisation trusts with a Group subsidiary, such as the depositor for the securitisation, providing more limited R&Ws. There are no stated expiration provisions applicable to most R&Ws made by the Group, the Acquired Subsidiary or these third parties.

 

Under certain circumstances, the Group and/or the Acquired Subsidiary may be required to repurchase the related loans or make other payments related to such loans if the R&Ws are breached.

 

The unresolved repurchase requests received on or before 30 June 2017 associated with all R&Ws made by the Group or the Acquired Subsidiary on loans sold to GSEs and others and private-label activities had an original unpaid principal balance of approximately $2.1bn at the time of such sale.

 

The unresolved repurchase requests discussed above relate to civil actions that have been commenced by the trustees for certain RMBS securitisations in which the trustees allege that the Group and/or the Acquired Subsidiary must repurchase loans that violated the operative R&Ws. Such trustees and other parties making repurchase requests have also alleged that the operative R&Ws may have been violated with respect to a greater (but unspecified) amount of loans than the amount of loans previously stated in specific repurchase requests made by such trustees. Cumulative realised losses reported at 30 June 2017 on loans covered by R&Ws made by the Group or the Acquired Subsidiary are approximately $1.3bn. This litigation is ongoing.

 

In addition, the Acquired Subsidiary is subject to a more advanced civil action seeking, among other things, indemnification for losses allegedly suffered by a loan purchaser as a result of alleged breaches of R&Ws provided by the Acquired Subsidiary in connection with loan sales to the purchaser during the period 1997 to 2007. This litigation is ongoing.

 

RMBS Securities Claims

As a result of some of the RMBS activities described above, the Group has been party to a number of lawsuits filed by purchasers of RMBS sponsored and/or underwritten by the Group between 2005 and 2008. As a general matter, these lawsuits alleged, among other things, that the RMBS offering materials allegedly relied on by such purchasers contained materially false and misleading statements and/or omissions and generally demanded rescission and recovery of the consideration paid for the RMBS and recovery of monetary losses arising out of their ownership. The Group has resolved the majority of these claims, and only one action currently remains pending.

 

Approximately $0.1bn of the original face amount of RMBS related to the remaining pending action was outstanding as at 30 June 2017. There were virtually no cumulative realised losses reported on these RMBS as at 30 June 2017. The Group does not expect that, if it were to lose the remaining pending action, any such loss to be material.

 

Secondary Trading Investigation

The Group has received requests for information and subpoenas from the SEC, the US Attorney's Office for the District of Connecticut and the Special Inspector General for the US Troubled Asset Relief Program related to trading practices in the secondary market for both RMBS and CMBS. A settlement was announced in May 2017 pursuant to which BCI agreed to resolve this matter for $16.56m, consisting of $15.56m in disgorgement (to be repaid directly to customers) and $1m in a civil penalty (paid to the SEC).

 

Claimed Amounts/Financial Impact

Save for the May 2017 settlement, it is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period. The cost of resolving these actions could individually or in aggregate prove to be substantial.

 

Alternative trading systems and high-frequency trading

The SEC, the New York State Attorney General (NYAG) and regulators in certain other jurisdictions have been investigating a range of issues associated with alternative trading systems (ATSs), including dark pools, and the activities of high-frequency traders.

 

Background Information

In 2014, the NYAG filed a complaint (NYAG Complaint) against Barclays PLC and BCI in the Supreme Court of the State of New York alleging, amongst other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX, the Group's SEC-registered ATS. In February 2016, Barclays reached separate settlement agreements with the SEC and the NYAG to resolve those agencies' claims against Barclays PLC and BCI relating to the operation of LX and paid $35m to each.

 

Barclays PLC and BCI have been named in a purported class action by an institutional financial services firm under California law based on allegations similar to those in the NYAG Complaint. In October 2016, the federal court in California granted the motion of Barclays PLC and BCI to dismiss the entire complaint and plaintiffs have appealed the court's decision.

 

Following the filing of the NYAG Complaint, Barclays PLC and BCI were also named in a putative shareholder securities class action along with certain of its former CEOs, and its current and a former CFO, as well as an employee (Shareholder Class Action). The plaintiffs claim that holders of Barclays American Depository Receipts (ADRs) suffered damages when the ADRs declined in value as a result of the allegations in the NYAG Complaint. A motion to dismiss the complaint filed by the defendants (including Barclays PLC and BCI), was granted in part and denied in part by the court. In February 2016, the court certified the action as a class action which Barclays is appealing.

 

Claimed Amounts/Financial Impact

The class actions seek unspecified monetary damages and injunctive relief. It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

FERC and other civil actions

The US Federal Energy Regulatory Commission (FERC) has filed a civil action against Barclays Bank PLC and certain of its former traders in connection with allegations that Barclays Bank PLC manipulated the electricity markets in the Western US.

 

Background Information

In 2012, FERC issued an Order to Show Cause and Notice of Proposed Penalties (Order and Notice) against Barclays Bank PLC and four of its former traders asserting that Barclays Bank PLC and its former traders violated FERC's Anti-Manipulation Rule by manipulating the electricity markets in and around California from 2006 to 2008, and proposed civil penalties and profit disgorgement to be paid by Barclays Bank PLC.

 

In 2013, FERC filed a civil action against Barclays Bank PLC and its former traders in the US District Court in California seeking to collect a $435m civil penalty and disgorgement of $34.9m of profits, plus interest. In 2015, the US District Court in California ordered that it would bifurcate its assessment of liabilities and penalties from its assessment of disgorgement. In March 2017, the court denied FERC's motion for summary affirmance of the penalty assessment and ordered discovery. 

 

In 2015, a civil class action complaint seeking damages of $139.3m was filed in the US District Court for the SDNY against Barclays Bank PLC by Merced Irrigation District, a California utility company, asserting antitrust allegations in connection with Barclays Bank PLC's purported manipulation of the electricity markets in and around California. The factual allegations mirror those raised in the civil action filed by FERC. In 2016, Barclays Bank PLC motion to dismiss the civil class action for failure to state a claim was granted in part and denied in part by the SDNY. The matter is in discovery.

 

Claimed Amounts/Financial Impact

FERC has made claims against Barclays Bank PLC totalling $469.9m, plus interest, for civil penalties and profit disgorgement. The civil class action complaint refers to damages of $139.3m. These amounts do not necessarily reflect Barclays Bank PLC's potential financial exposure if a ruling were to be made against it in either action.

 

Treasury auction securities civil actions and related matters

Numerous putative class action complaints have been filed in US Federal Courts against BCI and other financial institutions that have served as primary dealers in US Treasury securities. The complaints have been consolidated in the US Federal Court in New York. The complaints generally allege that defendants conspired to manipulate the US Treasury securities market in violation of US federal antitrust laws, the CEA and state common law. Some complaints also allege that defendants engaged in illegal "spoofing" of the US Treasury market.

Certain governmental authorities are conducting investigations into activities relating to the trading of certain government securities in various markets and Barclays has been providing information to various authorities on an ongoing basis.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

American Depositary Shares 

Barclays PLC, Barclays Bank PLC and various former members of Barclays Bank PLC's Board of Directors have been named as defendants in a securities class action consolidated in the SDNY.

 

Background Information

The securities class action against Barclays PLC, Barclays Bank PLC and various former members of Barclays Bank PLC's Board of Directors alleges misstatements and omissions in offering documents for certain American Depositary Shares issued by Barclays Bank PLC in April 2008 with an original face amount of approximately $2.5 billion (the April 2008 Offering). The plaintiffs assert claims under the Securities Act of 1933, alleging misstatements and omissions concerning (amongst other things) Barclays Bank PLC's portfolio of mortgage-related (including US subprime-related) securities, Barclays Bank PLC's exposure to mortgage and credit market risk, and Barclays Bank PLC's financial condition. The plaintiffs have not specifically alleged the amount of their damages. In June 2016, the SDNY certified the action as a class action. Barclays has moved for summary judgement.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the action described on the Group or what effect that it might have upon the Group's operating results, cash flows or financial position in any particular period.

 

BDC Finance L.L.C.

BDC Finance L.L.C. (BDC) has filed a complaint against Barclays Bank PLC alleging breach of contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement (collectively, the Agreement).

 

Background Information

In 2008, BDC filed a complaint in the NY Supreme Court alleging that Barclays Bank PLC breached the Agreement when it failed to transfer approximately $40m of alleged excess collateral in response to BDC's 2008 demand (Demand).

 

BDC asserts that under the Agreement Barclays Bank PLC was not entitled to dispute the Demand before transferring the alleged excess collateral and that even if the Agreement entitled Barclays Bank PLC to dispute the Demand before making the transfer, Barclays Bank PLC failed to dispute the Demand. BDC demands damages totalling $298m plus attorneys' fees, expenses, and pre-judgement interest. A trial on liability issues concluded in April 2017 and the court's decision is pending.

 

In 2011, BDC's investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC's conduct relating to the Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious interference with business and prospective business relations. The parties agreed to stay this case.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period. BDC has made claims against the Group totalling $298m plus attorneys' fees, expenses, and pre-judgement interest. This amount does not necessarily reflect the Group's potential financial exposure if a ruling were to be made against it.

 

Civil actions in respect of the US Anti-Terrorism Act

Civil complaints against Barclays Bank PLC and other banks allege engagement in a conspiracy and violation of the US Anti-Terrorism Act (ATA).

 

Background Information

In 2015, an amended civil complaint was filed in the US Federal Court in the EDNY by a group of approximately 250 plaintiffs, alleging that Barclays Bank PLC and a number of other banks engaged in a conspiracy and violated the ATA by facilitating US dollar denominated transactions for the Government of Iran and various Iranian banks, which in turn funded Hezbollah and other attacks that injured or killed the plaintiffs' family members. Plaintiffs seek to recover for pain, suffering and mental anguish pursuant to the provisions of the ATA, which allows for the tripling of any proven damages and attorneys' fees. Plaintiffs filed a second amended complaint in July 2016, which, among other things, added various plaintiffs, bringing the total number of plaintiffs to approximately 350. In November 2016, defendants filed a motion to dismiss.

 

In November 2016, a separate civil complaint was filed in the US Federal Court in the Southern District of Illinois by a group of approximately 90 plaintiffs, alleging claims under the ATA against Barclays Bank PLC and a number of other banks. The allegations against Barclays Bank PLC are substantially similar to those in the second amended complaint filed in the US Federal Court in the EDNY action in July 2016. Plaintiffs filed an amended complaint in January 2017, which, among other things, added various plaintiffs, bringing the total number of plaintiffs to approximately 200. In April 2017, this action was transferred to the US Federal Court in the EDNY, where it is now pending.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect that they might have upon the Group's operating results, cash flows or financial position in any particular period.

 

Interest rate swap and credit default swap US civil actions

Barclays PLC, Barclays Bank PLC, and BCI, together with other financial institutions are defendants in interest rate swap and credit default swap antitrust civil actions in the SDNY.

 

Background Information

Barclays PLC, Barclays Bank PLC, and BCI, together with other financial institutions that act as market makers for interest rate swaps (IRS), Trade Web, and ICAP, are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages, treble damages and legal fees. Plaintiffs include certain swap execution facilities, as well as buy-side investors. The buy-side investors claim to represent a class that transacted in fixed-for-floating IRS with defendants in the US from 2008 to the present, including, for example, US retirement and pension funds, municipalities, university endowments, corporations, insurance companies and investment funds. Defendants have filed motions to dismiss. In June 2017, a separate suit was filed in the US District Court in the SDNY against the same financial institution defendants in the IRS cases, including Barclays PLC, Barclays Bank PLC, and BCI, claiming that certain conduct alleged in the IRS cases also caused plaintiff to suffer harm with respect to the Credit Default Swaps market. Defendants will also move to dismiss this action.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the actions described on the Group or what effect it have upon the Group's operating results, cash flows or financial position in any particular period.

 

CCUK Finance Limited and CIAC Corporation

In May 2017, Barclays Bank PLC was served with a civil claim by CCUK Finance Limited and CIAC Corporation issued in the English High Court alleging breach of a contractual indemnity, fraudulent misrepresentation and breach of warranty arising out of the sale of a portfolio of credit cards in 2007. Barclays Bank PLC has filed a defence and counterclaim. 

 

Claimed Amounts/Financial Impact

The claim seeks damages of not less than £1bn plus interest and costs. The damages claimed does not necessarily reflect Barclays Bank PLC's potential financial exposure if a ruling were to be made against it. It is not currently practicable to provide an estimate of the financial impact of the action described or what effect it might have upon operating results, cash flows or the Group's financial position in any particular period.

 

Portuguese Competition Authority investigation

The Portuguese Competition Authority is investigating whether competition law was infringed by the exchange of information about retail credit products amongst 15 banks in Portugal, including the Group, over a period of 11 years with particular reference to mortgages, consumer lending and lending to small and medium enterprises. The Group is cooperating with the investigation.

 

Claimed Amounts/Financial Impact

It is not currently practicable to provide an estimate of the financial impact of the action described or what effect it might have upon operating results, cash flows or the Group's financial position in any particular period.

 

General

The Group is engaged in various other legal, competition and regulatory matters in the UK and US and a number of other overseas jurisdictions. It is subject to legal proceedings by and against the Group which arise in the ordinary course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud, trusts, client assets, competition, data protection, money laundering, financial crime, employment, environmental and other statutory and common law issues.

 

The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in which the Group is or has been engaged. The Group is co-operating with the relevant authorities and keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis.

 

At the present time, the Group does not expect the ultimate resolution of any of these other matters to have a material adverse effect on its financial position. However, in light of the uncertainties involved in such matters and the matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters will not be material to the Group's results of operations or cash flow for a particular period, depending on, amongst other things, the amount of the loss resulting from the matter(s) and the amount of income otherwise reported for the reporting period.

 

 

20. Related party transactions

No related party transactions that have taken place in the half year ended 30 June 2017 have materially affected the financial position or the performance of the Group during this period.

 

Barclays Africa Group Limited

On 1 June 2017, Barclays reduced its holding in BAGL to 16.4% of BAGL's issued share capital with an obligation to contribute to a BEE scheme leaving a residual holding of 14.9%. This resulted in accounting deconsolidation of BAGL from the Group, with the holding recognised as an available for sale investment. For further detail, see Note 4.

 

As a consequence of the Group no longer being considered to have a significant influence over BAGL, it ceased to be a related party of the Group on 1 June 2017.

 

Other related party transactions

Other related party transactions in the half year ended 30 June 2017 were similar in nature to those disclosed in the 2016 Annual Report.

 

21. Segmental reporting

 

Analysis of results by business

Barclays

UK

Barclays

International

Head

Office

Barclays

Core1

Barclays

Non-Core2

Barclays

Group

Half year ended 30.06.17

£m

£m

£m

£m

£m

£m

Total income net of insurance claims

3,661

7,748

2

11,411

(530)

10,881

Credit impairment charges and other provisions

(398)

(625)

(1)

(1,024)

(30)

(1,054)

Net operating income

3,263

7,123

1

10,387

(560)

9,827

Operating expenses

(2,628)

(4,720)

(100)

(7,448)

(284)

(7,732)

Other net (expenses)/income3

(1)

214

(164)

49

197

246

Profit before tax

634

2,617

(263)

2,988

(647)

2,341

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

203.4

681.6

17.3

902.3

233.0

1,135.3

 

Analysis of results by business

Barclays

UK

Barclays

International

Head

Office

Barclays

Core

Barclays

Non-Core

Barclays

Group

Half year ended 30.06.16

£m

£m

£m

£m

£m

£m

Total income net of insurance claims

3,746

7,552

301

11,599

(586)

11,013

Credit impairment charges and other provisions

(366)

(509)

(1)

(876)

(55)

(931)

Net operating income

3,380

7,043

300

10,723

(641)

10,082

Operating expenses

(2,299)

(4,309)

(139)

(6,747)

(950)

(7,697)

Other net (expenses)/income2

(1)

19

(27)

(9)

(313)

(322)

Profit before tax

1,080

2,753

134

3,967

(1,904)

2,063

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

204.6

679.9

87.7

972.2

379.1

1,351.3

 

 

1

Barclays Core consists of Barclays UK, Barclays International and Head Office.

2

Barclays Non-Core segment was closed on 1 July 2017, with prospective financial performance being reintegrated into Barclays UK, Barclays International and Head Office.

3

Other net (expenses)/income represents: profit or (loss) on disposal of undertakings, share of results of associates and joint ventures, and impairment on assets held for sale.

 

 

Half year ended

Half year ended

Split of income by geographic region1

30.06.17

30.06.16

£m

£m

UK

5,649

5,915

Europe

731

1,159

Americas

4,093

3,417

Africa and Middle East

139

191

Asia

269

331

Total

10,881

11,013

 

1

The geographic region is based on counterparty location.

 

22. Barclays PLC parent balance sheet

 

As at

As at

30.06.17

31.12.16

Assets

£m

£m

Investment in subsidiaries

37,803

36,553

Loans and advances to subsidiaries

25,200

19,421

Financial investments

1,286

1,218

Derivative financial instruments

148

268

Other assets

106

105

Total assets

64,543

57,565

Liabilities

Deposits from banks

515

547

Subordinated liabilities

5,236

3,789

Debt securities in issue

21,225

16,893

Other liabilities

68

14

Total liabilities

27,044

21,243

Equity

Called up share capital

4,258

4,241

Share premium account

17,740

17,601

Other equity instruments

7,697

6,453

Other reserves

473

420

Retained earnings

7,331

7,607

Total equity

37,499

36,322

Total liabilities and equity

64,543

57,565

 

 

Investment in subsidiary

The investment in subsidiary of £37,803m (December 2016: £36,553m) represents investments made into Barclays Bank PLC, including £7,736m (December 2016: £6,486m) of Additional Tier 1 (AT1) securities. The increase of £1,250m during the period was driven by a £1,250m AT1 issuance by Barclays PLC during the first quarter.

 

Loans and advances to subsidiary, subordinated liabilities and debt securities in issue

During H117, Barclays PLC issued $2.0bn of Fixed Rate Subordinated Notes included within the subordinated liabilities balance of £5,236m (December 2016: £3,789m), and $5.0bn of Fixed and Floating Rate Senior Notes and £0.95bn of Fixed Rate Senior Notes included within the debt securities in issue balance of £21,225m (December 2016: £16,893m). The proceeds raised through these transactions were used to invest in Barclays Bank PLC Notes in each case with a ranking corresponding to the notes issued by Barclays PLC and included within the loans and advances to subsidiary balance of £25,200m (December 2016: £19,421m) and financial investments balance of £1,286m (December 2016 £1,218m).

 

Management of internal investments, loans and advances

Barclays PLC retains the discretion to manage the nature of its internal investments in the subsidiaries according to their regulatory and business needs. As we implement our structural reform programme, Barclays PLC will invest capital and funding to Barclays Bank PLC and other Group subsidiaries such as the Group service company, the US IHC and the UK ring-fenced bank.

 

Appendix: Non-IFRS Performance Measures

 

The Barclays management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the business' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of Barclays PLC and its subsidiaries (the Group). They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management.

Any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

 

Non-IFRS performance measures glossary

 

Measure

Definition

Barclays Core

Barclays Core includes Barclays UK, Barclays International and Head Office. A reconciliation of Core statutory results is included on page 95.

 

Return on average tangible shareholders' equity

 

Statutory profit after tax attributable to ordinary shareholders, including an adjustment for the tax credit in reserves in respect of other equity instruments, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 96-97.

 

Return on average allocated tangible shareholders' equity

 

Statutory profit after tax attributable to ordinary shareholders, including an adjustment for the tax credit in reserves in respect of other equity instruments, as a proportion of average allocated tangible shareholders' equity. The components of the calculation have been included on pages 96-97.

 

Period end allocated tangible equity

Allocated tangible equity is calculated as 12.0% (2016: 11.5%) of CRD IV fully loaded risk weighted assets for each business, adjusted for CRD IV fully loaded capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office tangible equity represents the difference between the Group's tangible equity and the amounts allocated to businesses.

 

Average tangible shareholders' equity

Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period.

 

Average allocated tangible shareholders' equity

Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible shareholders' equity for the period is the average of the monthly averages within that period.

 

Cost: income ratio

Total operating expenses divided by total income.

 

Basic earnings/(loss) per share contribution (Barclays Core and Non-Core)

 

The calculation is consistent with the IFRS measure and applied to the Barclays Core and Non-Core: statutory profit after tax attributable to ordinary shareholders, including an adjustment for the tax credit in reserves in respect of other equity instruments, divided by the Group basic weighted average number of shares. The components of the calculation have been included on page 98.

 

Loan loss rate

 

Is quoted in basis points and represents total annualised loan impairment divided by gross loans and advances to customers and banks held at amortised cost at the balance sheet date.

 

Loan: deposit ratio

 

Loans and advances divided by customer accounts calculated for Barclays UK, Barclays International and Non-Core, excluding investment banking businesses. This excludes particular liabilities issued by the retail businesses that have characteristics comparable to retail deposits (for example structured Certificates of Deposit and retail bonds), which are included within debt securities in issue.

 

Net interest margin

 

Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 30.

 

Tangible net asset value per share

Calculated by dividing shareholders equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 98.

 

Barclays Core Reconciliation

 

Half year ended 30.06.17

Half year ended 30.06.16

Barclays UK

Barclays International

Head Office

Barclays Core

Barclays UK

Barclays International

Head Office

Barclays Core

£m

£m

£m

£m

£m

£m

£m

£m

Total income

3,661

7,748

2

11,411

3,746

7,552

301

11,599

Credit impairment charges and other provisions

(398)

(625)

(1)

(1,024)

(366)

(509)

(1)

(876)

Net operating income

3,263

7,123

1

10,387

3,380

7,043

300

10,723

Operating expenses excluding litigation and conduct

(1,933)

(4,711)

(89)

(6,733)

(1,899)

(4,295)

(121)

(6,315)

Litigation and conduct

(695)

(9)

(11)

(715)

(400)

(14)

(18)

(432)

Operating expenses

(2,628)

(4,720)

(100)

(7,448)

(2,299)

(4,309)

(139)

(6,747)

Other net (expenses)/income

(1)

214

(164)

49

(1)

19

(27)

(9)

Profit/(loss) before tax

634

2,617

(263)

2,988

1,080

2,753

134

3,967

Attributable profit/(loss)

185

1,656

(298)

1,543

608

1,746

90

2,444

Average allocated tangible equity (£bn)

8.8

27.5

8.2

44.5

9.1

25.0

5.8

39.9

Risk weighted assets (£bn)

66.1

212.2

26.2

304.6

67.1

209.3

43.2

319.6

 

Returns

 

Return on average allocated tangible equity is calculated as profit for the period attributable to ordinary equity holders of the parent (adjusted for the tax credit recorded in reserves in respect of interest payments on other equity instruments) divided by average allocated tangible equity for the period as appropriate, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 12.0% (2016: 11.5%) of CRD IV fully loaded risk weighted assets for each business, adjusted for CRD IV fully loaded capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average tangible equity represents the difference between the Group's average tangible equity and the amounts allocated to businesses.

 

Half year ended

Half year ended

30.06.17

30.06.16

Attributable profit

£m

£m

Barclays UK

185

608

Corporate and Investment Bank

1,083

868

Consumer, Cards and Payments

573

878

Barclays International

1,656

1,746

Head Office

(298)

90

Barclays Core

1,543

2,444

Barclays Non-Core

(419)

(1,490)

Africa Banking discontinued operation

(2,335)

156

Barclays Group

(1,211)

1,110

Tax credit in respect of interest payments on other equity instruments

Barclays UK

18

14

Corporate and Investment Bank

45

35

Consumer, Cards and Payments

9

5

Barclays International

54

40

Head Office

-

(4)

Barclays Core

72

50

Barclays Non-Core

10

8

Africa Banking discontinued operation

-

-

Barclays Group

82

58

Profit/(loss) attributable to ordinary equity holders of the parent

Barclays UK

203

622

Corporate and Investment Bank

1,128

903

Consumer, Cards and Payments

582

883

Barclays International

1,710

1,786

Head Office

(298)

86

Barclays Core

1,615

2,494

Barclays Non-Core

(409)

(1,482)

Africa Banking discontinued operation

(2,335)

156

Barclays Group

(1,129)

1,168

Half year ended

Half year ended

30.06.17

30.06.16

Average allocated tangible equity

£bn

£bn

Barclays UK

8.8

9.1

Corporate and Investment Bank

23.3

21.5

Consumer, Cards and Payments

4.2

3.5

Barclays International

27.5

25.0

Head Office1

8.2

5.8

Barclays Core

44.5

39.9

Barclays Non-Core

4.9

8.5

Barclays Group

49.4

48.3

Return on average allocated tangible equity

%

%

Barclays UK

4.6%

13.6%

Corporate and Investment Bank

9.7%

8.4%

Consumer, Cards and Payments

28.0%

50.9%

Barclays International

12.4%

14.3%

Barclays Core2

7.3%

12.5%

Barclays Group

(4.6%)

4.8%

 

Returns excluding charges for PPI, impairment of Barclays' holding in BAGL and loss on the sale of BAGL

 

Half year ended

 

30.06.17

 

£m

 

Barclays Core profit attributable to ordinary equity holders

1,615

 

Impact of charges for PPI

(692)

 

Barclays Core profit attributable to ordinary equity holders of the parent excluding charges for PPI

2,307

 

 

Average allocated tangible equity

£bn

 

Barclays Core

44.5

 

 

Return on average allocated tangible equity excluding charges for PPI

%

 

Barclays Core2

10.4%

 

 

£m

 

Barclays Group profit attributable to ordinary equity holders

(1,129)

 

Impact of charges for PPI

(692)

 

Impact of impairment of Barclays' holding in BAGL

(1,008)

 

Impact of loss on the sale of BAGL

(1,435)

 

Barclays Group profit attributable to ordinary equity holders of the parent excluding charges for PPI, impairment of Barclays' holding in BAGL and loss on the sale of BAGL

2,006

 

 

Average allocated tangible equity

£bn

 

Barclays Group

49.4

 

 

Return on average allocated tangible equity excluding charges for PPI, impairment of Barclays' holding in BAGL and loss on the sale of BAGL

 

%

 

Barclays Group

8.1%

 

 

 

1

Includes the Africa Banking discontinued operation.

2

Includes Head Office.

 

Earnings per share

Half year ended

Half year ended

30.06.17

30.06.16

Profit/(loss) attributable to ordinary equity holders of the parent1

£m

£m

Barclays Core

1,615

2,494

Barclays Non-Core

(409)

(1,482)

Africa Banking discontinued operation

(2,335)

156

Barclays Group

(1,129)

1,168

m

m

Basic weighted average number of shares

16,989

16,859

Basic earnings per ordinary share

p

p

Barclays Core contribution

9.5

14.8

Barclays Non-Core contribution

(2.4)

(8.8)

Barclays Group

(6.6)

6.9

 

 

 

Earnings per share excluding charges for PPI, impairment of Barclays' holding in BAGL and loss on the sale of BAGL

Half year ended

30.06.17

Profit attributable to ordinary equity holders of the parent excluding charges for PPI, impairment of Barclays' holding in BAGL and loss on the sale of BAGL

£m

Barclays Group profit attributable to ordinary equity holders

(1,129)

Impact of charges for PPI

(692)

Impact of impairment of Barclays' holding in BAGL

(1,008)

Impact of loss on the sale of BAGL

(1,435)

Barclays Group profit attributable to ordinary equity holders of the parent excluding charges for PPI, impairment of Barclays' holding in BAGL and loss on the sale of BAGL

2,006

m

Basic weighted average number of shares

16,989

Basic earnings per ordinary share excluding charges for PPI, impairment of Barclays' holding in BAGL and loss on the sale of BAGL

p

Barclays Group

11.8

 

 

1

The profit after tax attributable to other equity holders of £301m (H116: £208m) is offset by a tax credit recorded in reserves of 82m (H116: £58m). The net amount of £219m (H116: £150m), along with non-controlling interests (NCI) is deducted from profit after tax in order to calculate earnings per share and return on average tangible shareholders' equity.

 

Tangible net asset value

As at

As at

30.06.17

31.12.16

£m

£m

Total equity excluding non-controlling interests

63,866

64,873

Other equity instruments

(7,694)

(6,449)

Goodwill and intangibles1

(7,724)

(9,245)

Tangible shareholders' equity attributable to ordinary shareholders of the parent

48,448

49,179

m

m

Shares in issue

17,034

16,963

p

p

Tangible net asset value per share

284

290

 

 

1

Comparative figures include goodwill and intangibles in relation to Africa Banking.

 

Shareholder Information

Results timetable1

Date

Ex-dividend date

10 August 2017

Dividend Record date

11 August 2017

Scrip reference share price set and made available to shareholders

17 August 2017

Cut off time of 4.30 pm (London time) for the receipt of Mandate Forms or Revocation Forms (as applicable)

25 August 2017

Dividend Payment date /first day of dealing in New Shares

18 September 2017

Q3 2017 Results Announcement

31 October 2017

For qualifying US and Canadian resident ADR holders, the interim dividend of 1.0p per ordinary share becomes 4.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above.

% Change3

Exchange rates2

30.06.17

31.12.16

30.06.16

31.12.16

30.06.16

Period end - US$/£

1.30

1.23

1.34

6%

(3%)

6 month average - US$/£

1.26

1.28

1.43

(2%)

(12%)

3 month average - US$/£

1.28

1.24

1.43

3%

(10%)

Period end - €/£

1.14

1.17

1.21

(3%)

(6%)

6 month average - €/£

1.16

1.16

1.29

-

(10%)

3 month average - €/£

1.16

1.15

1.27

1%

(9%)

Period end - ZAR/£

16.98

16.78

19.63

1%

(13%)

6 month average - ZAR/£

16.61

17.90

22.17

(7%)

(25%)

3 month average - ZAR/£

16.85

17.29

21.51

(3%)

(22%)

Share price data

30.06.17

31.12.16

30.06.16

Barclays PLC (p)

202.75

223.45

138.60

Barclays PLC number of shares (m)

17,034

16,963

16,913

 Barclays Africa Group Limited (formerly Absa Group Limited) (ZAR)

143.75

168.69

144.08

 Barclays Africa Group Limited (formerly Absa Group Limited) number of shares (m)

848

848

848

For further information please contact

Investor relations

Media relations

Kathryn McLeland +44 (0) 20 7116 4943

Thomas Hoskin +44 (0) 20 7116 4755

More information on Barclays can be found on our website: home.barclays

Registered office

1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839

Registrar

Equiniti, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA United Kingdom.

Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas.

 

 

1

Note that these announcement dates are provisional and subject to change. Any changes to the Scrip Dividend Programme dates will be made available at home.barclays/dividends.

2

The average rates shown above are derived from daily spot rates during the year.

3

The change is the impact to GBP reported information.

4

Lines open 8.30am to 5.30pm UK time, Monday to Friday, excluding UK public holidays in England and Wales.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUUPMUPMPWM
Date   Source Headline
30th Mar 20217:00 amRNSResults of placing in Gamma Communications
29th Mar 20214:47 pmRNSProposed placing in Gamma Communications
16th Mar 20217:00 amRNSResults of placing in Wizz Air
15th Mar 20214:44 pmRNSProposed placing in Wizz Air
9th Mar 20215:25 pmRNSFCA Combined Supplement 2 of 2020
18th Feb 20216:25 pmRNSAnnual Report on Form 20-F
18th Feb 202110:47 amRNSFCA Supplement 1_2020 Barclays Bank Ireland BP16
18th Feb 202110:46 amRNSFCA Supplement 2_2020_Barclays Bank Ireland BP9
18th Feb 202110:39 amRNSFCA Combined Supplement 1_2020 - RNS Announcement
18th Feb 20217:00 amRNSAnnual Financial Report
17th Feb 20217:00 amRNSResults of placing in Hargreaves Lansdown
16th Feb 20214:41 pmRNSProposed placing in Hargreaves Lansdown
29th Jan 20213:16 pmRNSPublication of Suppl.Prospcts
15th Jan 20214:42 pmRNSNotice to Holders of Results of Adjourned Meeting
7th Jan 20213:45 pmRNSFinal Result of Tender Offer to Noteholders
21st Dec 20203:45 pmRNSResult of Tender Offer to Noteholders
16th Dec 20206:27 pmRNSNotice to Security Holders of Results of Meetings
16th Dec 20206:27 pmRNSNotice of Security Holders Adjourned Meetings
16th Dec 20206:26 pmRNSNotice to Security Holders of Results of Meetings
9th Dec 20203:31 pmRNSPublication of a Prospectus
7th Dec 20205:52 pmRNSTender Offer to Noteholders
24th Nov 20201:45 pmRNSAmendment - Notice to holders of Securities
23rd Nov 20207:37 amRNSNotice to holders of outstanding Securities
5th Oct 202010:28 amRNSPost Stab- Commerzbank AT1 No Stabilisation Notice
1st Oct 20207:00 amRNSDirectorate Change
15th Sep 20207:00 amRNSResults of placing in Watches of Switzerland Group
14th Sep 20204:50 pmRNSProposed placing in Watches of Switzerland Group
8th Sep 20208:23 amRNSPre-Stabilisation Notice - Commerzbank AT1
28th Aug 20207:00 amRNSNotice of Redemption
26th Aug 20205:24 pmRNSPublication of BP2 pursuant to the GSSP
12th Aug 202011:36 amRNSArticle 8
12th Aug 202011:10 amRNSArticle 8
7th Aug 202010:50 amRNSPublication of Suppl.Prospcts
29th Jul 20207:00 amRNSHalf-year Report
17th Jul 20202:59 pmRNSPost Stabilisation Notice Exxon - no stabilisation
17th Jul 202011:32 amRNSAnnouncement of Partial Redemption
30th Jun 20202:20 pmRNSPublication of 2020 GSSP Base Prospectus 16
26th Jun 20202:23 pmRNSArticle 8
23rd Jun 20203:06 pmRNSExxon Pre-Stabilisation Notice
22nd Jun 202010:22 amRNSArticle 8
19th Jun 20204:51 pmRNSArticle 8
12th Jun 202012:56 pmRNSBarclays PLC Post Stabilisation Notice
20th May 20205:11 pmRNSArticle 8
15th May 20204:51 pmRNSPublication of Suppl.Prospcts
15th May 20202:32 pmRNSBarclays PLC T2 Pre-Stabilisation Notice
14th May 20203:22 pmRNSArticle 8
12th May 202011:00 amRNSDoc re. rights attached to debt securities
4th May 20204:45 pmRNSPublication of a Prospectus
6th Apr 20205:18 pmRNSDelisting Notice
31st Mar 20201:05 pmRNSNotice to Noteholders Series 11492 Class MV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.